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ABSTRACT 
Mitochondria are double membrane-bound organelles that play a significant role in 
producing energy for the cell, as well as mediating an array of metabolic pathways. Long-lived 
mitochondria that are unable to sustain the energetic requirements of the cell are targeted for 
lysosomal degradation through a process termed mitophagy. Parkin is a ubiquitin ligase that is 
involved in mitophagy and the turnover of mitochondria. Parkin is extensively studied in neuronal 
tissue, but its role in skeletal muscle has not been fully explored. The overall purpose of this 
dissertation was to examine the effects of aging and exercise on Parkin-mediated mitophagy in 
skeletal muscle.  
 We first investigated the role of Parkin in the regulation of mitophagy during exercise in 
young and old muscle. To do this, we subjected young and aged groups of wild-type (WT) and 
Parkin knockout (KO) mice to an acute bout of endurance exercise. We found a robust exercise-
induced rise in mitophagy flux in young WT animals, but did not observe this in the absence of 
Parkin. Basal mitophagy flux was elevated in aged animals, but this did not increase additionally 
with exercise. We also noted a reduced transcriptional drive towards mitochondrial biogenesis in 
KO and aged animals. The results demonstrate that acute exercise can selectively increase 
mitochondrial targeting for degradation, and that this process is dependent on Parkin, as well as 
with age.  
 We next focused on the role of Parkin in mitochondrial turnover with endurance training. 
We found that mitophagy flux did not increase with training, but that flux lessened with a 
subsequent bout of acute exercise. This exercise-induced adaptation was not observed in trained 
KO animals. Our data indicate that exercise-induced mitochondrial biogenesis diminishes Parkin-
mediated mitophagy as an adaptive response to repeated bouts of exercise.  
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 The significance of this research is that we have indicated a role for Parkin in maintaining 
mitochondrial turnover, and show that Parkin can facilitate mitophagy, dependent on organelle 
content and quality in skeletal muscle.  
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CHAPTER 1: 
INTRODUCTION 
Skeletal muscle plays a significant role in locomotion and whole-body metabolism. 
Beyond its fundamental role in movement, muscle displays a remarkable ability to adapt to 
different imposed metabolic stressors. The understanding of muscle plasticity, and how it 
contributes to our overall well-being, is a highly relevant area of investigation. The degree to which 
these transformations occur is in part due to changes in mitochondrial turnover. Mitochondria are 
considered for their primary function as energy producers for the cell. However, it is also 
recognized that mitochondria are highly dynamic structures that can regulate the phenotype of 
muscle fibres by the induction of several signaling pathways.  
Endurance training can improve the oxidative capacity of muscle. This can be achieved 
through the activation of mitochondrial biogenesis, which allows for greater organelle density and 
improved substrate fuel utilization. Conversely, a decrease in mitochondrial content can lower 
ATP production while enhancing muscle fatigability, and this can consequently promote muscle 
atrophy. These detrimental effects are observed in sarcopenia, which is the age-related loss of 
muscle mass and function. Aged muscle also displays mitochondria that are prone to producing 
greater reactive oxygen species that can yield macromolecular damage. This can create a vicious 
cycle that accelerates cellular damage in muscle with advancing age.  
Parkin is a ubiquitin ligase responsible for the selective targeting of long-lived, damaged 
mitochondria. This process is termed mitophagy and can aid in mitochondrial turnover. Parkin-
mediated mitophagy is well-studied in neurodegeneration. Furthermore, mitophagy has been 
demonstrated to be altered under different disease states, including heart failure, diabetes, and 
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aging. The balance between organelle biogenesis and degradation is essential to maintain 
mitochondrial content and energetic homeostasis. 
However, a clear understanding of the molecular mechanisms that govern Parkin and 
mitochondrial turnover is lacking. Furthermore, the importance of Parkin and mitophagy in 
regulating skeletal muscle health remains undetermined. The study of this relationship under 
different physiological states (i.e. exercise and aging) will markedly improve our knowledge of 
muscle plasticity. In North America, an aging population is growing, with more people recognizing 
that maintaining an active lifestyle is essential for long-term health. The expansion of our 
knowledge on the molecular underpinnings that govern mitochondrial turnover during exercise 
can help older individuals achieve a longer and greater quality of life. Exercise is an effective 
prescription to enhance mitochondrial quality control that, in turn, can enhance skeletal muscle 
function and promote healthy aging.  
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CHAPTER 2: 
LITERATURE REVIEW 
2.1 Skeletal Muscle and Mitochondria 
2.1.1. Skeletal muscle plasticity 
 Skeletal muscle is a metabolic organ involved in movement, posture and breathing. It 
contains an architectural array of enzymes and muscle-specific protein isoforms that control force 
production. The elegant coordination of these structures provide muscle with the intrinsic ability 
to induce different biochemical and metabolic characteristics. This malleable property is called 
plasticity and allows for the muscle to adapt to various stimuli such as endurance training, disuse 
and aging. Alterations in gene expression and protein translation arise for these adaptations to 
occur. To understand these molecular conundrums following contractile perturbations, 
physiologists require a fundamental understanding of muscle structure and function   
 Excitation of a muscle is coupled with a sequential number of events that evoke contraction 
(Figure 1). Depolarization at the pre-synaptic membrane of an α-motorneuron unleashes increased 
quantal amounts of acetylcholine at the neuromuscular junction. Acetylcholine diffuses across the 
synaptic cleft and binds onto nicotinic acetylcholine channel receptors on the sarcolemma 
membrane of the muscle fibre. Opening of the channels allows for the rapid entrance of sodium 
ions and depolarization at the postsynaptic membrane. The propagation of the muscle action 
potential transverses into tubules and activate voltage-gated dihydropyridine receptors (26, 359). 
These receptors directly interact with ryanodine calcium release channels located on the lateral 
sacs of the sarcoplasmic reticulum (SR) (95). Calcium discharge allows for increased calcium 
binding on myofilaments to enhance cross-linking and generate force. Sarcomeric relaxation 
occurs when calcium-ATPase pumps calcium into the lateral sacs of the SR. These energy 
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demanding events are met by adjacent mitochondria to the calcium release channels. Mitochondria 
perform as calcium “sinks”, and the transient increase in organelle calcium stimulates oxidative 
phosphorylation (OXPHOS) and ATP production (35). This signaling is bi-directional as local 
mitochondrial reactive oxygen species (ROS) emission can affect ryanodine calcium release 
activity (381, 474). The importance of this interplay between mitochondria and muscle function 
have been exemplified many times in the research. In the following section, a review on the 
functional properties of muscle mitochondria will be given.  
2.1.2. Electron transport chain 
 Mitochondria are double-membrane bound organelles that have evolved to support 
eukaryotic cells and their energetic requirements. A majority of this energy is produced within the 
mitochondrial matrix, which houses the citric acid cycle. The process begins with the entry of 
catabolized macromolecules (i.e. carbohydrates, fatty acids and proteins) as a two-carbon atom 
product acetyl coenzyme A. Through a series of carefully controlled chemical reactions, the citric 
acid cycle manufactures two fully reduced substrates: nicotinamide adenine dinucleotide (NADH) 
and flavin adenine dinucleotide (FADH2). Both molecules are shuttled and oxidized by the electron 
transport chain (ETC) to aid in OXPHOS. The ETC is positioned on the inner mitochondrial 
membrane (IMM) and contain five complexes (Figure 2). Briefly, NADH is oxidized by complex 
I NADH dehydrogenase and ensures the translocation of protons across the IMM into the 
intermembrane space (IMS), and the generation and transfer of NADH’s electrons to complex III 
cytochrome bc1 complex. Electrons are liberated from FADH2 at complex II succinate 
dehydrogenase and transferred to complex III. Protons are driven across the IMM as electrons are 
transported through complexes III and IV. Electrons are terminally accepted at complex IV 
cytochrome c oxidase, where oxygen is reduced to water. The accretion of protons in the  
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IMS generates a membrane potential across the IMM. Release of this potential energy occurs when 
hydrogen atoms re-enter the matrix through complex V ATP synthase, as ADP is converted to 
energy-rich ATP in the matrix (292). ADP is transported from the cytosol by IMM adenine 
nucleotide translocator in exchange for matrix ATP, providing mitochondrial energy to the cytosol 
(112, 280).   
2.1.3. Reactive oxygen species  
 Within each ETC complex is a redox site that can leak electrons to oxygen within the 
organelle. The one-electron reduction of oxygen can generate superoxide anions and can become 
a precursor for reactive oxygen species (ROS) (440). The rate of ROS production is dependent on 
mitochondria that are basally (state IV) or actively (state III) respiring. In a basal state, there is a 
lower rate of electron transport and higher backpressure of electrons. This provides a fortuitous 
opportunity for ROS formation. Superoxide anions generally reside in the matrix or IMS (124), or 
can be carried out to the cytosol by voltage-dependent anion channels (VDACs) (123). ROS-
induced cellular damage is an effect of imbalanced, excessive formation of ROS and limited 
antioxidant defenses. Sustained oxidative stress can yield damage to DNA, lipids and proteins. 
Mitochondrial DNA is highly susceptible to ROS, due to its uncoiled conformation and lack of 
proofreading enzymes, compared to nuclear DNA (436). Superoxide dismutases (SODs) can 
counteract oxidative stress by converting superoxide anions into less damaging species of oxygen 
and hydrogen peroxide. Mitochondrial matrix SOD contains manganese at its catalytic site, 
whereas the cytoplasmic SOD isozyme contains copper and zinc (440). Glutathione peroxidase 
and catalase can further reduce hydrogen peroxide into water (270). Attenuated expression of these 
enzymes is believed to accelerate muscle wasting with age (414, 445), and supports the free radical 
theory of aging (133).  
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2.1.4. Mitochondrial protein import  
Mitochondria exist in a dynamic reticular network (216) and assist in muscle energy 
distribution (105). An organelle that is unable to recover from oxidative damage can segregate 
from this network for targeted degradation (see next section on mitochondrial quality control) 
(174). Healthy mitochondria can coalesce and form a network that enhances bioenergetic function 
(387). The mitochondrial network is responsive to its environment and contributes to the adaptive 
plasticity of muscle (318). For the expansion of the reticular network to occur, the coordination of 
mitochondrial and nuclear genomes is required. Many of the proteins in the mitochondrial 
proteome are encoded within the nucleus, while approximately 1% are encoded by mitochondrial 
DNA. The expression of nuclear genes encoding mitochondrial proteins (NUGEMPs) is regulated 
by transcriptional factors (e.g. PGC-1α) and they are translated in the cytosol as precursor proteins. 
The majority of mitochondrial proteins carry amino-terminal pre-sequences that are recognized by 
receptors found on the OMM (310) (Figure 2). With the assistance of molecular chaperones, heat-
shock protein (Hsp) 70 and mitochondrial-import stimulation factor (MSF), mitochondrial 
preproteins are unfolded and transferred to the translocases of the outer membrane (TOM) complex 
(291, 480). Once through the TOM complex, preproteins are subsequently imported into the 
matrix, OMM, IMM, or IMS. Matrix-destined proteins depend on specialized translocases of the 
inner membrane (Tim23 complex) and pre-sequence translocase-associated motors (PAM 
complex) for their transport across the IMM (466). A membrane potential is essential to generate 
an electrophoretic effect on the positively charged pre-sequence, “pulling” the preprotein into the 
matrix where the pre-sequence is cleaved by mitochondrial processing peptidase (MPP) (19, 336, 
466). Protein refolding occurs with molecular chaperones (Hsp60 and Hsp10) soon after the 
protein’s arrival in the matrix.  
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2.1.5. Subsarcolemmal (SS) and intermyofibrillar (IMF) mitochondria 
 Electron microscopy studies have detected two distinct populations of muscle 
mitochondria. SS mitochondria are located underneath the sarcolemmal membrane, often near 
myonuclei, and IMF mitochondria that are localized between myofibrils (216, 303, 317). The two 
populations differ morphologically where SS mitochondria are generally observed as spherical and 
lack organelle connectivity (205, 317, 337), while IMF mitochondria are elongated and exist in a 
reticular network near the Z-lines of sarcomeres (15, 216, 337). Mitochondrial populations can be 
isolated via homogenization and centrifugation (229). The characterization of SS and IMF 
mitochondria have yielded subtle, but divergent biochemical and functional differences. SS 
mitochondria exhibit a higher membrane potential, which may predispose them to ROS production 
(2). Free radicals produced by SS mitochondria may serve as signaling molecules, based on the 
proximity of SS to the myonuclei for gene expression (155) and to capillaries for transport (106). 
Access to blood flow can provide SS mitochondria with the ability to oxidize fatty acids (225). On 
the other hand, IMF mitochondria can respire in greater amounts both basally and in response to 
ADP (63, 229). This, in turn, can generate an elevated amount of matrix ATP that is required for 
IMF mitochondrial protein import (419) and protein synthesis (63). When compared to SS 
mitochondria, IMF mitochondria express a greater number of proteins required for OXPHOS (94). 
Together, these data suggest that IMF mitochondria have a greater propensity to generate the ATP 
required for contractile activity, based on their myofibril juxtaposition. Thus, the divergent 
functional properties of SS and IMF mitochondria allow for these two populations of mitochondria 
to adapt differently to muscle aging (52, 267), and in response to exercise (1, 417) (Table 1). These 
mitochondrial differences and their role in contributing to muscle plasticity will be elaborated in 
the aging and training adaptation sections of this literature review.   
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2.2 Mitochondria Quality Control  
Mitochondria lie at the intersection of health, longevity and disease. Proper maintenance 
of the organelle is critical for cellular and tissue function. As such, continual mitochondrial 
surveillance is essential to maintain energetic homeostasis within the cell. When mitochondria 
become damaged, mechanisms are swiftly activated to restore mitochondrial function. Due to the 
post-mitotic nature of skeletal muscle, dilution of dysfunctional mitochondria through cellular 
division is unable to occur. Consequently, intracellular pathways have evolved to defend skeletal 
muscle cells from this caveat. Recent scientific advances have illuminated mitochondrial specific 
quality control mechanisms that are stress-dependent. Contingent on the level of organelle injury, 
mitochondria can undergo several cellular checkpoints before elimination from the cell (Figure 
3).  
2.2.1. Mitochondrial dynamics: Fusion and fission 
A primary feature of mitochondrial dysfunction is a loss of membrane potential. When 
mitochondrial membrane potential is dissipated across the IMM, the ETC’s ability to transfer 
electrons and hydrogen atoms is diminished. Ultimately, the generation of ATP is compromised. 
At this crossroad, a dysfunctional mitochondrion can encounter several fates. First, restoration of 
the membrane potential and dilution of damaged proteins can occur via organelle fusion. Cross-
complementation with other mitochondria can mitigate damage through the exchange of mtDNA, 
lipids and proteins. This can maximize the oxidative capacity of mitochondria in response to an 
environmental stress, so long as the stress is below a critical threshold. Fusion arises concurrently 
in the IMM and OMM as two mitochondria come together. Mitofusin 1 and 2 (Mfn1/2) mediate 
OMM fusion (378), whereas optic atrophy 1 (Opa1) mediates IMM fusion (6, 75). Though 
mammals contain two different mitofusin homologs (Mfn1 and Mfn2), both proteins are generally  
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expressed in the same cell, while each can independently support mitochondrial fusion (56). The 
importance of fusion in human disease is shown in non-proliferating neurons, where mutations in 
the fusion machinery can result in two human diseases, dominant optic atrophy (6) and Charcot 
Marie Tooth disease type 2A (493).  
If mitochondrial stress levels reach beyond a critical threshold, mitochondria can segregate 
from the reticular network and undergo fission. Unlike fusion, organelle fission events generally 
begin on the OMM. Fission is initiated when adaptor fission protein 1 (Fis1) (302) and 
mitochondrial fission factor (Mff) (101) localize to separation sites and recruit cytosolic dynamin-
like protein (Drp1) onto the OMM (400). Drp1 surrounds, constricts and severs the OMM and the 
IMM until the mitochondrion is partitioned from the reticular network. Once separated, the 
dysfunctional mitochondrion is either targeted for removal (mitophagy) (441, 442) or can return 
to the network if mitochondrial membrane potential is recovered (43, 479). It remains unknown 
whether any human diseases are related to fission protein mutations. However, recent research has 
revealed the importance of mitochondrial fusion and fission events, particularly in skeletal muscle 
health (57, 175, 362).  
2.2.2. Unfolded protein response 
For localized regions of mitochondrial damage, quality control mechanisms are available 
to prevent the complete removal of mitochondria. Most mitochondrial proteins are nuclear-
encoded and require protein import for proper organelle assembly. An unbalanced contribution 
between nuclear and mitochondrial genomes can result in unassembled ETC complexes and 
increased mitochondrial stress. Cellular perturbations including mitochondrial biogenesis (290) 
and oxidative stress (478) can impact the protein-folding environment within mitochondria. As a 
result, an increase of misfolded proteins within mitochondria beyond the capacity of chaperone 
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proteins to handle them can activate the mitochondrial unfolded protein response (UPRmt). This 
response can upregulate the transcriptional expression of nuclear-encoded mitochondrial proteases 
and chaperones (490). These chaperones, which include mtHSP70, HSP60 and HSP10, cooperate 
with protein import for the folding of matrix-destined proteins into a competent state (310). 
Proteins that fail to fold correctly are degraded by proteases to prevent protein aggregation. Lon 
and ClpP are ATP-dependent proteases found in the matrix. The Lon protease family provides a 
protective environment by degrading protein aggregates (22) and mildly-oxidized proteins (37). 
Lon performs a regulatory role in maintaining mtDNA copy numbers by targeting mitochondrial 
transcription factor A (TFAM) for degradation in the matrix (284). Furthermore, Lon protein 
expression is also reduced in aged skeletal muscle, and this might contribute to the proteotoxic-
induced mitochondrial dysfunction seen with aging (38).  
Initial work on ClpP has shown this protease to have a lower sensitivity for the detection 
of misfolded proteins than Lon (129). ClpP has also recently emerged as an important signaling 
protease in the activation of UPRmt. Work done by the Haynes laboratory using C. elegans 
demonstrated that ClpP can degrade unfolded proteins into peptides, which results in their efflux 
from mitochondria into the cytosol (136). Accumulation of these peptides in the cytosol can affect 
the translocation of transcription factors into the nucleus that can upregulate the induction of 
mitochondrial chaperone and protease genes (137). The mechanism by which peptides affect the 
localization of these transcription factors remains unanswered. More importantly, the effect of 
UPRmt activation on mitochondrial peptide release in mammals is an illuminating avenue of future 
research. In UPRmt mammalian studies, the use of aggregate-prone matrix-destined proteins 
provokes phosphorylation of JNK2, leading to the activation and binding of c-Jun onto AP-1 sites 
found on the promoter of CHOP and C/EBPβ (160, 490). The expression and heterodimerization 
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of CHOP and C/EBPβ is followed by these factors binding onto CHOP promoter sites of 
mitochondrial chaperones and proteases (160, 490). Interestingly, these CHOP promoter sites are 
flanked by two conserved UPRmt response elements (MUREs) that are found in several promoter 
regions of several human mitochondrial chaperones and proteases, including HSP60, HSP10 and 
ClpP (5). The discovery of MUREs provide additional insight into the integrative role of stress-
responsive transcription factors and kinases in mediating the mitochondrial stress response.   
2.2.3. Ubiquitin-proteasome system (UPS) 
The turnover of cytosolic and OMM proteins is critical in the maintenance of mitochondrial 
function and morphology. The ubiquitin-proteasome system (UPS) is traditionally thought of as a 
degradative system responsible for the turnover of cytosolic proteins. The UPS can mark cytosolic 
mitochondrial-destined proteins that are misfolded or mistargeted for removal. Current studies 
reveal a role for the UPS in regulating the OMM proteome. In mammalian cells, oxidative stress 
and mitochondrial damage can induce the mitochondrial localization of AAA-ATPase p97, a 
component of the UPS, and cytosolic protein Vms1 (143, 144). Vms1 acts to bridge mitochondria 
with components of the UPS for the turnover of OMM proteins. Deletion of Vms1 in mammalian 
cells is deleterious, and reduces mitochondrial respiratory capacity and cell viability (143). 
Additionally, p97 has been shown to retro-translocate OMM proteins from the mitochondrion to 
the cytosolic proteasome for degradation (423, 475). Intriguingly, mitochondrial function and the 
UPS exhibit a mutualistic relationship. Inhibition of the 26S proteasome system prevents 
mitophagy from occurring, suggesting that the UPS precedes mitochondrial degradation (53, 423). 
Prevention of the actions of the UPS can negatively result in the accumulation of defective 
mitochondrial proteins and alter mitochondrial morphology (277, 350). Reciprocally, lowered 
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ATP production and heightened oxidative stress brought about by ETC perturbations can adversely 
affect proteasomal assembly and activity (165, 264) 
2.2.4. Mitochondrial-derived vesicles  
Aberrant proteins that accumulate on the OMM beyond the capabilities of the UPRmt and 
the UPS can induce global mitochondrial stress. Under these circumstances, small or entire 
portions of mitochondria are sequestered for degradation. Pioneering microscopy work from the 
McBride laboratory has demonstrated that small mitochondrial-derived vesicles (MDVs) can bud 
from the mitochondrial membrane. The use of immuno-fluorescence and electron microscopy 
exposes the complexity of these vesicles. MDVs can selectively incorporate various protein cargo, 
depending on the nature of the mitochondrial stress induced (407). For example, the addition of 
complex III inhibitor (antimycin A) to mitochondria can produce MDVs enriched with IMM 
complex III subunit core 2 (407). However, when a general ROS inducer is used, MDVs that are 
generated contain only OMM protein VDAC, but not complex III subunit core 2 (407). These 
results reveal that MDVs can be single membrane bound vesicles containing OMM proteins, or 
also double membrane bound for oxidized matrix/IMM proteins (413). It is unknown how matrix 
proteins can trigger vesicle formation, but it appears that protein aggregation within the matrix can 
initiate the warping of the membrane. This process is independent of Drp1, and distinct from 
mitochondrial fission under basal or stimulated MDV conditions (406).  
 Once MDVs are formed, they can be delivered to the lysosome for protein degradation 
(406) or to the peroxisome for lipid degradation (311). The full function of peroxisome delivery 
remains unclear, but membrane-anchored protein ligase MAPL is known to assist with this 
trafficking (297, 311). For example, MDVs destined for peroxisomes contain MAPL but exclude 
mitochondrial OMM translocase protein TOM20 (311). Conversely, vesicles containing TOM20 
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exclude MAPL and do not fuse with peroxisomes, indicating a high level of cargo specificity in 
determining MDV fate (311). This selectivity is also seen with MDV delivery to the lysosome. 
Protein kinase PINK1 and E3 ubiquitin ligase Parkin are both required for the biogenesis and 
lysosomal targeting of MDVs (285). Interestingly, PINK1 and Parkin are also involved in the 
selective removal of entire mitochondria from the cell (see below). It is hypothesized that PINK1 
and Parkin localize on small regions of failed import machinery (e.g. TOM20) as a trigger for 
MDV generation, rather than fully depolarized mitochondria, which would prompt mitophagy 
(413). Lysosomal delivery of MDVs is independent of the autophagy machinery, suggesting a 
complementation between MDVs and mitophagy (285, 406). Finally, the functional importance of 
MDV in physiological and disease states remain unknown, and is a promising avenue of future 
research.  
2.2.5. Selective mitochondrial degradation: Autophagy and Mitophagy 
 Autophagy is a catabolic, evolutionary-conserved process responsible for the turnover of 
damaged proteins and organelles. Autophagy consists of three forms: microautophagy, 
macroautophagy and chaperone-mediated autophagy (CMA). Although all three processes are 
distinct, they all coalesce at the lysosome with the degradation and recycling of delivered cargo. 
CMA is the most selective process of the three, and requires assistance from heat shock cognate 
70 protein (hsc70). Chaperone-mediated transport to the lysosome closely resembles the process 
of protein targeting to organelles within the cell. Hsc70 selectively binds soluble cytosolic proteins 
with an exposed amino acid KFERQ motif (77) and facilitates their transport through the 
lysosome-associated membrane protein type 2A (LAMP-2A) receptor (69). Microautophagy is a 
nonselective process in which small cytoplasmic soluble proteins are directly internalized into 
lysosomes via invaginations of the lysosomal membrane. Macroautophagy, herein called 
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autophagy, is the most prevalent and well-studied autophagic pathway. This process is 
characterized by the engulfment of defective proteins and organelles in their entirety, enclosed in 
double membrane bound vesicles called autophagosomes and terminally delivered to lysosomes 
(autophagolysosome) for degradation. The disintegrated substrates are then released into the 
cytosol as constituents for de novo synthesis of macromolecules. Insufficient or excessive 
autophagy can be a “double-edged sword”, and regulation of this process is necessary for proper 
cellular function (402).  
 The molecular mechanisms of autophagy were first discovered in the early 1990s by 
Yoshinori Ohsumi’s laboratory. Through a series of elegant experiments, Ohsumi and his 
colleagues discovered autophagy in yeast under nutrient-depleted conditions (420). His work, 
along with Klionsky’s research group, illustrated that the autophagic process in yeast was largely 
similar to the lysosomal system found in mammalian cells (12, 131, 392). Taking advantage of 
yeast genetics, Ohsumi et. al further isolated and characterized 15 apg genes (autophagy-defective 
mutants) involved in yeast autophagy (437). APG yeast mutants were characterized by reduced 
viability and diminished protein bulk degradation, when faced with starvation (437). Since this 
initial finding, the autophagy field has exploded with the identification of novel autophagy proteins 
in yeast and other organisms. In 2003, principal autophagy researchers proposed a unified 
nomenclature system to reduce confusion in the scientific community by replacing all “autophagy-
related” genes and proteins with ATG and Atg, respectively. Moving forward in this review, the 
new nomenclature will be used.  
The formation of the autophagosome will be discussed first, as it is a common feature of 
autophagy and is coordinated by Atg proteins (Figure 4). The initial step in autophagosomal 
formation begins with two ubiquitination-like modifications, shown to be conserved in yeast and  
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humans. Initiation begins with the activation of Atg12 with Atg7, an E1 ubiquitin-like activator 
requiring ATP (294). This process progresses when Atg10, an E2 conjugating-like enzyme, 
displaces Atg7 and facilitates the irreversible formation of Atg12-Atg5 conjugate (309). Atg16L, 
in conjunction with Atg12-Atg5, associates with the autophagic isolation membrane during 
autophagosomal formation (293). The second conjugation system involves ubiquitin-like protein 
Atg8 being cleaved by Atg4, and activated by Atg7 (319). Atg3 then conjugates Atg8 with 
phospholipid phosphatidylethanolamine (PE), a membrane component of the autophagosomal 
membrane (319). It has been demonstrated that Atg12-Atg5 conjugation is required for Atg8 
lipidation to occur, establishing a hierarchy of the two conjugation systems (125, 295, 323).  
In contrast to Atg12 and Atg5, four Atg8 homologues have been identified in mammals: 
microtubule-associated protein 1 light chain 3 (LC3) (274), γ-aminobutyric acid (GABA)A-
receptor-associated protein (GABARAP) (459), Golgi-associated ATPase enhancer of 16 kDa 
(GATE-16) (371), and Atg8L (424). LC3 can exist in two forms and can be post-translationally 
modified. LC3-I is found in the cytosol, whereas the cleaved and lipidated form of LC3-II 
precipitates onto the autophagosomal membrane after processing (195). LC3-II is commonly used 
as an autophagosomal marker in mammals (214, 296). The remaining three Atg8 homologues are 
less commonly used as autophagy indicators but GABARAP and GATE-16 also partake in 
lipidation and localize to the autophagosomal membrane (196). GABARAP is also involved in 
GABA receptor clustering (58) and cytoskeleton transport (459), while GATE-16 can modulate 
vesicle transport within the Golgi (371). Atg8L is the least studied Atg8 homologue and its role in 
the cell remains elusive. However, all Atg8 homologues are similarly processed and modified by 
Atg4 (140), Atg7 (424, 426) and Atg3 (424, 425) homologues.  
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The two conjugation systems of Atg12-Atg5 and Atg8/LC3 are necessary for the 
elongation and closure of the autophagosome. Upstream of this autophagic process requires the 
activation and nucleation of two important complexes. One of these complexes is a family of 
phosphoinositide (PI) 3-kinases (PI3Ks) which control important cellular functions including 
cytoskeleton remodeling and membrane trafficking (259). There are three different PI3K classes 
but all three classes phosphorylate phosphatidylinositol at position 3 of the inositol ring (184). 
Class I and II PI3Ks are mainly involved in receptor-induced trafficking events, such as 
pinocytosis, phagocytosis, and exocytosis (259). In contrast, class III PI3Ks generally mediate 
receptor-independent trafficking events, such as endocytic membrane traffic, phagosome 
maturation and autophagy (259). PI3K can associate with Beclin1, a mammalian homologue of 
Atg6 (253), along with accessory factors Atg14, Vps15 and Vps34, to form an initiation complex 
required for autophagosome biosynthesis (100, 368, 427). Ulk1 is the second constitutive complex 
consisting of Atg13 and FIP200 (130, 289) involved in autophagy induction.   
 The formation of the autophagosome is a critical aspect of the removal of defective proteins 
and organelles. In a metabolic tissue such as muscle, the activation of autophagy is sensitive to 
environmental cues to maintain cellular homeostasis and growth. The energetic status of the cell 
is governed by ATP production and the hydrolysis of ATP’s high energy pyrophosphate bonds. 
The ratio of the nucleotide AMP, compared to ATP levels, can mediate the activation of AMP-
activated protein kinase (AMPK). AMPK is a heterotrimeric complex consisting of a catalytic α 
subunit, and regulatory β and γ subunits. Elevated cellular AMP can bind onto the γ subunit of 
AMPK and allow for its allosteric activation. Upstream AMPK kinase, LKB1, can then 
phosphorylate threonine residue 172 of the α subunit. The stimulation of the catalytic subunit 
triggers a phosphorylation cascade of downstream targets (46), including the activation of 
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autophagy complexes of Ulk1 and PI3K (210, 211). AMPK can also inhibit protein synthesis 
pathways, such as rapamycin-sensitive mTOR through the phosphorylation of suppressor complex 
TSC2 (173) and binding partner raptor (120). The inhibition of protein synthesis allows for protein 
clearance and recycling to proceed by autophagy.  
Calcium is another well-established controller of numerous cellular processes including 
autophagy. In muscle, calcium levels are tightly regulated by the sarcoplasmic reticulum (SR) and 
mitochondria (268). Evidence suggests the existence of structural interactions between these two 
organelles via inositol trisphosphate (InsP3) receptor calcium channel (IP3R) (87). Muscle 
contractile events primarily rely on mitochondrial ATP production and this is necessary for the 
propagation of calcium release and refilling of the SR (237). With elevated SR calcium levels, 
Beclin1 can directly regulate IP3R activity and stimulate LC3 lipidation (74). Furthermore, 
mitochondrial uptake of IP3R calcium release is essential for organelle bioenergetics, and an 
impairment in this transfer can activate AMPK-dependent autophagy (48, 452). 
Mitochondria are generally accepted as primary sites of reactive oxygen species (ROS) 
emission (304). These damaging species can be detoxified by superoxide dismutase (SOD), 
NADH and glutathione, and also by catalase in the cytosol (383). It is hypothesized that chronic 
impairment of mitochondrial function, and a disrupted balance between ROS production and 
elimination, can trigger organelle removal by mitophagy (see below). There are several 
mechanisms by which ROS can positively regulate autophagy. First, AMPK can be activated via 
the oxidation of reactive cysteines located at its α subunit (47, 492). Second, phosphorylation of 
autophagy adaptor protein p62 increases its affinity for Keap1, a component of the Cul3-ubiquitin 
E3 ligase complex responsible for degrading Nrf2 (170, 241). The inhibition of Nrf2 degradation 
and its cytosolic accumulation results in its translocation into the nucleus, where it can bind to 
22 
 
antioxidant-responsive elements (AREs) located in the promoter regions of antioxidant genes and 
activate their transcription (222). AMPK (121), mTOR (170), and Ulk1 (257) are several 
autophagy-related kinases suggested to regulate p62 phosphorylation. Moreover, a less studied 
group of antioxidant-like proteins called Sestrins can similarly activate Nrf2 (13) via mTORC1 
inhibition and AMPK activation (248).  Lastly, ROS can directly regulate autophagy proteins in a 
redox-dependent manner. Scherz-Shouval et al. demonstrated that the oxidation of Atg4 
inactivates its delipidating activity on LC3, allowing for autophagosomal elongation to continue 
(384). It is hypothesized that this occurs in the proximity of dysfunctional mitochondria so that 
autophagosomal engulfment can occur (383). Here, the data propose mitochondria as a major 
source of ROS required for autophagy. In turn, autophagy can eliminate organelle oxidative stress 
to protect the cell from additional oxidative damage. This can also be specifically achieved by 
activating mitophagy.   
Mitophagy is a cargo-specific process of autophagy involved in the removal of superfluous 
mitochondria. In the 1960s, mitophagy was first studied in mammals with the use of rat liver tissue 
perfused with glucagon (10). Examination by electron microscopy revealed an increased number 
of lysosomes containing mitochondria within the liver (10). Almost half a century later, Lemasters 
and colleagues coined this non-random process as mitophagy, and postulated the beneficial effects 
of mitophagy against oxidative stress, mitochondrial dysfunction and aging (209, 252). As 
discussed earlier, mitophagy is characterized as a terminal step in organelle quality control. 
Mitochondrial depolarization and sustained damage yields organelle fragmentation to assist in 
mitophagy (441, 479). In the following section, two general mitophagy pathways will be 
discussed: 1) ubiquitin-dependent pathways that rely on ubiquitin ligases and autophagy adaptor 
proteins, and 2) ubiquitin-independent pathways that depend on specific mitochondrial receptors.  
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Several cellular ubiquitin ligases exist, but the most well-studied ligase involved in 
mitophagy is Parkin, along with its associated kinase PINK1 (PTEN-induced putative kinase 1). 
Mutations in the Parkin gene are thought to cause autosomal recessive Parkinson's disease (72). 
The effect of Parkin with age will be discussed in the aging section of this literature review. Here 
we will discuss the mechanistic and structural basis for the activation of Parkin by PINK1. In the 
presence of functional mitochondria, cytosolic PINK1 protein levels are maintained at low levels 
through membrane potential-dependent import into the organelle (187). PINK1 arrives through the 
TOM complex (242), and is degraded by the IMM rhomboid protease PARL (73, 115, 187, 286). 
The remnants of PINK1 degradation can retro-translocate from the mitochondria, and into the 
cytosol where they are recognized and degraded by the proteasome (477). When the mitochondrial 
membrane potential dissipates, PINK1 can stabilize and accumulate on the OMM where it can 
selectively recruit cytosolic Parkin to impaired mitochondria (187, 224, 306, 454).  
 Parkin is an E3 ubiquitin ligase that performs the terminal step of ubiquitination. This 
process is initiated by ATP-dependent activation of E1’s catalytic cysteine residue and the 
formation of a thioester bond with the C-terminal carboxyl group of ubiquitin. The charged 
ubiquitin is transferred to a second cysteine of an E2 enzyme. In the last step, E2 enzyme ubiquitin 
conjugates with an E3 enzyme to transfer ubiquitin to a lysine residue of a target substrate. Parkin 
can bind to several E2 ubiquitin conjugating enzymes, including UbcH7, UbcH8 and UbcH13 
(321). In addition, Parkin can produce various ubiquitin lysine residue linkages that can mediate 
differing signal transduction and trafficking pathways. These include: monoubiquitination (122, 
189, 281, 299), lysine 48-linked polyubiquitination (53, 258), and lysine 63-linked 
polyubiquitination (82, 276, 322). For example, upon mitochondrial depolarization, Parkin can 
target Miro1, a mitochondrial trafficking protein, for proteasomal degradation, thereby isolating 
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the damaged organelle from the mitochondrial reticular network (29, 461). Parkin can also target 
mitochondrial fusion/fission proteins to the proteasome in favour of a less reticular network in 
order for mitophagy to occur (59, 423, 441, 460).   
Numerous studies have examined how Parkin E3 ligase activity is achieved. To date, E3 
ubiquitin ligases are grouped in one of three classes: RING (really interesting new gene) ligase, 
HECT (homologous to the E6-AP carboxyl terminus) ligase and RING-HECT hybrid (25, 85). 
RING ligases function as a platform for ubiquitin transfer between E2 enzymes to target substrates, 
but do not directly interact with ubiquitin themselves. Conversely, HECT ligases contain an active 
cysteine site that can form an intermediate thioester bond with ubiquitin. Interestingly, X-ray 
crystallography has exposed Parkin as a RING-HECT hybrid, containing a RING domain as well 
as a catalytic cysteine residue (358, 465). Under basal conditions, Parkin is in an autoinhibited 
state due to three intraspecific interactions. First, the ubiquitin-like (Ubl) domain at the N-terminus 
can bind to the C-terminal RBR (ring-between-ring) domain in cis and consequently inhibit Parkin 
(55). The RBR region contains an E2-binding RING1 domain, an IBR (in-between-ring) domain 
and a RING2 domain that contains the catalytic cysteine residue 431 for charged ubiquitin docking 
(394). Second, the RING0 domain (not part of the RBR) can obstruct the ubiquitin acceptor site in 
RING2 (435, 463). Third, the linking of IBR and RING2 (known as the repressor element of 
Parkin) can bind with RING1 and block its E2 ubiquitin binding site (435, 463).    
PINK1 acts upstream of Parkin and is required for Parkin recruitment to damaged 
mitochondria (206, 306, 454). PINK1 can directly phosphorylate Parkin’s Ubl domain on residue 
serine 65 to activate Parkin (171, 224, 320, 322). However, early studies suggested that 
PINK1/Parkin do not always perform in such a linear relationship. For example, it appears that 
PINK1 requires autophosphorylation to recruit Parkin (320), and that PINK1 does not always 
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phosphorylate Parkin (454), or that PINK1 phosphorylates mitochondrial substrates for Parkin 
recruitment (59). These observations have led researchers to investigate additional PINK1 
substrates involved in Parkin activation. In 2014, three independent laboratory groups concurrently 
found that PINK1 can similarly phosphorylate residue serine 65 of ubiquitin, and that phospho-
ubiquitin can also activate Parkin (200, 206, 228). However, the order of events required for 
phospho-ubiquitin amplification remains unanswered. Does Parkin incorporate only phospho-
ubiquitin directly into chains, or does ubiquitin phosphorylation precede chain formation? 
Furthermore, what role does phospho-ubiquitin have in other alternative ubiquitin ligases 
implicated in mitophagy? These questions remain unanswered. Mitochondrial ubiquitin ligase 1 
(482) and Glycoprotein 78 (99) are two ubiquitin ligases also implicated in mitophagy that are 
Parkin-dependent and -independent, respectively. Interestingly, both ligases and Parkin act on 
shared targets to maintain mitochondrial integrity (59, 99, 482). This suggest that E3 ubiquitin 
ligases may function redundantly in organelle quality control.  
Proteomic analysis on Parkin activation has yielded numerous associations with OMM 
proteins, autophagy receptors and the proteasome (54, 380). Parkin ubiquitination sites on the 
cytoplasmic surface of OMM targets include VDACs, Mfn1/2, Miro1, Fis1, TOM20 and TOM70 
(380). These data reaffirm the idea that Parkin can influence the OMM proteome, and that Parkin 
depolarization-dependent localization to these outer surface targets can activate proteasomal (53, 
423) and mitochondrial degradation (59, 103, 242, 441, 461) to occur.  
Five autophagy receptors have been demonstrated to have a ubiquitin binding domain (168) 
and a LC3 interacting region (LIR) (28) that facilitate the connection between OMM ubiquitin 
targets and autophagic machinery. These five receptors are: p62/SQSTM1 (103, 223, 305, 328), 
NBR1 (215), TAX1BP1 (439), NDP52 (456), and OPTN (397, 468). Initial studies did not resolve 
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the differences between these receptors and their role in mitophagy. In 2015, Youle et. al found 
that NDP52 and OPTN are the primary receptors for mitophagy, and are directly recruited to 
phospho-ubiquitin on mitochondria in a PINK1-dependent manner (243). They also showed that 
NDP52 and OPTN can recruit Ulk1 downstream for autophagy induction (243). Additional studies 
have found that TBK1 is a secondary kinase galvanized during PINK1/Parkin-mediated 
mitophagy, and that it primarily phosphorylates and enhances OPTN binding to ubiquitin (145, 
356). TBK1 activation can additionally phosphorylate p62, NDP52, and TAX1BP1 to reinforce 
mitochondrial ubiquitination and degradation (145, 356).  
In mammalian cells, mitophagy can also occur in the absence of ubiquitin. The process 
relies on OMM integral receptors with LIR motifs. The first two receptors, BNIP3 and NIX, are 
part of the homologous BCL2 homology 3 (BH3) protein family, and can mediate cell death and 
mitophagy (487). In several studies, BNIP3 and NIX are illustrated as being required for autophagy 
(70, 128, 249) and for mitochondrial-mediated apoptosis to occur (172, 348, 354). However, 
controversy exists regarding whether these two proteins directly mediate organelle depolarization 
(70, 376, 486) or if their localization depends on membrane potential (399). A loss in NIX can 
inhibit mitochondrial membrane potential and impair mitochondrial clearance in erythroid cell 
development (81, 376, 390, 486). Interestingly, NIX directly binds to GABARAP but not to LC3, 
despite sharing the same LIR motif as BNIP3 (314, 389). The third receptor FUNDC1 is involved 
in hypoxia-mediated mitophagy, and it is activated by dephosphorylation to enhance its interaction 
with LC3 (262). BNIP3 and NIX can likewise operate mitophagy under hypoxic conditions (21, 
485).  
Lastly, there is a class of mitophagy receptors that are not integral OMM proteins, and that 
do not depend on ubiquitin. AMBRA1 is a unique protein involved in autophagy induction as well 
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as Parkin-mediated mitophagy. Under basal conditions, mTOR and anti-apoptotic Bcl-2 inhibit 
AMBRA1 (308). When autophagy is induced, Ulk1 stimulates AMBRA1 and the PI3K complex 
to enable autophagosome nucleation (17, 278). AMBRA1 can interact with mitochondrial Parkin 
to recruit activated PI3K to damaged organelles (167). Moreover, AMBRA1 can initiate 
perinuclear mitophagy through its LIR motif, independent of Parkin and p62 (410). Cardiolipin 
was recently found to contain LC3-binding sites, and the redistribution of cardiolipin from the 
IMM to the OMM can also serve as a mitophagic trigger (60).  
 
2.3 Muscle Adaptations to Aerobic Exercise 
2.3.1. Metabolic adaptations of muscle to exercise 
Physical inactivity is a global pandemic considered as a major cause of death worldwide 
(219). Sedentary behaviour has been long regarded an important determinant of the occurrence of 
chronic metabolic syndromes including obesity and diabetes (96, 476). The beneficial effects of 
regular exercise and health date back to the 5th century BC, when Hippocrates said that “Eating 
alone will not keep a man well; he must also take exercise. For food and exercise… work together 
to produce health” (374). It has been demonstrated many times that regular exercise can aid in the 
prevention of metabolic syndromes (235), and age-related loss of muscle mass (50). However, 
only recently have molecular biologists uncovered the signaling pathways involved in mediating 
the adaptive responses to exercise. The focus of this review will be on the effect of these signaling 
pathways in skeletal muscle in response to exercise.  
Chronic, repeated bouts of exercise can elicit alterations in muscle metabolism. Seminal 
work by John Holloszy in the late 1960s demonstrated that muscle can undergo biochemical 
adaptations following endurance training, and that an increase in muscle oxygen consumption was 
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an outcome of mitochondrial biogenesis (153). Long-term training can evoke mitochondrial 
adaptations that are fibre-type specific (159). In the case of a muscle that contains a greater 
composition of fast oxidative-glycolytic fibres, a dramatic alteration in enzymatic profile toward 
that of more slow oxidative fibres is observed with prolonged, high intensity training (114, 141). 
Endurance training can also induce adaptations in higher oxidative muscle fibres to a smaller 
degree (164). Furthermore, SS mitochondrial volume increases significantly relative to IMF 
mitochondria in all muscle fibre types following endurance training (164). Training-induced 
alterations in mitochondrial protein and enzyme expression occur at a gradual rate that outpace 
increases in whole body oxygen consumption (107, 142).These progressive changes reflect the 
activation of signaling pathways involved in mitochondrial biogenesis, and other exercise-
responsive genes. A temporal sequence of transcriptional and translational events occurs prior to 
organelle biogenesis. For instance, transcriptional mRNA upregulation occurs after a single bout 
of endurance exercise (273, 340). Acute exercise can act as a stimulus towards achieving 
adaptation, but on its own cannot alter muscle metabolic capacity. Over time, the cumulative 
effects of successive exercise bouts can yield a gradual accumulation in protein content leading to 
improved whole muscle metabolism and exercise performance. The increased expression of 
metabolic enzymes can result in the enhanced sensitivity of mitochondrial respiratory control, such 
that a lower ADP concentration is sufficient to achieve the same level of oxygen consumption in 
muscle (83). Thus, following endurance training, the increase in mitochondrial content in muscle 
can induce a lower amount of ADP required to stimulate respiration per mitochondrion at the same 
absolute power output. This can consequently reduce the amount of ROS generated per oxygen 
consumed per gram of tissue (71). The reduced formation of ADP can attenuate glycolysis and the 
production of lactic acid. In addition, highly oxidative muscle fibres contain diminished expression 
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patterns of AMP deaminase and 5′-nucleotidase enzymes, relative to glycolytic fibres (438). 
Therefore, this can yield a lower rate of AMP synthesis that, in turn, can lower AMPK activation. 
Endurance training can lower kinase signaling (265) and GLUT-4 translocation to the plasma 
membrane (357). The reduction in carbohydrate handling and glycogen depletion after training is 
compensated by a proportional increase in lipid uptake and oxidation in muscle (421). Collectively, 
endurance training can improve exercise performance by increasing mitochondrial content, 
reducing metabolic by-products, glycogen storage sparing, and improving oxygen to ATP 
coupling.    
2.3.2. Gene expression: PGC-1a signaling and exercise  
 Regular endurance exercise has an established function in stimulating mitochondrial 
biogenesis and function (157) (Figure 5). A portion of this process is mediated by PGC-1α, a 
transcriptional coactivator that regulates genes involved in energy metabolism (126). PGC-1α can 
bind and enhance the activity of several transcription factors, including nuclear respiratory factor 
(NRF)-1/2 and estrogen-related receptor-α (ERRα), which in turn can upregulate the transcription 
of NUGEMPs (169, 386, 473). PGC-1β and PGC-1-related coactivator (PRC) are two other 
members that belong to the PGC-1 coactivator family, with both factors being able to trans-activate 
nuclear respiratory factors involved in biogenesis (382). However, it is suggested that these 
coregulatory proteins act independent of PGC-1α, as it has been shown that PGC-1 family 
members, as well as NRF-1/2 and ERRα, do not exhibit compensatory responses to reduced levels 
of PGC-1α (126, 443). Nonetheless, PGC-1α transcription is enhanced following exercise training, 
implicating its role in mitochondrial biogenesis in skeletal muscle (341). This is supported in 
animal studies that illustrate that global or muscle-specific deletion of PGC-1α can blunt 
mitochondrial biogenesis during endurance training (104, 251, 483). In addition to its role in the 
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nucleus, PGC-1α can translocate to the mitochondria in response to exercise, and can bind with 
TFAM on the D-loop of mtDNA to promote the transcription of specific mitochondrial-encoded 
genes (370). The ectopic expression of PGC-1α in muscle cells can induce molecular adaptations 
that include increased mtDNA expression, enhanced mitochondrial biogenesis and substrate 
utilization, as well as improved cellular respiration (464, 473). In rodents, the overexpression of 
PGC-1α can recapitulate the phenotype of trained muscle, illustrated by improved exercise 
performance, an increase in mitochondrial respiratory capacity, and greater ATP synthesis (44). 
 During repeated bouts of muscle contractions, energetic- and contraction-related signaling 
pathways are activated to regulate the expression of PGC-1α. The three primary kinases involved 
in regulating PGC-1α in skeletal muscle are AMPK, p38 MAPK and CAMK. AMPK is activated 
primarily when cellular levels of AMP are increased (199, 301). A depletion of ATP because of 
exercise can increase the cellular AMP/ATP ratio and activate AMPK. For example, acute exercise 
can phosphorylate and activate AMPK in an intensity-dependent manner (467). On the other hand, 
chronic endurance training can promote AMPK-mediated mitochondrial biogenesis through NRF-
1 activation and expression of respiratory proteins (24). The treatment of AMP mimetic 5-
aminoimidazole-4-carboxamide ribonucleoside (AICAR) in muscle cell culture can activate 
AMPK and its regulation on the PGC-1α promoter (178). The specific deletion of AMPK in 
skeletal muscle of mice can impair exercise performance and increase mitochondrial dysfunction 
(239). AMPK can also post-translationally modify PGC-1α by phosphorylating it at residues 
threonine-177 and serine-538 (179). Moreover, the translocation of PGC-1α to the nucleus and 
mitochondria during exercise may also be dependent on AMPK activation (405), but the 
mechanism by which AMPK activation can mediate PGC-1α translocation remains undetermined.  
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 A role for p38 mitogen-activated protein kinase (MAPK) during exercise in skeletal muscle 
is well-established (9). It has been demonstrated numerous times that the activation of p38 MAPK 
promotes PGC-1α transcription during exercise-induced muscle adaptations (4, 347, 481). In vivo 
optical bioluminescence imaging provides direct evidence that putative regulatory factors that are 
typically activated by p38 MAPK, are required for PGC-1α promoter responsiveness to contractile 
activity (3, 489). The constitutive activation of p38 MAPK aids in mitochondrial adaptations in 
skeletal muscle (4), but mice with muscle-specific gene deletion of p38γ MAPK, but not those of 
p38α and p38β, were shown to be required for endurance exercise-induced mitochondrial 
biogenesis (343). An alternative mechanism of p38 MAPK activation is via the generation of free 
oxygen radicals brought about by exercise through the activity of respiratory chain complexes, and 
that of xanthine oxidase and NADPH oxidase (304). Research has shown that acute exercise can 
activate MAPK signaling in a ROS-dependent manner (334, 346, 488). Finally, calcium release 
from the SR during muscle contractions is essential for the formation of cross-bridges between 
myosin and actin filaments. The increase in cytosolic calcium within muscle can modulate the 
activity of calmodulin-dependent protein kinase (CaMKs). CaMKII is the main CaMK isoform 
present in skeletal muscle, and it is phosphorylated during exercise in an intensity-dependent 
manner (365). Due to calcium’s pervasive role during muscle contractions, it may not be too 
surprising that CAMKII can undertake cross-talk with other pathways that influence PGC-1α 
transcription. It has been suggested that CAMKII can function as an upstream kinase of p38 and 
AMPK as a regulator of PGC-1α expression during exercise (177, 185, 365, 469, 471).        
2.3.3. Regulation of autophagy and mitophagy with exercise 
 It is hypothesized that exercise can induce autophagy (138, 139, 233, 261, 446). During 
muscle contraction events, autophagy activation can function to remove dysfunctional organelles 
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and proteins from the cell. This can, in turn, improve cellular function. For example, it is well 
established that physical exercise can result in elevated oxidative stress (349). As mentioned 
earlier, exercise-induced ROS production is an important modulator in muscle signaling. However, 
chronically elevated levels of ROS can also be damaging to organelles and contractile proteins. 
Thus, the induction of autophagy with exercise-induced ROS emission is required to remove 
damaged proteins and organelles in muscle. The terminal degradation of these substrates at the 
lysosome provide a source of amino acids that can be recycled as a source of energy in muscle 
cells during energetic stress. In response to exercise, mitochondrial proteins have been observed 
to have a half-life of approximately 1 week (36, 142, 428). The earliest examination of the 
influence of exercise on autophagy was studied in the 1980s, where autophagic vacuoles were 
detected in the muscles of mice following prolonged strenuous exercise (375). For a period, the 
molecular mechanisms that regulated autophagy during exercise remained poorly understood. 
Within this past decade, research on this topic has rapidly accelerated. The first studies to show 
molecular evidence of autophagy activation with exercise occurred in the early 2010s. For 
instance, Collagen VI null mice display impaired autophagy induction following acute exercise 
and after 3 months of voluntary exercise (118). This study was the first to suggest that autophagy 
activation may be important in mediating muscle adaptations to exercise training. In another study, 
mice containing a constitutively inactive form of Bcl-2 that prevents the activation of autophagy 
protein Beclin1 had impaired autophagy induction in muscle with exercise (138). Furthermore, 
animals containing inactive Bcl-2 displayed overall reduced endurance performance and increased 
glucose intolerance when placed on a high-fat diet (138).  
It appears that physical activity is a potent stimulus for autophagy induction in skeletal 
muscle, and that this is dependent on the type and duration of exercise. An acute bout of endurance 
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exercise can evoke a robust response in autophagy activation (118, 182, 446), where an increased 
expression of autophagosomal marker LC3II is observed. Interestingly, chronic exercise training 
elicits an increased capacity for the formation of autophagosomes, and this is required for muscle 
adaptation to occur (98, 194, 261). It is proposed that the alterations in energy supply brought 
about by exercise can activate AMPK and Ulk1 (233). This is a debated topic, as existing studies 
support (97, 298, 325) and refute (182, 451) AMPK’s involvement in autophagy activation during 
exercise. AMPK can activate Ulk1 at multiple phosphorylation sites that allows for Ulk1 activation 
during mitophagy (86, 152, 211, 433). Several studies have shown that acute exercise can stimulate 
Ulk phosphorylation during mitophagy (233, 298), suggesting the importance of Ulk1 signaling in 
mediating mitochondrial turnover in response to exercise. The effect of Ulk1 on PINK1/Parkin-
mediated mitophagy in response to exercise remains unknown. Because of the ease of genetic 
manipulation in mice, a limited number of studies have focused on autophagy and exercise in 
human subjects. In general, autophagy activation in human skeletal muscle occurs during high, 
intensity endurance exercise (98, 180, 181, 388), based on “classic” measurements of LC3 
lipidation and p62 expression.  
Autophagy is a highly dynamic process that involves the synthesis and degradation of the 
autophagosome, an outcome called flux. Several commercially available autophagy inhibitors can 
act in skeletal muscle to prevent autophagy from occurring (192). The treatment with an inhibitor 
and the consequent accumulation of autophagosomes within the cell can give researchers an 
indication of autophagy flux. For example, colchicine can destabilize the microtubule network, 
thereby preventing the delivery of an autophagosome to the lysosome for degradation. As a result, 
this will give an indication of autophagy flux up to the point of the lysosome. The description of 
autophagy flux without proper controls and inhibitors is incorrect. However, the utilization of 
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inhibitors in humans is not appropriate or feasible, and may be a limitation for measuring 
autophagy flux in human studies. Nonetheless, autophagy inhibitors are currently applied in many 
cell and animal models, allowing researchers to have a basic understanding of autophagy 
regulation. In one study, mice that were pre-treated with colchicine, and subjected to acute 
exercise, exhibited increased autophagy and mitophagy flux (446). Specifically, the study found 
that acute exercise was able to induce the mitochondrial localization of Parkin, ubiquitin, p62 and 
LC3II (446). Remarkably, these effects were abolished in the absence of PGC-1α, implicating a 
role for PGC-1α in mediating mitophagy in muscle during exercise. In future studies, the proper 
assessment of flux is essential to advancing our knowledge of autophagy activation during exercise 
and endurance training. There is a considerable amount of research on autophagy in muscle with 
physical exercise, but evidence on exercise-induced mitophagy is still lacking. A limitation in the 
study of mitophagy is the examination of autophagy markers in whole muscle. For example, whole 
muscle Parkin protein content has been shown to increase (181) and decrease (182) with endurance 
exercise. Therefore, researchers cannot assume that mitophagy is activated or supressed solely on 
whole muscle measurements. Rather, direct measurements of autophagy markers on isolated 
mitochondria would provide a more accurate interpretation of mitophagy in vivo. Fortunately, the 
recent development of mitophagy reporters (i.e. MitoTimer) can now be supplemented in the 
toolboxes of researchers as a method to investigate mechanisms of mitophagy signaling in vivo. 
MitoTimer is a mitochondria-targeted fluorescent protein that can be used to study mitochondrial 
turnover, dependent on its ability to irreversibly transition from green to red fluorescence over a 
period of 48 hours (148, 431). Newly synthesized MitoTimer is green, and its increase in 
mitochondria reflects greater protein import and increased mitochondrial biogenesis. As 
MitoTimer becomes oxidized, it irreversibly shifts to red. Following chronic voluntary wheel 
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running in mice, an increase in green fluorescence is observed, indicating greater biogenesis (234). 
In contrast, mice on a high-fat diet expressed a higher ratio of red to green MitoTimer, and this 
ratio was completely reduced by voluntary wheel running (234). Organelle turnover is reduced 
when autophagy is inhibited, and this can lead to the accumulation of red MitoTimer (93). 
Furthermore, co-localization of red MitoTimer and lysosomal markers can provide evidence of 
selective degradation of “aged” mitochondria through mitophagy. This was observed in rodents 
following an acute bout of endurance exercise, providing direct evidence of exercise-induced 
mitophagy in muscle (233). Collectively, these data establish MitoTimer as a useful tool in 
monitoring mitochondrial turnover, and may provide additional insight into mitochondrial biology 
and regulation during other metabolic challenges, such as obesity and aging.  
2.3.4. Coordination of mitochondrial biogenesis and mitophagy 
 To maintain a healthy pool of mitochondria, cells are required to maintain a balance 
between the synthesis and degradation of organelles. The studies on the underlying mechanisms 
involved in this balance have yielded the discovery of several transcriptional factors, such as TFEB 
which is an important regulator of lysosomal biogenesis and autophagy (379, 396). The induction 
of TFEB has been found to regulate genes involved in fatty acid oxidation and mitochondrial 
biogenesis, that are partly mediated by PGC-1α (395). It has been proposed that TFEB and PGC-
1α function in a co-regulatory loop that maintains a balance between mitochondrial biogenesis and 
degradation, and that this loop is in the general control of amino acid synthesis 5-like 1 (GCN5L1) 
(391). However, this relationship has been contested in exercise-related studies, as TFEB is 
required for mediating exercise-induced adaptations, and this process can be dependent (88) or 
independent of PGC-1α activity (275).  
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 Parkin is well known for its role in mitophagy, but a less studied area of Parkin activity is 
its possible regulation on mitochondrial biogenesis. In vitro overexpression of Parkin can increase 
mtDNA replication as well as mitochondrial content (232, 366). More importantly, overexpressed 
Parkin can directly associate with TFAM on promoter sites of mtDNA to enhance transcription 
(232). Another mechanism linking Parkin with mitochondrial biogenesis is the recent 
identification of Parkin interacting substrate, PARIS (401). PARIS is a transcription factor that can 
bind to the promoter region of PGC-1α and repress its transcription, as well as downregulate the 
downstream target NRF-1 (401). Parkin is involved in the ubiquitination and UPS-dependent 
elimination of PARIS, and that the loss of Parkin can contribute to PARIS-dependent declines in 
mitochondrial content and respiration (409). Moreover, PINK1 can interact and phosphorylate 
serine residues 322 and 613 of PARIS to enhance its ubiquitination and clearance by Parkin (250). 
Whether the Parkin-PARIS-PGC-1α axis is involved in regulating mitochondrial turnover in 
muscle with exercise remains unknown. Future research on uncovering the mechanisms involved 
in fine-tuning mitochondrial content via this mechanism is of paramount importance.   
 
2.4 Aging of Skeletal Muscle 
2.4.1. Metabolic alterations with sarcopenia 
Sarcopenia is an age-related process that can manifest itself as a multifactorial syndrome. 
Several factors that may contribute to sarcopenia have been proposed. These include a decline in 
endocrine function, lipid oxidation impairment, insulin resistance and chronic diseases (89). The 
decline in skeletal muscle quality is thought to play a critical role in muscle metabolism in the 
development of sarcopenia. Although the age-related decline in muscle mitochondrial content is 
controversial (146), a reduction in organelle content and function in aged muscle can occasionally 
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elicit muscle wasting, and can also promote the metabolic pathogenesis of type 2 diabetes (335), 
and an increase in abdominal fat deposits (51, 220, 244). An impairment in insulin signaling and 
incomplete fatty acid oxidation can induce mitochondrial stress (226). Inefficient substrate 
metabolism reduces mitochondrial bioenergetic capacity (207) and may increase superoxide 
formation with age (52). In addition to macromolecule damage (e.g. proteins, DNA), free radicals 
can induce the activation of stress pathways that inhibit insulin-stimulated glucose transport in 
muscle (31, 272). For example, the overexpression of mitochondrial antioxidant enzymes, such as 
catalase and superoxide dismutase, can prevent age-associated muscle insulin resistance (151), and 
mitochondrial dysfunction (247). As a result, the uncontrolled generation of free radicals can 
produce irreversible protein modifications that accumulate with age. Glycative and oxidative 
modifications are common examples of protein alterations that can negatively affect mitochondrial 
function and also resist proteasomal degradation, precipitating in a continual cycle of cellular 
damage and stress (20, 150). However, recent research has also indicated that mitochondrial ROS 
may not be a key regulator of muscle atrophy during aging. This is evident by studies 
demonstrating that the loss of muscle mass and function in old animals were not altered when 
supplemented with mitochondrial-targeted antioxidants (372, 373). The involvement of 
mitochondrial dysfunction in muscle atrophy during aging remains a contentious topic that 
requires further investigation.  
In addition, protein synthesis and protein degradation can contribute to lower protein 
turnover rates in aged muscle. The decline in anabolic hormones, such as insulin-like growth 
factor-1 (IGF-1), can lead to reduced muscle protein synthesis rates. IGF-1 is a hormone that is 
analogous to insulin, but that binds to a separate receptor to stimulate cell growth and proliferation, 
and it is mainly mediated by the secretion of growth hormone (GH). IGF-1 and GH are shown to 
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both decrease with age (236, 315, 332). GH replacement strategies appear to initially reverse the 
phenotypic features of aging (increase lean body mass and decrease fat mass), but long term 
administration can also lead to the development of diabetes, glucose intolerance and increased 
cancer risk (18, 30, 127). On the other hand, the down-regulation of IGF-1 receptors in rodents 
produces extended lifespans, with reductions in fat mass (32) and improved resistance to oxidative 
stress (156).  
With these confounding data, what exactly is the role of insulin in aging and protein 
metabolism? It is proposed that insulin action on protein metabolism with advancing age is reduced 
(34, 119), even with nutritional supplementation (455). These data suggest that muscle protein 
synthesis is resistant to the anabolic action of insulin (352), and may be a factor in advancing 
sarcopenia. A decrease in muscle protein synthesis rates can negatively impact mitochondrial 
function in the elderly (335) and in insulin-resistant individuals (300). In healthy individuals, 
insulin can promote mitochondrial protein synthesis, while individuals with type 2 diabetes may 
suffer a lower capacity for ATP production (207, 411). It remains undetermined if mitochondrial 
dysfunction with age is the result, or cause, of insulin resistance.  
2.4.2. Mitochondrial DNA and age 
 It is well established that sarcopenia features a decline in skeletal muscle mitochondria 
(52). Electron micrographs from aged rodent muscle reveal that SS and IMF mitochondrial 
contents are both reduced, and appear more fragmented  (176). In aged human muscle, these 
decrements are reflected by changes in maximal oxygen uptake and oxidative enzyme activities 
(64, 364). The diminished content of mitochondria in aged muscle is partly due to a reduced 
expression of the transcriptional coactivator PGC-1α (52), a protein involved in the coordinated 
transcription of NUGEMPs. It is therefore possible that age-related alterations arising in nuclear 
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genes encoding the protein import machinery (PIM) can reduce the assembly of the ETC (149). 
However, aged animals do not exhibit an impaired capacity for matrix-destined protein import into 
the organelle (67, 267). However, precursor proteins may be more rapidly degraded in the cytosol 
(166). Old animals also display a greater assembly rate of the outer TOM complex, which may 
serve as a compensatory mechanism to restore mitochondrial content or function within aged 
muscle (191). The restoration of the protein import pathway may aid in the import of TFAM, an 
important regulator of mtDNA transcription, and its absence in muscle reduces mtDNA abundance 
(470). Studies in humans (255) and rodents (333) demonstrate that TFAM is elevated in aged 
muscle, suggesting a role for TFAM in the maintenance and/or recovery of mitochondrial content 
and function with age. 
A stoichiometric imbalance between nuclear- and mitochondrial-encoded proteins can 
activate the UPRmt. Recent research suggests a link between UPRmt and aging. A majority of 
UPRmt investigation has been completed on lower order organisms. The link between the UPRmt 
and lifespan was first examined in worms that were long-lived with the knockdown of nuclear-
encoded cytochrome c oxidase subunit 4 (COX4) (84). Interestingly, mitochondrial mutants that 
lived longer required the activation of the UPRmt, while long-lived mutants that did not have 
mitochondrial mutations relied on insulin/IGF-1 signaling, independent of UPRmt activation (84). 
Flies with a muscle-specific knockout of a subunit of complex I exhibit lifespan extension, 
accompanied by UPRmt and IGF-1 induction (324). It is enticing to speculate that UPRmt activation 
can modulate the aging process though IGF-1  signaling, but the nature of the stimulus can yield 
varying cellular responses in different tissues (331). Furthermore, higher order organisms, such as 
mice, do not appear to rely on the IGF-1/insulin pathway with UPRmt activation (162, 263). This 
divergence may be a result of IGF-1 requirement on lower order organism development (78, 329).  
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 With advancing age, there is a greater propensity for mitochondria to generate ROS, despite 
no changes in antioxidant enzyme activity (52). An elevation in free radicals within aged muscle 
can trigger mtDNA and nDNA decay. According to the mitochondrial theory of aging, an 
accumulation of mtDNA mutations can lead to aging in humans and animals (132). Mammalian 
mtDNA encodes 13 polypeptides that are critical components of the electron transport chain 
(ETC). Small point mutations and large scale deletions can occur in several aged human tissues 
(197, 254). MtDNA mutations in skeletal muscle can negatively impact OXPHOS, decrease ATP 
generation, and affect general muscle performance. Mitochondria are unique as multiple copies of 
mtDNA can exist within an organelle. Therefore, pathological mutations are inherited via maternal 
inheritance and cellular segregation leading to mtDNA distribution termed heteroplasmy, which 
refers to the proportion of mutant to wild-type mtDNA copies within a mitochondrion. 
Heteroplasmy can range from 1% to 99%, with the severity of symptoms dependent on the 
pathological nature of the mutations. A histological phenotype can be observed in patients with 
age-induced mtDNA mutations, and those with mitochondrial myopathies. These mutations can 
lead to abnormal ETC activity at specific sites along muscle fibres (458). A cross-section of old 
muscle compared to a young muscle will contain an absence of cytochrome c oxidase (COX) 
activity, and an upregulation of nuclear-encoded succinate dehydrogenase (SDH) activity (147, 
246, 269). This is the outcome of the nuclear genome compensating for mtDNA defects. This is 
ineffective, however, as COX activity remains required for proper ETC function.  
Aged fibres from animals (147) and humans (41) are highly susceptible to atrophy and 
dysfunction at specific regions that have a mtDNA mutation load exceeding that of 90% total 
mtDNA. At these sites, mtDNA deletions can disrupt genes encoding COX, NADH 
dehydrogenase, ATP synthase, and a few mitochondrial transfer RNAs. The mitochondrial 4977 
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bp deletion, also known as the common deletion, is one of the most frequently observed mtDNA 
mutations associated with age and disease. This specific mtDNA mutation is highly detectable in 
post-mitotic tissues (i.e. muscle and brain) (65, 66, 260, 288). Common mutations in mtDNA can 
also occur at the displacement loop site where mtDNA transcription is initiated (90). For example, 
muscle biopsies taken from older individuals contain two point mutations, A189G and T408A, at 
the D-loop that can negatively affect the transcription of mtDNA (462). If mtDNA transcription is 
repressed, why do mtDNA mutations persist as an organism ages? Kowald and Kirkwood (227) 
hypothesized that mitochondrial transcription negatively regulates itself when there is a surplus of 
gene products. In young individuals, proteins are synthesized that can inhibit mtDNA transcription. 
The production of these inhibitory proteins is reduced with age, which can result in the propagation 
of mtDNA mutants. The alterations in mtDNA can be sustained in the absence of DNA polymerase 
gamma (PolG), an enzyme involved in mtDNA proofreading. Animals that are deficient in this 
proofreading enzyme present greater mtDNA damage and accelerated features of aging, and an 
increase in muscle caspase activation (apoptosis) (231, 436). Thus, mitochondrially mediated cell 
death is highly active in aged skeletal muscle, which may contribute to the progressive decline of 
muscle mass and function.  
2.4.3. Apoptosis and age 
Apoptosis, also known as programmed cell death, is an evolutionary conserved process 
involved in cellular development (353). While the cellular mechanisms that contribute to 
sarcopenia remain elusive, it has been suggested that apoptosis may be a contributing factor (52, 
79, 80). ROS are primarily produced by mitochondria and can trigger the release of pro-apoptotic 
factors during apoptosis. To enable this discharge, a permeability transition pore (mtPTP) exists 
but little is known about its structure. The Bcl-2 protein family assist in governing the mtPTP, 
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consisting of proteins that can either be pro- (Bax, BAD, Bak) or anti-apoptotic (Bcl-2 proper, Bcl-
xL, and Bcl-w). Proapoptotic homodimerization of these proteins (e.g. Bax and Bak) is crucial for 
the assembly of the mtPTP to induce cytochrome c release in the cytosol. Previous studies have 
shown a balance favouring proapoptosis in mitochondrial fractions of whole muscle from 
senescent animals (61, 79). Within the cytosol, cytochrome c binds with apoptotic protease 
activating factor-1 (Apaf-1) in the presence of ATP (256), which recruits pro-caspase-9 to generate 
a multiplex known as an apoptosome. In a series of proteolytic cleavages, also called the “caspase 
cascade”, caspase-9 and its effector caspase-3 are activated. Caspase-3 translocates to the nucleus 
to induce genomic DNA fragmentation. In addition to cytochrome c, other mitochondrial apoptotic 
factors are released into the cytosol, such as SMAC (small mitochondria-derived activator of 
caspases), AIF (apoptosis inducing factor) and EndoG (endonuclease G). SMAC can bind to 
inhibitors of apoptosis (IAPs), and promote cell death through the functional inactivation of these 
inhibitors. AIF and EndoG are proteins that can mediate apoptosis independent of apoptosome 
formation, and can translocate to the nucleus to induce apoptosis without caspase activation. The 
release of cytochrome c and EndoG from mitochondria is shown to increase with age in skeletal 
muscle (52, 111, 279), suggesting increased mitochondrial apoptotic susceptibility.  
2.4.4. Biochemical pathways with age 
At the expense of the cell, the termination of dysfunctional mitochondria can lead to 
apoptosis and cell death. This is a severe outcome and under less stressful conditions alternative 
quality control mechanisms can be implemented to retain organelle function. The turnover of long-
lived proteins and cytosolic organelles are crucial processes in the maintenance of function in an 
aging cell. Autophagy can aid in this removal process through the sequestration and delivery of 
cargo to lysosomes. Autophagy regulation is an emerging field of active research that can further 
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our knowledge of the aging process (16, 113, 218). Early studies primarily focused on a 
mechanistic view of autophagy and age on lower order organisms. These models were utilized to 
tease apart possible conserved genetic pathways of IGF-1 signaling and autophagy. For example, 
a deficiency of autophagy inhibitor mTOR in the nematode Caenorhabditis elegans was found to 
double the lifespan of the organism (450). Similarly, C. elegans with a loss-of-function mutation 
in the IGF-1 receptor are viable and live more than twice as long as wild type nematodes (208, 
213). IGF-1 can activate Akt, which in turn can phosphorylate mTOR to inhibit autophagy. These 
data suggest that autophagy may contribute to lifespan extension. Indeed, the inactivation of 
autophagy activator protein Beclin-1 cancels the effect of lifespan extension in C. elegans (287). 
These results illuminate the IGF-1/Akt/mTOR pathway as an important signaling mechanism 
involved in aging.  
With respect to muscle physiology, the IGF-1 pathway is also involved in skeletal muscle 
hypertrophy and atrophy (33, 363). Sarcopenia is accompanied by a reduction in circulating IGF-
1 levels, along with a loss of muscle mass and reduced protein synthesis. Therefore, it is possible 
that the IGF-1 pathway is involved in regulating muscle mass in aging skeletal muscle. However, 
recent research on aged mice indicates that the IGF-1/Akt pathway is not downregulated, but that 
mTOR activity is elevated in sarcopenia (377). These data support the idea that caloric restriction 
may aid in extending longevity. Caloric-restricted aged animals display metabolic reprogramming 
that impedes aging by enhancing protein turnover and decreasing macromolecular damage (7, 
245). When a cell encounters high energy demand and low energy supply, AMPK is activated and 
can inhibit mTOR activity. This can activate autophagy and re-establish the energetic status of the 
cell by increasing the availability of de novo substrates for macromolecule synthesis (23). The 
activation of AMPK (8, 11, 117, 434) and inhibition of mTOR (186, 198, 203, 345, 408, 450) can 
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extend lifespan in a variety of organisms. Evidence to support mTOR inhibition and caloric 
restriction is observed with the inhibition of 4E-BP, a downstream target of mTOR. 4E-BP 
(eukaryotic translation initiation factor 4E binding protein) is a repressor of mRNA translation and 
is inhibited upon mTOR activation and protein synthesis (135). Dietary restriction in flies can 
induce 4E-BP activity and lifespan extension by enhancing mitochondrial activity (491). These 
findings suggest that the attenuation of mTOR signaling and mitophagy activation might serve as 
a potential step by which caloric restriction can impact longevity. Alternatively, rapamycin 
treatment may be a possible therapeutic intervention to blunt mTOR activation and promote 
longevity (163, 408). Administration of rapamycin can extend the median and maximal lifespan 
of different mouse strains (134). AMPK regulation on mTOR provides a probable mechanism by 
which AMPK could influence lifespan (202). Therefore, activation of AMPK may be vital to 
prevent or reverse age-related physical degeneration.   
2.4.5. Autophagy and mitophagy with age 
AMPK activation can promote autophagy (42, 211) and mitophagy (86) by directly 
activating Ulk1 and inhibiting mTOR. Contraction-induced AMPK signaling is reduced in aged 
muscle (266, 355) and may consequently affect autophagy activation (42). Several studies 
hypothesize that the initiation and degradation of autophagosomes may be diminished with age 
(68, 367, 429). The notion of autophagy activation on decelerating the aging process is supported 
in studies that demonstrate AMPK overexpression (444) and mTOR knockdown (472) in different 
organisms produce extended lifespans. Moreover, autophagy is emerging as a critical process in 
the maintenance of muscle function with age. For example, autophagy impairment in aged muscle 
induces oxidation of contractile proteins and neuromuscular junction degeneration which can 
cause muscle weakness (49). In aged muscle, higher basal autophagy protein expression may 
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indicate diminished autophagic degradation (316). Furthermore, failure to activate autophagy in 
aged muscle satellite cells can impair muscle regenerative capacity (102). In post-mitotic tissue, 
defective mitophagy is often depicted as mitochondrial accumulation inside autophagosomes or 
lysosomes (102, 161, 393). Impairments in autophagosomal degradation can also be detected in 
aged post-mitotic tissue as lipofuscin granules (161, 316), an indication of lysosomal dysfunction 
(430). Lipofuscin formation can increase with sustained oxidative stress (39, 40). A possible 
method to mitigate lysosomal dysfunction is through the activation of recently identified 
transcription factor EB (TFEB) (379). Under non-stressful conditions, cytosolic TFEB is basally 
repressed by mTOR (330). Upon a catabolic stimulus, such as starvation or exercise (88, 275), 
mTOR can subsequently relieve its inhibition on TFEB and allow for its translocation into the 
nucleus where TFEB can express numerous genes involved in lysosomal biogenesis (327) and 
autophagy (396). A role for TFEB in aged muscle remains unknown and may serve as a therapeutic 
intervention in improving lysosomal function and autophagy. 
Few studies exist on the direct examination of mitophagy regulation with age. Many of 
these studies have focused on aging in lower order organisms, and therefore careful interpretation 
and extension of the data to mammalian aging is required. In conditions of mitochondrial 
dysfunction and low IGF-1 signaling, mitophagy activation is required for nematode lifespan 
extension (326). Administration of the chemical autophagy inducer, lithium, in the nematode is 
beneficial for longevity and improved mitochondrial function (422). Iron is an important 
component of complex III and IV of the ETC, and depletion of iron in worms can also trigger 
mitophagy and lifespan extension (385). In yeast, Uth1p is an OMM protein that can induce 
mitophagy with rapamycin treatment and starvation (45). Deletion of Uth1p reduces autophagic 
degradation of mitochondria and decreases longevity in yeast during nutrient deprivation (217).  
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As noted in detail earlier in this review, Parkin is a ligase involved in mitophagy, and recent 
work suggests a role for Parkin in aging. As implied by its name, Parkin is involved in Parkinson’s 
Disease (PD), an age-associated neurodegenerative disorder of the central nervous system. 
According to Statistics Canada in 2010, 55,000 Canadians aged 18 or older reported that they had 
been diagnosed with PD. PD is diagnosed by four main clinical manifestations: bradykinesia, 
muscular rigidity, resting tremor and postural instability (416). The impairment in motor function 
is attributed to a progressive loss of dopaminergic neurons in the substantia nigra, a region of the 
midbrain (92). The etiology of cell death in the substantia nigra remain unknown. However, the 
surviving neurons display cytoplasmic inclusions called Lewy bodies, which contain α-synuclein 
protein aggregates. Mutations in the α-synuclein gene have been identified in families with PD 
(344). Although the function of α-synuclein is not completely understood, studies suggest that it 
plays a role in regulating clustering of presynaptic vesicles (76). In the late 1990s, a Japanese 
research group identified PARK2 (Parkin) as the first gene involved in early-onset PD (283, 398). 
A few years later, PARK6 (PINK1) was the second gene discovered within a large Italian pedigree 
(447–449). The connection between PD and mitochondrial dysfunction was accidently discovered 
in the 1970s when drug users were exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine 
(MPTP), a contaminant from the synthesis of 1-methyl-4-phenyl-4-propionoxy-piperidine (MPPP) 
(238). MPTP is a lipophilic compound that can cross the blood brain barrier and, once metabolized 
by neuroglial cells, destroys primarily dopaminergic neurons. It was later found that the selective 
uptake of MPTP by dopaminergic neurons can cause inhibition of ETC complex I function (183, 
313). The discovery of a mitochondrial targeting sequence for PINK1 ultimately strengthened the 
involvement of mitochondrial dysfunction in the pathophysiology of PD. Despite these 
advancements, there is still no cure or effective treatment options for PD as a large majority of 
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cases are of idiopathic origin. Although the cause(s) of PD remain unknown, great strides on 
research examining the genetic basis of PD have provided researchers with a better understanding 
of mitochondrial quality control mechanisms that might underlie PD and other neurodegenerative 
diseases.  
Since PD is an age-related disease, a large focus has been on the role of Parkin with age. 
For example, overexpression of Parkin can extend lifespan in flies by reducing polyubiquitinated 
protein aggregates in muscle (351). Furthermore, Parkin KO mice crossed with PolG mutator mice 
exhibit accelerated dopaminergic neuronal cell death, indicating that endogenous Parkin preserves 
neuronal tissue from cellular death arising from mtDNA mutation accumulation (338). Indeed, 
Parkin overexpression can selectively eliminate mitochondria harboring deleterious mtDNA 
mutations in heteroplasmic cybrid cells (412). Unfolded proteins within the matrix can also trigger 
Parkin localization to the mitochondria independent of a membrane potential (188).  Alternatively, 
PINK1 can stabilize on the OMM when Lon protease is inactivated (432). Lon is a mitochondrial 
matrix protease involved in the handling of misfolded and aggregated proteins (27). Increased 
expression of Lon can extend lifespan in a fungal model of aging (271). In aged murine skeletal 
muscle, increased oxidative stress can downregulate Lon protease expression, and promote the 
accumulation of dysfunctional proteins within mitochondria (38). Parkin can also assist in the 
removal of OMM proteins by mediating the selective turnover of mitochondrial ETC proteins in 
flies (453). Drosophila Parkin null mutants exhibit reduced lifespan and severe muscle generation 
(116). In human skeletal muscle, Parkin expression is reduced in older subjects (111). These 
studies collectively demonstrate Parkin’s role in aging, but a large gap of knowledge exists for 
Parkin in a mammalian model of aging, particularly its effect on mitophagy in sarcopenic muscle. 
The study of mitophagy in vivo presents a challenge as mitochondria are constantly undergoing 
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turnover, and measuring this process at any one timepoint may not be representative of the entire 
process. Several autophagy inhibitors can prevent autophagy from occurring in skeletal muscle 
(192). If treatment of an inhibitor is followed by a greater accumulation of autophagosomal 
markers (i.e. LC3II), this can indicate greater autophagic flux. Initial evidence suggests that 
autophagic flux is enhanced in skeletal muscle of old animals (14). However, further research is 
required to clarify whether mitophagy flux is altered in aged muscle. There are several recently 
introduced methods that can provide information on mitochondrial turnover. Mito-Keima is a 
coral-derived, mitochondrial-targeted fluorescent protein that stably emits green at a neutral pH 
(autophagosomal induction and formation) and red at a acidic pH (autophagosomal fusion with the 
lysosome) (204). This fluorescent protein was recently used in a reporter mouse model. The results 
indicate that mitophagy was lower in the dentate gyrus brain region of aged mice (415). In future 
studies, the utilization of this reporter can provide novel data on mitophagy regulation in different 
tissues under various conditions (i.e. aging and exercise).  
2.4.6. Muscle plasticity, exercise and age 
 Sarcopenia is characterized by a loss in muscle mass and strength. It is reported that muscle 
strength decreases (3 to 4% per year) more rapidly than muscle mass (1% per year), suggesting an 
overall decline in muscle quality (109). There is a wealth of evidence that demonstrates that 
physical activity and endurance exercise can help prevent some of the sarcopenia by attenuating 
muscle mass loss, and thereby improve the quality of life (154, 240, 307). An outcome of regular 
endurance exercise is an increase in mitochondrial biogenesis (50, 91, 201, 221, 403), that can 
improve age-related changes in mtDNA integrity and muscle oxidative capacity (369). Several 
pharmacological interventions exist that can activate mitochondrial biogenesis (158), and aid in 
aging muscle function, but do not fully recapitulate the beneficial effects of whole body exercise. 
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Why is it that aged muscle adapts so differently than young muscle? What are these mechanisms 
and how are they altered with exercise? A literature search in the aging field provides many 
examples in which the beneficial effects of exercise are not evident. This is mainly attributed to 
differing experimental age groups (404, 457), and uncontrolled activity levels that can produce 
varying results (158). One method to control these activity levels is the use of a chronic electrical 
stimulation model (418). This method is utilized mainly on rodents, but can allow for controlled 
workloads on the stimulated leg of the rodent, with full muscle fibre recruitment. The use of this 
experimental model has revealed that mitochondrial content can increase in the muscles of both 
young and aged animals, but that this increase is significantly attenuated in aged muscle (267). 
This reduced adaptive plasticity in aged muscle is mainly due to lower mitochondrial protein 
import and regulatory proteins involved in mitochondrial biogenesis (267). The attenuated 
activation of upstream signaling kinases in response to contractile activity in aged muscle may 
consequently reduce downstream targets that are responsible for regulating mitochondrial 
biogenesis (266, 355). These data indicate that aged skeletal muscle can adapt to exercise, but that 
initial signaling mechanisms involved in gene transcription are blunted (14). Future studies will 
need to examine if altering stimulus strength and duration on aged muscle can achieve similar 
adaptations as seen in young muscle (361).   
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CHAPTER 3: 
PhD DISSERTATION OBJECTIVES AND HYPOTHESES 
Based on the literature review, mitochondrial turnover is essential for the maintenance of 
proper organelle content and quality. Parkin is an important regulator of this process. Both Parkin 
and mitochondrial turnover appear to be altered with exercise and age. However, it is not clear 
whether if Parkin is involved in mediating mitophagy in skeletal muscle under different metabolic 
states, namely exercise and aging. Mitochondrial biogenesis can increase with endurance exercise, 
and decrease with aging, with evidence pointing towards Parkin being involved in both processes. 
Therefore, we were interested in evaluating a role for Parkin in the regulation of skeletal muscle 
mitochondrial turnover with age and exercise. The purpose of this dissertation was to investigate 
the mechanisms by which Parkin can modulate age- and endurance exercise-induced adaptations 
in skeletal muscle, and the degree of its activation and involvement in mitophagy and 
mitochondrial biogenesis. Thus, the objectives of my dissertation were three-fold:   
 
Objective 1: To investigate the role of Parkin on mitophagic signaling, basally and during acute 
exercise, using a Parkin knock-out model.  
Hypotheses: 
 1) We hypothesized that mitophagy flux would be induced with acute exercise. 
2) We posited that the lack of Parkin would impair mitochondrial function and attenuate 
mitophagy flux, as well as reduce the expression of key transcription factors involved in 
mitochondrial biogenesis.  
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Objective 2: To assess the degree of influence that age has on Parkin-mediated mitophagy basally 
and following acute exercise. 
Hypotheses: 
1) We posited that the lack of Parkin with advancing age would result in additional 
decrements in mitochondrial content and function, as well as reduced muscle mass. 
2) We hypothesized that the absence of Parkin would impair mitophagy flux in aged 
muscle, and that these pathways would remain attenuated with a subsequent bout of acute 
exercise.  
 
Objective 3: To delineate the importance of Parkin-mediated mitophagy in exercise-induced 
mitochondrial biogenesis.   
Hypotheses: 
1) We expected that the absence of Parkin would reduce the degree of adaptive response 
to endurance training as measured by the expression of several mitochondrial content 
markers. 
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ABSTRACT 
The maintenance of muscle health with advancing age is dependent on mitochondrial 
homeostasis. While reductions in mitochondrial biogenesis have been observed with age, less is 
known regarding organelle degradation. Parkin is an E3 ubiquitin ligase implicated in mitophagy, 
but few studies have examined Parkin’s contribution to mitochondrial turnover in muscle. Wild 
type (WT) and Parkin knockout (KO) mice were used to delineate a role for Parkin-mediated 
mitochondrial degradation in aged muscle, in concurrence with exercise. Aged animals exhibited 
declines in muscle mass and mitochondrial content, paralleled by a nuclear environment endorsing 
the transcriptional repression of mitochondrial biogenesis. Mitophagic signaling was enhanced 
following acute endurance exercise in young WT mice, but was abolished in the absence of Parkin. 
Basal mitophagy flux of the autophagosomal protein LC3II was augmented in aged animals, but 
did not increase additionally with exercise when compared to young animals. In the absence of 
Parkin, exercise increased the nuclear localization of PARIS, corresponding to a decrease in 
nuclear PGC-1α. Remarkably, exercise enhanced mitochondrial ubiquitination in both young WT 
and KO animals. This suggested compensation of alternative ubiquitin ligases that were, however, 
unable to restore the diminished exercise-induced mitophagy in KO mice. Under basal conditions, 
we demonstrated that Parkin was required for mitochondrial Mfn2 ubiquitination. We also 
observed an abrogation of exercise-induced mitophagy in aged muscle. Our results demonstrate 
that acute exercise-induced mitophagy is dependent on Parkin, and attenuated with age, which 
likely contributes to changes in mitochondrial content and quality in aging muscle. 
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INTRODUCTION 
Mitochondria have emerged as an important nexus of stress within the cell. Including their 
canonical function as energy producers, mitochondria also exhibit pleiotropic roles in regulating 
metabolic signaling. In a tissue such as muscle, mitochondria can respond to sustained energetic 
requirements by increasing organelle content via a process termed mitochondrial biogenesis. This 
expansion is critical for muscle adaptation to occur in response to exercise training (17). A plethora 
of studies have established the broad beneficial effects of exercise, but the molecular mechanisms 
that accompany improved muscle quality remain obscure. Recent research has suggested that 
autophagy is a possible mechanism for potentiating muscle plasticity in response to exercise (16, 
60).  
Autophagy is a catabolic, evolutionary-conserved process involved in the engulfment of 
dysfunctional organelles and protein aggregates. Mitophagy is a specific form of autophagy, 
accountable for the elimination of dysfunctional mitochondria following damage or stress. Once 
an entire mitochondrion becomes depolarized, organelle fragmentation permits mitophagy to 
eliminate the dysfunctional segment from the mitochondrial reticular network (7, 59, 63). This 
change in mitochondrial morphology is initiated and regulated in part by the E3 ubiquitin ligase 
Parkin (10, 46). Under non-stressful conditions, mitochondrial PTEN-induced putative kinase 1 
(PINK1) is rapidly imported into the organelle and degraded by the inner mitochondrial membrane 
rhomboid protease presenilin-associated rhomboid-like protein (PARL) (23). When a 
mitochondrion encounters a loss in membrane potential, PINK1 stabilizes and accumulates on the 
outer mitochondrial membrane to selectively recruit Parkin (30, 40). The mitochondrial 
translocation of Parkin induces ubiquitin localization on outer mitochondrial membrane targets, 
and is further activated by PINK1 phosphorylation of ubiquitin (25, 26, 28). Adapter protein 
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sequestosome 1 (p62) interacts with mitochondrial ubiquitin and with microtubule-associated 
protein light chain 3 (LC3) on the autophagic phagophore membrane (2, 44). These tagged 
dysfunctional mitochondria are encapsulated into autophagosomes and sequestered to the 
lysosome for proteolytic degradation. 
In muscles with disrupted autophagic signaling, pathology entailing disorganized swollen 
mitochondria is displayed (36). This suggests that mitophagy may have a role in the preservation 
of organelle content and function in muscle. While work has been done on Parkin in muscle on 
lower model organisms (14, 47) and in cell culture (48), the physiological function of Parkin in 
mammalian skeletal muscle function, and in response to physiologically relevant stressors such as 
exercise, remains unknown. Recent studies have investigated the influence of autophagy activation 
in skeletal muscle following a bout of endurance exercise (15, 16, 49, 60). We have previously 
demonstrated that mitochondrial Parkin localization is enhanced in response to acute exercise (60). 
Therefore, in this study, we sought to examine Parkin’s role in skeletal muscle function, and 
whether Parkin is required for acute exercise-induced mitophagy flux using a Parkin KO mouse 
model.   
Similar to the phenotype of autophagy deficiency, aged muscle displays an accumulation 
of dysfunctional mitochondria in lysosomal lipofuscin bodies (42). Aged animals also demonstrate 
an elevated amount of mitochondrial ROS emission (6), which can perpetuate organelle damage. 
Indeed, autophagy inhibition in muscle can elicit a reduction in muscle contractile activity due to 
non-autophagocytosed mitochondria (36). This notion is part of the mitochondrial-lysosomal axis 
theory of aging that postulates that increasing organelle dysfunction irreversibly leads to the 
deterioration of post-mitotic cells (4). In skeletal muscle, this process is manifested as sarcopenia, 
which is characterized by the age-related loss of muscle function and strength (5, 34), and a 
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reduced transcriptional drive for mitochondrial biogenesis (6). Yet, the selective degradation of 
mitochondria and its role with advancing age remains unclear. We have previously shown that the 
expression of autophagy proteins and their localization to mitochondria are not decreased, but 
rather that the induction of mitophagy remains impaired in aged muscle (42). Interestingly, the 
overexpression of Parkin has been shown to enhance mitophagic flux and extend lifespan in lower 
model organisms (47). Thus, we hypothesized that Parkin may play an increasing role in regulating 
skeletal muscle function and mitochondrial degradation with age. The aims of our study were to 
investigate: 1) the role of Parkin in acute exercise-induced mitophagy, and 2) possible age-related 
alterations in mitophagic flux brought about by endurance exercise. 
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MATERIALS AND METHODS 
Mice. C57BL/6 (WT) and B6; 129S4-Park2tm1Shn/J (Parkin KO) mice (Jackson Labs, 
006582) were housed in a 12 h light–dark cycle room and allowed access to food and water ad 
libitum. The generation of these mice has been previously described (12). Progeny were genotyped 
by obtaining ear clippings for DNA extraction. DNA was subsequently incubated with JumpStart 
REDtaq polymerase (Sigma-Aldrich, St. Louis, MO) along with forward and reverse primers for 
the WT or altered Parkin gene. These products were amplified using PCR and separated on a 1.5% 
agarose gel containing ethidium bromide for visualization the genotype. The minimum age 
threshold for young and aged conditions were 3 and 18 months, respectively.  
Exercise Protocol and Blood Lactate. To evaluate mitophagy flux, animals were 
administered colchicine, or an equal amount of vehicle (water), via intraperitoneal injections every 
24 hours (0.4 mg·kg−1·day−1) (24) for 2 days prior to the day of exercise and euthanization. After 
2 days of habituation on the treadmill, along with the vehicle or colchicine injections, animals in 
the exercise (Ex) and exercise and 2 hours recovery (ExR) groups were subjected to exhaustive 
treadmill exercise on a 10° incline. Young WT and KO animals ran at 0 m/min for 5 minutes, 5 
m/min for 5 minutes, 10 m/min for 10 minutes, 15 m/min for 15 minutes, 20 m/min for 20 minutes 
followed by incremental exercise at 1 m/min for every 1 minute until to failure. Aged WT and KO 
animals ran a similar protocol but Ex groups began incremental exercise after 10 m/min for 10 
minutes. There were no ExR groups for aged WT and KO animals due to a lower sample size. The 
exercise bout ended when animals appeared visibly exhausted and could not continue, even in the 
presence of air jet stimulation. Metabolic stress was also assessed by measuring blood lactate from 
a small tail bleed using the Lactate Scout+ analyzer (EKF Diagnostics, Magdeburg, Germany). All 
animals were sacrificed by cervical dislocation immediately after exercise (Ex), or 2 hours 
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postexercise (ExR). All animal protocols were submitted and approved by the York University 
Animal Care Committee. Animals were treated in accordance with Canadian Council of Animal 
Care guidelines. 
Muscle Extraction and Cytochrome c Oxidase (COX) Enzyme Activity. The quadriceps 
muscle was surgically removed and immediately freeze-clamped with metal tongs pre-cooled in 
liquid nitrogen and subsequently weighed and stored at –80 °C for future use. Frozen muscle 
samples were pulverized into powder, then dissolved in whole muscle extraction buffer, followed 
by sonication and centrifugation. Supernatant fractions were recovered and protein content was 
determined by the Bradford technique. In addition, COX activity measurements were performed 
on young and aged groups of Parkin KO and WT mice to measure whole muscle mitochondrial 
content. Briefly, whole muscle extracts were added to a test solution containing fully reduced 
cytochrome c. Enzyme activity was determined by the maximal oxidation rate of completely 
reduced cytochrome c, evaluated as the rate of change in absorbance at 550 nm using a Synergy 
HT microplate reader, as previously described (37). The data were gathered and calculated using 
KC4 software. 
Mitochondrial Isolation. Mixed hindlimb muscles were immediately placed into ice-cold 
mitochondrial isolation buffer, followed by mincing and homogenization. Intermyofibrillar (IMF) 
mitochondrial subfractions were fractionated by performing differential centrifugation, as 
described previously (8, 37, 50, 64). Mitochondria were resuspended in 100mM KCl, 10mM 
MOPS, and 0.2% BSA. Freshly isolated mitochondria were used for mitochondrial respiration and 
reactive oxygen species (ROS) emission assays, and aliquots of mitochondrial extracts were stored 
at –80ºC for mitochondrial co-immunoprecipitation assay and immunoblotting analyses. The 
protein concentration values of the isolated mitochondria were determined using the Bradford 
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method. 
Mitochondrial Respiration and ROS Production Assay. Basal IMF mitochondrial 
respiration (state 4) rates were performed in the presence of 10 mM glutamate (Sigma) followed 
by the addition of 0.44 mM ADP (state 3, Sigma). During state 3, NADH was added to ensure 
intact inner mitochondrial membrane integrity. No differences in respiration rates were observed 
when NADH was added to isolated mitochondria samples. All respiration rates were performed 
using the Mitocell S200 Micro Respirometry System (Strathkelvin Instruments, North 
Lanarkshire, UK). ROS emission was measured using isolated mitochondria from WT and Parkin 
KO mice that were incubated in a 96 well plate with VO2 buffer (in mM: 250 sucrose, 50 KCl, 25 
Tris, and 10 K2HPO4, pH 7.4) at 37 °C for 30 minutes under state 4 and 3 conditions. 2',7'-
dichlorodihydrofluorescein diacetate (50 µM H2DCFDA, ThermoFisher) was subsequently added 
and fluorescence between 480 and 520 nm was measured on a Bio-Tek Synergy HT microplate 
reader to directly measure ROS emission. ROS emission was expressed per nanoatom of O2 
consumed, as measured during mitochondrial respiration. 
Nuclear and Cytosolic Fractionation. Freshly isolated tibialis anterior muscle was 
removed in Con, Ex, and ExR groups and placed into ice-cold phosphate buffered saline containing 
protease inhibitor cocktail complete, ETDA-free (Roche Applied Science) and phosphatase 
inhibitor cocktail (Sigma). Nuclear and cytosolic components were obtained using a commercially 
available NE-PER Nuclear and Cytoplasmic Extraction Reagents kit (ThermoFisher), according 
to the manufacturer's instructions.  
Mitochondrial Co-immunoprecipitation Assay. Isolated IMF mitochondrial fractions were 
solubilized with 1% Triton X-100 and supplemented with protease and phosphatase inhibitor 
cocktails. Mitochondria were incubated with anti-Mfn2 (M6444, Lot No. 103M4780, Sigma) 
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overnight at 4°C on a nutator mixer, and the supernatant was collected by centrifugation at 12,000 
g for 10 minutes at 4°C. The following day protein A/G plus-agarose immunoprecipitation reagent 
(sc-2003, Santa Cruz) was added to the mixture and incubated for 1 hour at 4°C on a nutator mixer. 
The supernatant fraction was removed from the beads after centrifugation, representing unbound 
proteins. The collected beads were washed three times and eluted three times with 50 μl of SDS-
PAGE gel loading buffer to obtain the maximum elution of purified complexes. Co-
immunoprecipitates were used for immunoblot analysis for ubiquitin (SPA-203, Lot No. 1051534, 
Enzo Life Sciences). Anti-IgG antibody was used as a non-specific control. 
Immunoblotting. Muscle extracts and isolated nuclear, cytosol and mitochondrial fractions 
were separated using SDS-PAGE (12-15% polyacrylamide) and later electroblotted onto 
nitrocellulose membranes. Membranes were blocked with 5% skim milk in TBST (Tris-buffered 
saline-Tween 20, 25 mM Tris HCl (pH 7.5), 1 mM NaCl, and 0.1% Tween 20) solution for 1 hour 
at room temperature. Next, blots were incubated with primary antibodies against LC3/microtubule-
associated protein light chain 3 (4108, Lot No. 3, Cell Signaling), p62/sequestosome 1 (P0067, 
Lot No. 015M4877V, Sigma), ubiquitin (SPA-203, Lot No. 1051534, Enzo Life Sciences), Parkin 
(4211, Lot No. 4, Cell Signaling), PGC-1α/peroxisome proliferator-activated receptor-γ 
coactivator-1α (ab3242, Lot No. 2691399, Millipore), PARIS/parkin-interacting substrate 
(ab130867, Lot No. GR235090-1, abcam), H2B/histone 2B (2943S, Lot No. 4, Cell Signaling), 
VDAC/voltage-dependent anion channel (ab14734, Lot No. GR121056-7) and α-tubulin (CP06, 
Lot No. D00175772, Millipore) overnight at 4 °C. On the next day, the blots were rinsed three 
times in TBST, followed by a 1 hour incubation period at room temperature with appropriate 
horseradish peroxidase-conjugated secondary antibodies. The blots were again washed three times 
in TBST and visually detected using enhanced chemiluminescence (Clarity ECL Western blotting 
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substrates, Bio-Rad, CA) and photographic film. Of note, the top band of p62 was quantified when 
two bands were visible. Films were then scanned and quantified using ImageJ software (Version 
1.48, NIH, USA). 
Statistical Analysis. Data were analyzed with Graph Pad 6.0 software, and values are 
reported as means ± SEM. Data were analysed using two-way analysis of variance (ANOVA), 
except for Fig. 1A which was analysed using a student’s t-test. For all two-way ANOVA analyses, 
Tukey's post hoc test was used to identify individual differences when statistical significance was 
observed. Statistical differences were considered significant if P < 0.05. 
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RESULTS 
Aged mice exhibit reduced whole muscle mass and mitochondrial content. To determine the 
role of Parkin and age in skeletal muscle, we first assessed the anatomical characteristics of young 
and aged groups of WT and Parkin KO animals. Total body mass did not differ between WT and 
KO mice, but both genotypes displayed a 1.6- and 1.8-fold increase in body mass with age, 
respectively (P < 0.05; Table 1). Quadriceps muscle mass did not differ between young animals, 
while aged WT and KO animals exhibited 12% decreases in whole quadriceps muscle mass when 
corrected for tibia length, compared to young mice (Table 1). Thus, we attribute the age-related 
increase in body mass to an increase in body fat, as illustrated by the significant ~8-fold increase 
in epididymal fat mass when corrected for total body mass, irrespective of genotype (P < 0.05; 
Table 1). In addition, we measured Parkin protein expression in young and aged whole quadriceps 
muscle. We found a robust ~4-fold increased expression of Parkin in aged, compared to young 
muscle (P < 0.05; Fig. 1A). Whole muscle mitochondrial content was assessed by using a 
cytochrome c oxidase (COX) activity assay. There was no difference between young WT and KO 
animals, and both genotypes exhibited similar decrements of ~40% with age (P < 0.05; Fig. 1B).  
We also examined state 4 and glutamate/pyruvate-driven state 3 mitochondrial respiration. No 
effect of age was observed. When young animals were compared, no differences between 
genotypes were noted in state 4 respiration, however a 20% decrease in state 3 mitochondrial 
respiration was detected in KO mice compared to WT counterparts (P < 0.05; Fig. 1C). In young 
WT and KO animals, no difference in ROS emission was observed under state 4 and 3 conditions. 
However, with age, Parkin KO animals displayed a ~2.7-fold increase in state 4 ROS production, 
when compared to WT animals (P < 0.05; Fig. 1D). 
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Aging results in reduced exercise performance and mitochondrial Parkin localization, along 
with increased acidosis. We next investigated the role of Parkin with aging and exercise 
performance. In young WT animals, we found a 1.5-fold increase in Parkin localization to 
mitochondria immediately following an acute bout of exercise (P < 0.05; Fig. 2A). Parkin 
localization on mitochondria was severely reduced with age, and the exercise-induced response 
was abolished (P < 0.05; Fig. 2A). To determine Parkin’s requirement in endurance performance, 
we subjected young and aged groups of WT and KO mice to a bout of acute, prolonged exercise. 
No significant differences were detected for total distance run between young WT and KO animals, 
and both genotypes exhibited elevated blood lactate concentrations of ~8 mM immediately 
following exercise (P < 0.05; Fig. 2C). Aged mice ran only 25% of the distances of their younger 
counterparts (P < 0.05; Fig. 2B), and this response was accompanied by 1.5-2-fold higher exercise-
induced increases in blood lactate levels with age (P < 0.05; Fig. 2C).     
Mitophagy flux is induced following exercise, but this signaling is attenuated in the absence 
of Parkin, and with age. To evaluate a role for Parkin on mitophagy during exercise, mice were 
subjected to acute exercise to induce mitophagy flux. Following each condition, mitochondria 
were isolated from the hindlimb muscles of mice to examine the mitochondrial localization of 
autophagy proteins, and autophagy flux was calculated based on the difference between 
colchicine- and vehicle-treated animals. Our results indicate that basal mitophagy LC3II and p62 
flux was not significantly different between young WT and KO animals. During exercise, 
mitochondrial LC3II flux was elevated by 2.7-fold in young WT animals (P < 0.05; Fig. 3A and 
3B). This was attenuated in the absence of Parkin. We also detected a 2-fold increase in p62 flux 
in young mice with exercise (P < 0.05; Fig. 3A and 3C). These data indicate that exercise can 
induce mitophagic flux, and that the magnitude of this increase is Parkin-dependent.  
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We then directly compared the role of Parkin-mediated mitophagy between young and aged 
animals. Basal LC3II and p62 flux were significantly higher in aged WT animals, when compared 
to young WT animals (P < 0.05; Fig. 4A–C). With exercise, LC3II flux and p62 flux in aged WT 
animals did not increase additionally when compared to young WT animals (Fig. 4A–C). In the 
absence of Parkin, basal LC3II and p62 flux were also elevated in aged mice, compared to young 
mice (P < 0.05; Fig. 4D–F), and were not significantly different following exercise (Fig. 4D–F). 
In contrast to young KO animals, basal LC3II flux (P < 0.05; Fig. 4G) and p62 flux (P < 0.05; Fig. 
4H) were both significantly elevated in aged KO. Furthermore, the magnitude of basal LC3II flux 
was significantly higher in aged KO when compared to aged WT animals (P < 0.05; Fig. 4G). Our 
data indicate that mitophagic signaling is enhanced within aged muscle, and this effect may reduce 
the potentiation of exercise on mitophagy flux.  
Acute exercise induces mitochondrial ubiquitination in young animals, but is attenuated with 
age. To assess the potential role of Parkin in exercise-induced protein ubiquitination, we examined 
global ubiquitination on isolated mitochondrial fractions from young WT and KO animals. Basal 
ubiquitin flux did not differ between genotypes (Fig. 5A and 5B). Ubiquitin flux increased by ~4.1-
fold in young WT, immediately following exercise (P < 0.05; Fig. 5A and 5B), corresponding with 
the increase in Parkin localization on mitochondria in young WT animals. Remarkably, 
mitochondrial ubiquitination was also similarly increased by exercise in young KO animals (P < 
0.05; Fig. 5A and 5B). In aged muscle, there were also no differences in basal ubiquitin flux on 
isolated mitochondria between WT and KO animals (Fig. 5C and 5D). However, in contrast to 
young animals, ubiquitin flux was considerably higher with age (compare control conditions in 
Fig. 5D vs 5B), and the effect of acute exercise to increase mitochondrial ubiquitination was 
completely abolished (Fig. 5C and 5D).    
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We extended this analysis further to assess the potential function of Parkin on the 
ubiquitination of specific proteins during exercise. We evaluated Mitofusin-2 (Mfn2) 
ubiquitination, a known outer mitochondrial membrane target of Parkin, using mitochondrial co-
immunoprecipitation to resolve Mfn2-ubiquitin complexes following exercise in young and aged 
Parkin KO and WT mice. The basal formation of Mfn2-ubiquitin complexes was significantly 
reduced by 52% in young KO animals, relative to young WT controls (P < 0.05; Fig. 5E and 5F). 
Consistent with the translocation of Parkin to the mitochondria with exercise, we found that 
exercise significantly enhanced Mfn2 ubiquitination on mitochondria of young animals by ~2-
fold, relative to young WT control animals (P < 0.05; Fig. 5F). With age, Mfn2 ubiquitination was 
increased basally by ~2-fold (P < 0.05; Fig. 5E and 5F), in both WT and KO counterparts. This 
ubiquitination remained unchanged with exercise (Fig. 5E and 5F). These data indicate that Parkin 
is involved in maintaining basal mitochondrial protein ubiquitination in muscle, and that exercise 
can promote protein ubiquitination even in the absence of Parkin, in young animals.   
PGC-1α and PARIS localization to the nucleus are negatively correlated in response to 
exercise in young animals, but this relationship is abolished with age. Parkin is not only involved 
in the ubiquitination of mitochondrial proteins, but has also been shown to regulate the levels of 
transcriptional regulators, such as Parkin interacting substrate, PARIS. It is known that PARIS 
transcriptionally represses PGC-1α, known as the master regulator of mitochondrial biogenesis, in 
the absence of Parkin. Interestingly, the basal levels of PARIS localized to the nucleus did not 
differ between young WT and KO animals (Fig. 6A and 6B). In aged animals, nuclear PARIS 
localization, when corrected for total PARIS content, was 1.3-2-fold higher in KO and WT 
animals, when compared to young counterparts (P < 0.05; Fig. 6A and 6B). Similarly, nuclear 
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PGC-1α abundance was not affected by the absence of Parkin, but was reduced by 35-40% in aged 
WT and KO mice (P < 0.05; Fig. 6A and 6C). 
We next explored if exercise could influence the subcellular localization of these 
transcriptional regulators. A significant interaction between genotype and exercise on nuclear 
PARIS localization was found in young animals (P < 0.05; Fig. 7A and 7C). With acute exercise, 
nuclear PARIS localization diminished in WT animals, but was enhanced in the nuclear fractions 
of mice lacking Parkin. A similar interaction was found for PGC-1α in the nucleus of young mice 
following exercise (P < 0.05; Fig. 7A and 7E). PGC-1α increased significantly by 2.2-fold in the 
nucleus of WT animals, immediately after exercise (P < 0.05; Fig. 7A and 7E). This exercise-
induced increase of nuclear PGC-1α abundance was completely negated in the absence of Parkin. 
In aged animals, nuclear PGC-1α and PARIS remained unchanged following exercise (Fig. 7B, 
7D and 7F). These data suggest that exercise can induce the translocation of PGC-1α and PARIS 
but that this is qualitatively different in the absence of Parkin, and abolished with age.  
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DISCUSSION 
Sarcopenia is defined as a loss of muscle mass and strength that occurs with age (22). It is 
established that sarcopenia is governed, in part, by lowered mitochondrial content (6, 34, 42) and 
reduced transcriptional regulation towards mitochondrial biogenesis (33). Although much is 
known about the synthesis of mitochondria, fewer studies have examined mitochondrial 
degradation (i.e. mitophagy) with age. Thus, the purpose of our research was to evaluate 
mitochondrial content and function, along with rates of mitophagy, in the context of sarcopenic 
muscle loss. Consistent with previous studies (34, 42), we observed that aged animals displayed 
sarcopenia, accompanied by decrements in whole muscle mitochondrial volume. This occurred 
concomitant with the age-related reductions in endurance performance, accompanied by elevated 
lactic acid levels during exercise. In contrast to these changes in mitochondrial content, we 
detected no differences in glutamate-stimulated mitochondrial respiration rates between young and 
aged animals. Mitochondrial dysfunction is a common age-related outcome (3, 9, 29, 38), but it is 
not always observed in aged muscle (6, 20, 34, 45), likely a result, in part, of divergent physical 
activity patterns among aged cohorts (18).  
Parkin is an E3 ubiquitin ligase selectively recruited to dysfunctional mitochondria during 
mitophagy (39). Under basal conditions, endogenous Parkin is predominately found in the cytosol 
(39, 55). During conditions of elevated mitochondrial stress, PINK1 stabilizes on the outer 
mitochondrial membrane and selectively recruits Parkin from the cytosol to activate it (40). Once 
activated, Parkin transfers ubiquitin onto outer mitochondrial membrane targets, such as Mfn2 (7, 
10) and VDAC (11), to induce the removal of superfluous mitochondria. Mitophagy is a highly 
dynamic process that continually degrades superfluous, dysfunctional mitochondria within the 
cell. The measurement of autophagy pathway proteins at any given timepoint is acknowledged to 
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provide only a snapshot that may not be representative of the process. As such, different inhibitors 
are commonly used to block certain steps of autophagy to measure flux. In our study, the 
microtubule-destabilizing drug colchicine was acutely injected intraperitoneally, thereby 
preventing autophagosomal transport to lysosomes for degradation (24). As a result, autophagy 
proteins did not degrade and accumulated in the cytosol, providing an indication of autophagic 
activity. To determine mitophagic flux, we calculated the difference between colchicine- and 
vehicle-treated isolated mitochondria of the same condition. 
It has been shown that autophagy is required to maintain muscle mass and myofiber integrity 
(36), and that overexpression of Parkin can positively impact longevity (19, 47). We observed no 
difference in muscle mass and mitochondrial content between young WT and Parkin KO animals, 
and there was no apparent additional decline in muscle or mitochondria in the absence of Parkin 
in aged animals. These findings indicate that the basal regulation of muscle mass is Parkin-
independent. Interestingly, state 3 (active) mitochondrial respiration was significantly lower in 
young KO animals when compared to WT animals. Given that state 3 respiration is a surrogate 
measure for maximal ATP production in well-coupled mitochondria, KO mice should 
hypothetically have a lower maximal exercise capacity than WT mice. The lack of difference in 
running performance between young WT and KO mice, along with similar blood lactate levels, 
suggest the presence of a normal excess of mitochondrial capacity within muscle. However, we 
did observe an elevation in mitochondrial ROS production in aged KO animals. This is likely a 
consequence of altered glutamate-stimulated ETC complex I function in aged KO skeletal muscle, 
as others have reported that the absence of Parkin sensitizes complex I to oxidative stress (43) and 
mitochondrial toxins (48). This is consistent with a previous study showing that oxidative stress is 
exacerbated with a loss of Parkin activity in neuronal cells (57).  
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To further explore the physiological function of Parkin on mitophagy, we assessed Parkin’s 
ability to translocate to mitochondria with exercise and age, as previous studies have shown that 
mitophagy may be required for exercise-induced remodeling of muscle (60). We did observe that 
mitochondrial localization of Parkin increased immediately following exercise in young WT 
animals, consistent with our previous study (60), but that this was attenuated with age. This 
observation, along with an increased expression of Parkin in aged muscle, suggests an impairment 
of Parkin translocation to the mitochondria with age and exercise. A similar attenuation in Parkin 
and its association with the organelle was documented in aged cardiac mouse muscle (19). 
Upon mitochondrial depolarization, a multitude of outer mitochondrial membrane proteins are 
targeted for Parkin ubiquitination (52). Thus, our expectation was that basal ubiquitination would 
be reduced in the absence of Parkin. Although we detected no differences in mitochondrial 
ubiquitin flux when multiple protein targets were evaluated, further scrutiny using a mitochondrial 
co-immunoprecipitation assay of Mfn2, a bona fide target of Parkin (7, 10, 13), revealed a basal 
reduction of Mfn2-ubiquitin in young KO animals. However, neither the absence of Parkin, nor 
the consequent reduction in target ubiquitination, were sufficient to impact mitophagic LC3II, p62 
and ubiquitin flux in resting muscle. This suggests the existence of multiple mechanisms that 
compensate to determine basal mitophagic flux in Parkin KO animals.  
During exercise, we found that Mfn2 ubiquitin flux was enhanced in young WT animals, and 
that this increase paralleled changes in LC3II and p62 flux, which corroborates previous studies 
showing that mitophagic flux is enhanced following an acute bout of exercise (60). Unexpectedly, 
this was also found during exercise in young KO animals, further supporting the existence of 
alternative unidentified E3 ubiquitin ligases that could be compensating for the lack of Parkin. 
However, these may not be sufficient, as exercise-induced mitophagic LC3II flux remained 
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impaired in young KO animals. With age, Parkin ubiquitination on general and specific OMM 
targets was enhanced, and remained unchanged in the absence of Parkin. Furthermore, age had an 
abating effect on exercise-induced ubiquitin signaling in aged animals. We speculate that this may 
be due to the altered activity of deubiquitinating enzymes (DUBs) contained on mitochondria and 
may be altered with age and/or exercise, which likely play a role in ubiquitin signaling and 
organelle degradation (1, 61).   
The attenuated exercise-induced ubiquitin signaling that we observed in our aging animals 
appears to be a fundamental characteristic of aging muscle, since we have previously observed 
reduced signaling in response to our experimental model of endurance exercise (33). However, the 
requirement of Parkin and the effect of age on mitophagic flux in exercising muscle remains 
unknown. Under basal conditions, we did not detect a difference in mitophagic flux of LC3II, p62 
and ubiquitin between young WT and KO animals. Our results did confirm an acute exercise-
induced elevation of mitophagic LC3II flux in young animals, which was attenuated in the absence 
of Parkin. Interestingly, basal LC3II and p62 mitophagic flux were enhanced in aged WT muscle, 
and this was paralleled by greater generalized mitochondrial ubiquitination, as well as protein-
specific (i.e. Mfn2) ubiquitination. This is in line with previous studies documenting reductions in 
Mfn2 protein abundance in aged muscle (21, 53). These data fortify the concept that Parkin and its 
association with OMM targets is altered with age. We extended these conclusions in an aged 
exercising mouse model, and found that the induction of LC3II and p62 mitophagic signaling with 
exercise was attenuated in aged muscle. This was likely due, in part, to an elevated baseline 
expression of these mitophagic proteins. Our data suggest that basal autophagosomal formation is 
not reduced with age, and that the increased expression and mitochondrial localization of ubiquitin, 
LC3II and p62 suggest the existence of accelerated mitophagy flux, at least up to the point of 
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lysosomal degradation. Although definitive data do not yet exist in skeletal muscle, our previous 
results suggest the idea of defective lysosomal function with age. We have previously provided 
evidence that aged muscle displays lipofuscin granules within lysosomes, a clear indicator of 
lysosomal impairment (42). This supports the mitochondrial-lysosomal axis theory of aging (4), 
which hypothesizes that impairments in lysosomal activity may contribute to mitochondrial 
accumulation and dysfunction in aged post-mitotic tissue, such as muscle (6, 34, 42). The lysosome 
is a vital organelle for autophagosomal degradation, and its biogenesis is regulated by transcription 
factor EB (TFEB) (51). Roles for TFEB in mitochondrial turnover (41, 54) and exercise (27, 35) 
have been recently documented. However, future studies will need to examine the possibility of 
lysosomal biogenesis and function by examining possible differences in TFEB activation between 
young and aged animals. 
In recent years, there has been mounting attention on identifying regulatory factors that can 
control the two opposing processes of mitochondrial biogenesis and mitophagy. Recent work has 
documented a potential Parkin-PARIS-PGC-1α relationship. With a collapse in mitochondrial 
membrane potential, PARIS can localize on mitochondria where it is targeted for proteasomal 
degradation by PINK1 and Parkin (31). This can, in turn, diminish the repressive effect of PARIS 
on PGC-1α, permitting the transcription of nuclear genes encoding mitochondrial proteins (56) 
and improved cellular respiration (58). When Parkin is absent, it has been reported that PARIS can 
increase within the nucleus and transcriptionally repress PGC-1α (56, 58). This presents a potential 
nexus for the regulation of mitochondrial biogenesis and degradation, and remains unexplored in 
the context of a physiologically relevant stressor such as exercise. Thus, we expected KO animals 
to display an elevation in PARIS and a decrease in PGC-1α. Interestingly, our results illustrate a 
negative correlation between PARIS and PGC-1α localization in the nucleus that is dependent on 
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exercise, and on the presence of Parkin in young animals. This reciprocal relationship was not 
visible under resting, basal conditions. However, with exercise the nuclear abundance of PGC-1α 
was increased in young WT animals, as reported by other studies (32, 49, 60, 62), and the nuclear 
translocation of PARIS was also enhanced with exercise, but only in young KO animals. This 
finding recapitulates previous work showing that nuclear PARIS levels increase with Parkin 
knockdown, and that it translocates into the nucleus under conditions of cellular stress (31). In 
aged muscle, we expected that elevated Parkin expression would repress PARIS and activate PGC-
1α. In contrast, nuclear PARIS abundance was increased in aged muscle of both WT and KO 
animals, while the levels of nuclear PGC-1α were reduced. This likely contributes to the impaired 
transcriptional drive for mitochondrial biogenesis in aged muscle, leading to the decrements in 
mitochondrial content observed with age. Furthermore, recent research has also revealed that 
mitochondrial Parkin activation is required for PARIS degradation (31). Since Parkin localization 
to the organelle is attenuated with age, this may explain the enhanced nuclear localization of PARIS 
in aged muscle. These findings suggest an important Parkin-PARIS-PGC-1α axis that may be 
involved in muscle remodeling with exercise and warrants further investigation.  
In summary, our data describe a role for Parkin-mediated mitochondrial degradation during 
exercise in muscle. Importantly, our study demonstrates that basal mitophagic flux is not depressed 
but rather enhanced with age, at least up to the level of the lysosome. We show for the first time 
that acute exercise-induced mitophagic flux is dependent on Parkin, and that this exercise signaling 
is weakened with age. Additional studies are required to determine whether there is a direct 
connection between mitophagy flux and lysosomal activity with age, and whether exercise or 
contractile activity can improve mitophagic flux along with lysosomal capacity. 
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FIGURE LEGENDS 
Fig. 1. Effect of aging and Parkin deficiency on mitochondrial content and function. (A): 
Representative Western blot of Parkin expression in young (Y) and aged (A) skeletal muscle of 
control wild-type (WT) mice above. A graphical representation is shown below (n = 4). (B): 
Cytochrome c oxidase (COX) activity in quadriceps muscle of young and aged Parkin KO and WT 
animals (n = 6). (C): Mitochondrial state 4 and state 3 respiration rates in KO compared with WT 
animals (n = 6–9, ¶P < 0.05, vs young WT state 3). (D): Mitochondrial ROS production expressed 
per natom of oxygen consumed in Parkin KO and WT mice (n = 6–9, #P < 0.05, vs remaining state 
4 conditions). Values are means ± SEM. *P < 0.05, main effect of age. WT, wild-type; KO, Parkin 
knock-out; A.U., arbitrary units.   
 
Fig. 2. Effect of Parkin and age on exercise performance. (A): Representative Western blot of 
Parkin localization on isolated mitochondria from young and aged WT muscle, prior to exercise 
(Con) and immediately following exercise (Ex). Quantification of mitochondrial Parkin 
localization is shown below, corrected for loading using mitochondrial voltage-dependent anion 
channel (VDAC) (n = 3). (B): Animal performance (i.e. total distance run) of WT and KO mice 
injected with water (Veh) or 0.4 mg/kg colchicine (Col) (n = 6–8). (C): Blood lactate levels 
measured prior to (Con), and immediately following exercise (Ex) (n = 6–8). Values are means ± 
SEM. †P < 0.05, interaction effect of exercise and age. *P < 0.05, main effect of age. ¶P < 0.05, 
vs young Con. #P < 0.05, significant difference from aged WT mice. WT, wild-type; KO, Parkin 
knock-out; A.U., arbitrary units. 
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Fig. 3. Mitophagy flux following an acute bout of exercise in young Parkin KO and WT mice. (A): 
Representative Western blots of LC3II and p62 localization on isolated mitochondria from WT 
and KO mice injected with water (Veh) or 0.4 mg/kg colchicine (Col). Quantification of 
mitochondrial LC3II flux (B) and p62 flux (C) is shown (n = 8). Mitophagy flux of LC3II and p62 
were assessed prior to exercise (C), immediately following exercise (Ex), and following 2 hours 
of recovery (ExR). Values are means ± SEM. ¶P< 0.05, vs WT Con and WT ExR. Voltage-
dependent anion channel (VDAC) was used as a mitochondrial loading control. WT, wild-type; 
KO, Parkin knock-out; LC3II, lipidated microtubule-associated protein 1A/1B-light chain 3; p62, 
sequestosome 1; A.U., arbitrary units. 
 
Fig. 4. Mitophagy flux following an acute bout of exercise in young and aged Parkin KO and WT 
mice. (A): Representative Western blots of LC3II and p62 localization on isolated mitochondria 
from young and aged WT injected with water (Veh) or 0.4 mg/kg colchicine (Col). Quantification 
of mitochondrial LC3II flux (B) and p62 flux (C) is shown (n = 6). (D): Representative Western 
blots of LC3II and p62 localization on isolated mitochondria from young and aged KO injected 
with water [Veh (Vehicle)] or 0.4 mg/kg colchicine (Col). Mitochondrial LC3II flux (E) and p62 
flux (F) with age and exercise are quantified (n = 6). Quantification of basal LC3II flux (G) and 
p62 flux (H) with age only. Mitophagy flux and localization of LC3II and p62 were assessed prior 
to exercise (C) and immediately following exercise (Ex). Values are means ± SEM. *P < 0.05, 
main effect of age. ¶P < 0.05, main effect of exercise. #P < 0.05, significant difference from aged 
WT mice. Voltage-dependent anion channel (VDAC) was used as a mitochondrial loading control. 
WT, wild-type; KO, Parkin knock-out; LC3II, lipidated microtubule-associated protein 1A/1B-
light chain 3; p62, sequestosome 1; A.U., arbitrary units. 
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Fig. 5. Mitochondrial ubiquitination following an acute bout of exercise in young and aged Parkin 
KO and WT mice. (A): Representative Western blot of ubiquitin (Ub) on isolated mitochondria 
from young WT and KO mice injected with water (Veh) or 0.4 mg/kg colchicine (Col). (B): 
Quantification of mitochondrial Ub flux in young WT and KO mice (n = 8). (C): Representative 
Western blot of ubiquitin (Ub) on isolated mitochondria from aged WT and KO mice injected with 
water (Veh) or 0.4 mg/kg colchicine (Col). (D): Quantification of mitochondrial Ub flux in aged 
WT and KO mice (n = 6). (E): Mfn2 was immunoprecipitated (IP) followed by immunoblotting 
(IB) for ubiquitin on isolated mitochondria from young and aged groups of Parkin KO and WT 
animals prior to, and immediately following exercise. (F): Graphical representation of 
mitochondrial Mfn2 ubiquitination relative to young WT control values (n = 6). In young animals, 
mitochondrial Ub flux was assessed prior to exercise (C), immediately following exercise (Ex), 
and following 2 hours of recovery (ExR). There was no recovery group for the aged animals in the 
measurement of mitochondrial ubiquitination following exercise (C–F). Values are means ± SEM. 
¶P< 0.05, main effect of exercise. #P< 0.05, vs young WT Con. Voltage-dependent anion channel 
(VDAC) was used as a mitochondrial loading control. Immunoglobulin G (IgG) was used as a 
negative control for co-immunoprecipitation validation. WT, wild-type; KO, Parkin knock-out; 
Ub, ubiquitin; Mfn2, Mitofusin-2; IgG, Immunoglobulin G; A.U., arbitrary units. 
 
Fig. 6. Effect of Parkin and age on PARIS and PGC-1α nuclear translocation. (A): Representative 
Western blots for PARIS, PGC-1α, H2B and α-tubulin. (B): Graphical quantification of [nuclear 
(N)] PARIS represented as a percentage of total [cytosol (C) + nuclear (N)] PARIS (n = 6). (C): 
PGC-1α nuclear abundance (n = 6). Values are means ± SEM. *P < 0.05, main effect of age. #P < 
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0.05, significant difference from aged mice. Nuclear and cytosol protein expression were corrected 
for loading using nuclear histone 2B (H2B) and α-tubulin, respectively. PARIS, Parkin-Interacting 
Substrate; PGC-1α, peroxisome proliferator gamma coactivator-1α. 
 
Fig. 7. Effect of Parkin and age on exercise-induced PARIS and PGC-1α subcellular localization. 
(A) and (B): Representative Western blots for PARIS, PGC-1α, H2B and α-tubulin are shown. 
Graphical representation of [nuclear (N)] PARIS represented as a percentage of total [cytosol (C) 
+ nuclear (N)] PARIS in young (C) and aged (D) mice (n = 5–8). Graphical quantification of PGC-
1α in nuclear fraction of young (E) and aged (F) animals (n = 6–7). In young animals, 
measurements of PARIS (C) and PGC-1α (E) were done prior to exercise (Con), immediately 
following exercise (Ex), and following 2 hours of recovery (ExR). There was no recovery group 
for aged animals in the evaluation of PARIS (D) and PGC-1α (F) subcellular localization following 
exercise. Values are means ± SEM. †P < 0.05, interaction effect of exercise and genotype. ¶P < 
0.05, vs WT Con. Histone 2B (H2B) was used as a nuclear loading control and α-tubulin was used 
as a cytosol loading control. PARIS, Parkin-Interacting Substrate; PGC-1α, peroxisome 
proliferator gamma coactivator-1α; WT, wild-type; KO, Parkin knock-out. 
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ABSTRACT 
 Parkin is a ubiquitin ligase that is involved in the selective removal of dysfunctional 
mitochondria. This process is termed mitophagy and can assist in mitochondrial quality control. 
Endurance training can produce adaptations in skeletal muscle toward a more oxidative phenotype, 
an outcome of enhanced mitochondrial biogenesis. It remains unknown if changes in Parkin-
mediated mitophagy are involved in the training-induced increases in mitochondrial content and 
function. Our results indicate that Parkin is required for the basal maintenance of mitochondrial 
function. The absence of Parkin did not alter mitophagy basally, however, acute exercise produced 
an elevation in mitophagy flux in a Parkin-dependent manner. Mitochondrial content was increased 
following training in KO animals, and this occurred without an induction of PGC-1α signaling. 
Interestingly, the adaptive response of increased muscle mitochondrial content to training did not 
influence basal mitophagy flux, despite an enhanced expression and localization of Parkin to 
mitochondria. Furthermore, exercise-induced mitophagy flux was attenuated with training in WT 
animals, suggesting a lower rate of mitochondrial degradation due to improved organelle quality 
with endurance training. In contrast, training did not improve mitochondrial dysfunction in KO 
animals, and the absence of Parkin with training may engender an accumulation of dysfunctional 
organelles. In KO animals, this is likely the reason for the impaired training-induced attenuation 
in mitophagy flux compared to WT animals. Our study demonstrates that exercise-induced 
mitophagy flux is Parkin-mediated, and reduced with training due to increased mitochondrial 
content and quality.    
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INTRODUCTION 
Skeletal muscle is a highly malleable tissue that displays a remarkable adaptive plasticity. 
Chronic contractile activity of muscle can evoke molecular and biochemical adaptations that 
enable muscle to improve its oxidative capacity (22, 64). This enhancement is, in part, the result 
of greater mitochondrial enzyme gene expression (16, 24). It is well established that endurance 
training can increase mitochondrial biogenesis and alter muscle metabolism (9, 41, 45). In trained 
muscle, an elevation in mitochondrial content improves oxidative phosphorylation, while lowering 
the reliance on glycolysis (7, 10). The process of generating new organelles is mediated, in part, 
by the transcriptional regulator peroxisome proliferator-activated receptor-γ coactivator-1α, PGC-
1α. During acute bouts of exercise, PGC-1α can translocate into the nucleus (40, 45, 66) and 
upregulate the transcription of nuclear genes encoding mitochondrial proteins (NUGEMPs) (65), 
as well as transcription factors (14, 55) such as mitochondrial transcription factor A (TFAM). 
TFAM is a nuclear-encoded protein involved in mitochondrial DNA (mtDNA) transcription, along 
with the expression of several protein subunits of the respiratory electron transport chain (37). 
Chronic contractile activity can increase TFAM protein expression, followed by accelerated 
mitochondrial protein import and mtDNA binding (18). TFAM abundance has been shown to 
increase in response to training in humans (2). Thus, the induction of mitochondrial biogenesis 
during exercise requires the coordination of both nuclear and mitochondrial genomes for 
subsequent organelle assembly and function (25, 71, 72).  
Mitochondria are considered to be primary sites for free radical formation (52, 74). When this 
production is left unchecked, oxidative stress can impair ATP generation and induce cellular injury. 
To combat against sustained damage, the selective removal of dysfunctional mitochondria, known 
as mitophagy, is swiftly activated. Organelle turnover is the balance between mitochondrial 
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biogenesis and mitophagy, and the combination of these processes aids in the maintenance of 
energetic homeostasis. An imbalance of these two opposing pathways can lead to the development 
of cardiovascular diseases (17, 67), cancer (3, 69), diabetes (26, 61) and accelerate aging (5, 49, 
54). The most well characterized pathway of mitophagy involves PTEN-induced putative kinase 
1 (PINK1) and ubiquitin ligase Parkin (51). Under non-stressful conditions, PINK1 import into 
polarized mitochondria ensues, and is followed by its proteolysis (27). During cellular 
perturbations in which a collapse in organelle membrane potential occurs, PINK1 import into the 
matrix is impaired and its stabilization on the outer mitochondrial membrane (OMM) serve to 
recruit and activate Parkin (44, 47, 70). PINK-1 mediated phosphorylation of Parkin (33, 59) and 
ubiquitin (30, 31, 35) allows for the accretion of polyubiquitin chains on several protein targets of 
the OMM. This mobilizes the autophagy adaptor protein p62 to tagged mitochondria through its 
ubiquitin binding domain (13, 34). Lipidated microtubule-associated protein-light chain 3 (LC3II) 
is a protein bound on the phagophore membrane that can associate with p62 (4, 50), ultimately 
resulting in the autophagosomal enclosure of dysfunctional mitochondria as a cellular safeguard 
from additional oxidative damage (58). The autophagosome is then terminally degraded at the 
lysosome.  
 Recent evidence suggest that acute exercise is sufficient to activate autophagy (20, 21). 
However, few studies have examined the potential role of mitophagy during exercise. We have 
previously shown that skeletal muscle of exercised mice exhibits enhanced mitophagy flux, and 
that this is partially dependent on PGC-1α (66). In another study, the acute inhibition of autophagy 
in mice led to an accumulation of dysfunctional mitochondria in locomotor muscles during 
damaging eccentric exercise (68). While these studies collectively demonstrate that mitochondrial 
degradation occurs during acute exercise, they do not clarify the effects of prior endurance training 
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and how it can influence mitophagy. Current research seems to propose that autophagy may be 
enhanced in endurance trained muscle as an adaptation in improving exercise performance (12, 
29, 32, 39). Yet, these studies do not provide a direct measurement of mitophagy using flux 
measurements, nor do they indicate how mitophagy may interact with the process of biogenesis 
that occurs with endurance training. In particular, Parkin has been shown to regulate both 
mitochondrial biogenesis and mitophagy, and the in vitro overexpression of wild-type Parkin can 
interact with TFAM to increase mtDNA transcription and replication, as well as increase 
mitochondrial mass (36, 53). Parkin can also increase PGC-1α protein expression through 
downregulation of Parkin-interacting substrate (PARIS) (60, 62). The activation of Parkin can 
target PARIS, a transcriptional repressor of PGC-1α, to the proteasome for degradation (38). Thus, 
Parkin may serve as a potential channel of communication between mitophagy and mitochondrial 
biogenesis. Thus, the purpose of our study was to investigate how Parkin is involved in mediating 
both biogenesis and mitophagy using, WT and Parkin KO mice that were either sedentary, or 
subjected to endurance training via voluntary wheel running. We also examined mitophagy flux in 
trained animals with a subsequent bout of acute exercise to determine the adaptive effect of prior 
endurance training.       
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MATERIALS AND METHODS 
Animal Model. C57BL/6 (WT) and B6; 129S4-Park2tm1Shn/J (Parkin KO; 006582) mice were 
obtained from Jackson Laboratories. The generation of these mice has been previously described 
(15). To genotype progeny, ear clippings were obtained from each animal for DNA extraction. 
JumpStart REDtaq polymerase (Sigma-Aldrich, St. Louis, MO) was incubated with DNA extracts, 
as well as forward and reverse primers specific to nucleotides of the WT or altered Parkin gene, 
and amplified using PCR. The reaction products were separated on a 1.5% agarose gel and 
visualized with the use of ethidium bromide.  
Voluntary Wheel Running. Three-month-old WT and Parkin KO mice were assigned to 
control or trained experimental groups. During the duration of the study, all mice were housed in 
a 12-hour light–dark cycle room, and were allowed access to water and food ad libitum. Runners 
were placed in cages with access to a freely rotating wheel attached to an external magnetic counter 
(Mini-Mitter, Bend, OR). The number of revolutions were noted every 24 hours for each animal, 
and converted into kilometers per week. The duration of the training protocol lasted 6 weeks.  
Endurance Exercise Protocol and Blood Lactate Measurement. Following the training 
protocol, cage wheels were taken out 2 days prior to treadmill habituation and acute exercise. 
During these 2 days, animals were injected intraperitoneally with colchicine (0.4 mg·kg−1·day−1), 
or an equal amount of vehicle (water) every 24 hours (28). Injections were performed in 
conjunction when mice were acclimatized to the treadmill. Vehicle- and colchicine treated animals 
in the exercise (Ex) group ran on a fixed, upward treadmill slope of 10°. Mice ran at 5 m/min for 
5 minutes, 10 m/min for 10 minutes, 15 m/min for 15 minutes, and 20 m/min for 20 minutes. The 
speed was then incrementally increased at 1 m/min for every 1 minute until exhaustion was 
achieved. Exhaustion was defined as the inability of the animal to continue running on the 
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treadmill, even in the presence of air jet stimulation. A small tail bleed was used to measure blood 
lactate with a Lactate Scout+ analyzer (EKF Diagnostics, Magdeburg, Germany). All animals were 
sacrificed by cervical dislocation immediately after exercise (Ex). All animal protocols were 
submitted and approved by the York University Animal Care Committee. Animals were treated in 
accordance with Canadian Council of Animal Care guidelines. 
Cytochrome c Oxidase (COX) Enzyme Activity. COX activity was measured as previously 
detailed (8), and performed on untrained and trained groups of WT and Parkin KO mice to measure 
whole muscle mitochondrial content. Briefly, protein extracts from mixed hindlimb muscles were 
added to a test solution containing fully reduced cytochrome c. Enzyme activity was determined 
by the maximal oxidation rate of completely reduced cytochrome c, measured by the change in 
absorbance at 550 nm using a Bio-Tek Synergy HT microplate reader, as previously described 
(45). 
Mitochondrial Isolation. Mixed hindlimb muscles from both sides of the animal were 
immediately placed into ice-cold mitochondrial isolation buffer, and were quickly minced and 
homogenized. Intermyofibrillar (IMF) mitochondrial sub-fractions were subjected to differential 
centrifugation, as described previously (6, 45, 57). Mitochondria were resuspended in 100mM 
KCl, 10mM MOPS, and 0.2% BSA. Freshly isolated mitochondria were used for mitochondrial 
respiration and reactive oxygen species (ROS) emission assays, and aliquots of mitochondrial 
extracts were stored at –80ºC for immunoblotting analyses. The protein concentration values of 
the isolated mitochondria were quantified using the Bradford method. 
Mitochondrial Respiration. Samples of isolated IMF mitochondria were incubated with VO2 
buffer (in mM: 250 sucrose, 50 KCl, 25 Tris, and 10 K2HPO4, pH 7.4) with continuous stirring in 
a respiratory chamber. Respiration rates (nanoatom of O2/min/mg) were driven by complex I of 
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the mitochondrial electron transport chain in the presence of 10 mM glutamate (state 4, Sigma) 
accompanied by the addition of 0.44 mM ADP (state 3, Sigma). The addition of NADH during 
state 3 respiration did not significantly alter respiration rates, indicating intact inner mitochondrial 
membrane integrity. All respiration rates were evaluated using the Mitocell S200 Micro 
Respirometry System (Strathkelvin Instruments, North Lanarkshire, UK).  
Mitochondrial ROS Production Assay. ROS emission was measured as done previously (45, 
56). Briefly, isolated IMF mitochondria were incubated with VO2 buffer at 37 °C for 30 minutes 
in a white polystyrene 96-well plate under state 4 and 3 conditions. The addition and oxidation of 
2',7'-dichlorodihydrofluorescein diacetate (50 µM H2DCFDA, ThermoFisher) emitted 
fluorescence between 480 and 520 nm, as measured with a Bio-Tek Synergy HT microplate reader, 
and is directly related to ROS emission. ROS emission was normalized per nanoatom of O2 
consumed, as measured during mitochondrial respiration. 
Immunoblotting. Whole quadricep muscle extracts were performed as described previously 
(56). Briefly, frozen muscle samples were pulverized, resuspended in buffer, sonicated and 
centrifuged. Muscle lysate was attained in the supernatant fraction, and the Bradford technique 
was used to determine protein content. Muscle homogenates and isolated mitochondrial fractions 
were separated using SDS-PAGE (12-15% polyacrylamide) and transferred to nitrocellulose 
membranes (BioRad). Blots were incubated overnight at 4 °C with primary antibodies against 
LC3/microtubule-associated protein light chain 3 (4108, Lot No. 3, Cell Signaling), 
p62/sequestosome 1 (P0067, Lot No. 015M4877V, Sigma), Parkin (4211, Lot No. 4, Cell 
Signaling), PGC-1α/peroxisome proliferator-activated receptor-γ coactivator-1α (ab3242, Lot No. 
2691399, Millipore), PARIS/parkin-interacting substrate (ab130867, Lot No. GR235090-1, 
abcam), COXI/cytochrome c oxidase subunit 1 (ab14705, Lot No. GR233531-3, abcam), 
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COXIV/cytochrome c oxidase subunvit 4 (ab140643, Lot No. GR192963-3, abcam), 
TFAM/mitochondrial transcription factor A (in house), VDAC/voltage-dependent anion channel 
(ab14734, Lot No. GR121056-7) and α-tubulin (CP06, Lot No. D00175772, Millipore). This was 
followed by an hour incubation period at room temperature with appropriate horseradish 
peroxidase-conjugated secondary antibodies. The membranes were visually distinguished using 
enhanced chemiluminescence (Clarity ECL Western blotting substrates, Bio-Rad, CA) and 
photographic film. Films were quantified using ImageJ software (Version 1.48, NIH, USA). 
Statistical Analysis. Data were analyzed with Graph Pad 6.0 software, and values are reported 
as means ± SEM. Data were analysed using two-way analysis of variance (ANOVA), except for 
Fig. 2A which was analysed using a student’s t-test. For all two-way ANOVA analyses, Tukey's 
post hoc test was used to identify individual differences when statistical significance was observed. 
Statistical differences were considered significant if P < 0.05. 
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RESULTS 
Physical characteristics of Parkin KO mice following endurance training. To determine 
the physiological importance of Parkin with training in skeletal muscle, we first assessed the 
physical characteristics of untrained and trained groups of WT and Parkin KO mice. During the 6 
weeks of voluntary wheel running, WT and Parkin KO mice did not significantly differ in running 
distance, with both genotypes running up to ~70 km/week (P < 0.05; Fig. 1A). Total body mass, 
quadriceps and heart weight were measured at the end of the 6 weeks of voluntary exercise. There 
was no significant effect of genotype or training on body mass (Fig. 1B), or quadriceps muscle 
mass when corrected for body weight (Fig. 1C). In addition, no differences between WT and KO 
animals existed with respect to heart mass when corrected for body weight, but both genotypes 
exhibited ~5-7% elevations following training (P < 0.05; Fig. 1D).    
The expression of several mitochondrial biogenesis regulatory factors is promoted 
following 6 weeks of voluntary exercise. We next examined the influence of endurance training on 
the expression of several protein markers involved in mitochondrial turnover. A large ~3-fold 
increase in Parkin expression was observed in trained, compared to untrained muscle (P < 0.05; 
Fig. 2A). In our study, COXIV expression did not differ between genotypes, or with training, when 
measured in whole muscle lysates (Fig. 2B). However, a significant interaction of genotype and 
training was observed for COXI (P < 0.05; Fig. 2B). Basal COXI expression did not differ between 
genotypes, but COXI expression was significantly elevated by 2.8- and 3.4-fold in both trained 
WT and Parkin KO animals, respectively, when compared to the untrained cohort (P < 0.05; Fig. 
2B). Parkin can regulate mitochondrial biogenesis by targeting Parkin interacting substrate 
(PARIS) to the proteasome for degradation. In the absence of Parkin, PARIS can transcriptionally 
repress PGC-1α, a transcriptional co-activator of mitochondrial biogenesis. Surprisingly, whole 
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muscle PGC-1α and PARIS protein expression did not differ between untrained WT and Parkin 
KO animals (Fig. 2C–2E). Rather, a significant interaction of training and genotype for PGC-1α 
emerged (P < 0.05; Fig. 2C). Training induced a 1.9-fold increase in whole muscle PGC-1α 
expression in WT animals that was abolished in the absence of Parkin (P < 0.05; Fig. 2C and 2D). 
Similarly, a main effect of training on whole muscle PARIS levels was observed between 
genotypes, concomitant with a significant 75% reduction in WT animals (P < 0.05; Fig. 2C and 
2E).  
Mitochondrial adaptations in Parkin KO animals following voluntary exercise. We next 
evaluated the effects of Parkin deficiency and exercise training on isolated mitochondria collected 
from the hindlimb muscles. Interestingly, the expression of nuclear-encoded mitochondrial 
proteins COXIV and TFAM did not differ between genotypes, or with training (Fig. 3A). 
Similarly, COXI expression did not differ between genotypes, but exhibited significant 2.1- and 
3.8-fold increases following 6 weeks of voluntary exercise training (P < 0.05; Fig. 3A and 3B). 
Mitochondrial yield represents the amount of mitochondrial protein extracted corrected for total 
muscle weight used for mitochondrial isolation. Although there was no difference between 
untrained WT and KO animals, both genotypes displayed significant increases with endurance 
training (P < 0.05; Fig. 3C). The biochemical assessment of cytochrome c oxidase (COX) activity 
confirmed the lack of difference between genotypes with respect to a marker of muscle 
mitochondrial content. However, voluntary wheel training significantly increased COX activity by 
~1.4-fold in both WT and Parkin KO mice (P < 0.05; Fig. 3D). We also examined whether 
mitochondrial respiration and reactive oxygen species (ROS) emission differed with voluntary 
wheel running, and in the absence of Parkin. No significant training effect was noted on 
mitochondrial respiration. However, a main effect of genotype was observed on state 3 
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mitochondrial respiration (P < 0.05; Fig. 3E). When untrained animals were compared, a 
significant 46% decrease in state 3 mitochondrial respiration was detected in KO, compared to WT 
mice (P < 0.05; Fig. 3E). Following endurance training, the impairment in organelle respiration 
remained significantly depressed in KO animals (P < 0.05; Fig. 3E). Similarly, a significant main 
effect of genotype was noted on mitochondrial ROS emission (P < 0.05; Fig. 3E) under state 4 
respiration conditions, and a significant interaction between genotype and the training response 
was observed. Whereas ROS emission tended to decline with training in WT animals, a significant 
1.8-fold difference in ROS emission was noted between trained KO and WT animals (P < 0.05; 
Fig. 3F). 
Endurance training results in improved exercise performance and attenuated 
mitochondrial Parkin localization following acute exercise. Following the 6 weeks of voluntary 
wheel training, we assessed the adaptive response of the muscle to an acute bout of exercise. In 
untrained WT animals, we found a 2-fold increase in Parkin localization to the mitochondria 
immediately following acute exercise (P < 0.05; Fig. 4A). In trained animals, organelle Parkin 
localization was already high under resting, control condition, and did not increase additionally 
with an acute bout of exercise (P < 0.05; Fig. 4A). Untrained WT and Parkin KO animals did not 
differ in their endurance performance when subjected to a bout of acute exercise (Fig. 4B). 
However, with training, both genotypes displayed ~1.8-fold increases in running distances when 
compared to their untrained counterparts (P < 0.05; Fig. 4B). Resting blood lactate levels were at 
~2 mM, and significantly rose to ~7-11 mM immediately after acute exercise (P < 0.05; Fig. 4C). 
There was no genotype effect on blood lactate levels after exercise, and a trend was observed for 
reduced lactate concentrations following training.  
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Mitophagy flux is induced following exercise, but this signaling is attenuated in the absence 
of Parkin, and with training. To determine a role for Parkin in mediating training-induced changes 
in exercise-induced mitophagy flux, mice were subjected to 6 weeks of voluntary wheel training, 
followed by a bout of acute exercise. Autophagy protein localization was quantified on isolated 
mitochondria from the hindlimb muscles of mice for each condition. Immunoblots were separated 
by genotypes due to the number of conditions. We normalized each experimental condition to an 
untrained WT sample, from the same data set, to determine any differences between genotypes 
(Fig. 5A, 5B, 6A and 6B). Following this, we calculated autophagy flux based on the difference 
between colchicine- and vehicle-treated animals. When untrained and trained animals were 
compared, no differences in LC3II and p62 flux were detected. In WT mice only, a main effect of 
acute exercise on LC3II and p62 flux was observed between untrained and trained groups (P < 
0.05; Fig. 5C and Fig. 6C). During acute exercise, a robust 2.4- and 2-fold increase in 
mitochondrial LC3II and p62 flux, respectively, was measured in untrained WT animals (P < 0.05; 
Fig. 5C). This response was attenuated with voluntary wheel training.  
To directly determine if Parkin was required for mediating these training-induced 
adaptations, we then compared mitophagy flux between WT and KO animals. In untrained 
animals, basal LC3II and p62 flux did not differ between genotypes (Fig. 5A–C and Fig. 6A–C). 
With an acute bout of exercise, LC3II and p62 flux did not increase in the absence of Parkin. 
Similarly, LC3II and p62 flux was not altered in KO animals with 6 weeks of voluntary wheel 
training, or with a subsequent bout of endurance exercise.  
To further analyze the adaptive potential of trained muscle, we calculated the fold change 
of mitophagy flux as a ratio of acute exercise-induced values over basal values. The analysis 
revealed a significant interaction of genotype and training on the fold change in LC3II flux (P < 
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0.05; Fig. 5D). Untrained WT animals displayed a 2.4-fold acute exercise-induced increase in 
LC3II flux, and this response was attenuated by 45% with training (Fig. 5D). As noted above, 
LC3II flux did not change with acute exercise in untrained and trained KO animals. In contrast to 
LC3II, a main effect of genotype was found when the fold change for p62 flux was calculated (P 
< 0.05; Fig. 6D). An increase in p62 flux was observed following a bout of endurance exercise in 
untrained WT animals. Following 6 weeks of voluntary wheel running, this response was 
attenuated by 43% (Fig. 6D). In the absence of Parkin, p62 flux remain depressed with acute 
exercise, and by training (Fig. 6D). 
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DISCUSSION 
Endurance exercise training is accompanied by an adaptive increase in muscle oxidative 
capacity. To produce this beneficial phenotype, successive bouts of acute exercise over 6 to 8 
weeks are required to elicit gradual, 50 to 100% elevations in mitochondrial protein content and 
enzyme activities (23). Prior to attaining an elevated mitochondrial content, a temporal sequence 
of transcriptional, translational and post-translational events must occur. However the precise 
mechanisms leading to this adaptive response are not fully established (11). Parkin is an E3 
ubiquitin ligase that is known to be involved in the clearance of defective mitochondria for 
lysosomal degradation (46). However, recent work has also indicated a possible role for Parkin in 
mitochondrial biogenesis. For example, in vitro overexpression of Parkin can associate with the 
regulatory protein TFAM, and enhance TFAM-mediated mtDNA transcription (36, 53). 
Furthermore, Parkin can directly target PARIS, a transcriptional repressor of PGC-1α, to the 
proteasome for degradation (60, 62), thereby promoting PGC-1α action on organelle biogenesis. 
Whether Parkin has a role in determining muscle function and adaptation to exercise training 
remains currently undetermined. 
To investigate this, we examined the effect of voluntary wheel running for 6 weeks in WT and 
Parkin KO mice. In WT animals, we found that training resulted in several expected beneficial 
consequences, such as improved running endurance performance, increases in markers of 
mitochondrial biogenesis and modest cardiac hypertrophy. Interestingly, a robust increase in 
Parkin expression was also measured in WT animals following 6 weeks of training. We 
hypothesized that this increase in Parkin would enhance PARIS degradation and thereby promote 
PGC-1α expression (60). As expected, we observed a significant increase in PGC-1α protein, 
accompanied by reduced PARIS expression following training in WT animals. These changes 
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likely contributed significantly to the training-induced increases in mitochondrial content and 
composition at the organelle level, observed as a result of training. 
 Our research was directed to evaluate the influence of Parkin on the regulation of muscle 
mitochondrial content based, in part, on recent work suggesting that Parkin can mediate both 
organelle biogenesis (38, 62) and degradation (46). Research in neuroblastoma cells and tissues 
has indicated that a deficiency in Parkin can enhance the repressive behaviour of PARIS on PGC-
1α transcription (60). This could lead to a progressive impairment of mitochondrial biogenesis in 
a Parkin-dependent manner. However, our findings in skeletal muscle indicate that KO animals 
did not display a difference in mitochondrial content when compared to WT littermates. Moreover, 
PARIS and PGC-1α expression in muscle did not vary between genotypes. Thus, a role for Parkin 
in maintaining mitochondrial content via this mechanism seems unlikely, at least in muscle. 
Alternatively, Parkin is mainly implicated in organelle degradation as a ubiquitin ligase 
accountable for the removal of defective mitochondria. Thus, the absence of Parkin could lower 
the rate of mitophagy and increase the accumulation of dysfunctional organelles (19, 73). 
Consistent with this, we found that KO mice exhibited reduced glutamate-ADP-stimulated state 
mitochondrial respiration, a result that was consistent with previous studies (48). Thus, in contrast 
to the lack of change in mitochondrial content, our data provide evidence that the absence of Parkin 
can evoke mitochondrial dysfunction, as we have previously shown (66). This is also consistent 
with a previously documented role for Parkin in the elimination of mitochondria with deleterious 
mtDNA mutations (63). This, further suggests that Parkin is useful for the maintenance of normal, 
healthy mitochondrial pool in muscle.   
We next sought to ascertain the role of Parkin in mediating exercise training-induced 
mitochondrial biogenesis in muscle. Our results clearly indicate that the absence of Parkin does 
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not impede the effect of exercise on mitochondrial content, as evident from increases in COX 
enzyme activity, as well as COXI subunit protein expression, even in KO animals. Surprisingly, 
these effects occurred in the absence of any induction of PGC-1α in trained KO animals, 
suggesting the presence of alternative signaling mechanisms in the absence of Parkin. This lack of 
PGC-1α induction with training was not likely accounted for by an increase in PARIS-mediated 
PGC-1α transcriptional repression, since training served to reduce PARIS expression. Our data 
illustrate that training can either reduce the synthesis of PARIS, or enhance its proteasomal 
degradation, even in the absence of Parkin-directed ubiquitination.  
Organelle biogenesis functions in concert with degradation to maintain mitochondrial content. 
The molecular events that are involved in mitochondrial degradation with either acute or chronic 
exercise remain poorly defined. It is hypothesized that acute exercise induces mitophagy as a 
cellular strategy of purging superfluous mitochondria (68). A general challenge of studying 
autophagy is accurately measuring “flux”, an outcome of autophagosomal formation and 
degradation. In our study, we utilized microtubule destabilization drug colchicine, which prevents 
autophagosome-lysosome fusion (28). We have previously provided evidence that mitophagy flux 
is enhanced following a single bout of endurance exercise (66), a finding that was replicated in 
this study. We detected significant mitochondrial Parkin localization immediately following acute 
exercise in WT animals, accompanied by an exercise-induced increase in the autophagosomal 
marker LC3II on isolated mitochondria, an effect that was abolished in the absence of Parkin. 
Thus, these results support a role for Parkin in mediating mitophagy during acute exercise.  
Following 6 weeks of voluntary wheel training, Parkin localization to mitochondria was 
significantly enhanced, in concurrence with the observed increase in Parkin expression in trained 
muscle. However, we did not observe any downstream consequences of this translocation, such as 
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an increase in basal mitophagic LC3II or p62 flux in trained WT animals. Instead, we speculate 
that this heightened expression and localization of Parkin to mitochondria may serve to “prime” 
mitophagy, and increase the cellular potential for mitochondrial turnover in response to future 
bouts of exercise. To examine this possibility, a subgroup of trained animals was treated to an 
additional bout of exercise to determine the functionality of this adaptation. Our results indicate 
that trained animals respond to acute exercise with an attenuated mitophagy flux, compare to 
untrained animals. This attenuation is likely a result of reduced exercise stress signaling toward 
kinases that normally initiate mitophagy, in the presence of a training-induced enhancement of 
mitochondrial content and function (1, 45). This would include reduced activation of AMPK, p38 
and ROS signaling (42, 43), accompanied by greater endurance performance and a trend for 
reduced lactate production in muscle with a higher oxidative capacity.  
To determine if Parkin is involved in mediating these beneficial adaptations, Parkin KO 
animals were also subjected to 6 weeks of endurance training. As with WT animals, endurance 
training had no impact on basal mitophagy flux in the absence of Parkin. However, unlike WT 
animals, the attenuation of acute exercise-induced mitophagy flux was not observed in KO animals 
following training, indicating that Parkin is required to facilitate mitochondrial turnover as a result 
of exercise, and to confer mitophagy adaptations to endurance training.  
Collectively, our study reveals several aspects of Parkin function in muscle with endurance 
exercise. First, Parkin is required for the maintenance of mitochondrial function as observed in 
KO animals that display both reduced mitochondrial respiration and enhanced ROS emission. 
Second, we found that KO animals do not exhibit reduced basal mitophagy flux, and this indicates 
that a compensatory mechanism possibly via the Nix pathway, or via an alternative ubiquitin ligase, 
must exist to maintain basal mitophagy flux. Additionally, acute exercise-induced mitophagy flux 
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did not increase in KO animals, implicating Parkin’s requirement in mitochondrial turnover with 
exercise. This lack of response to exercise (and possibly other cellular stress) in KO animals likely 
contributes to the accumulation of defective organelles, as documented here, in the absence of 
Parkin. Finally, mitochondrial content was enhanced following training in KO mice to the same 
degree as in WT animals, but unlike WT animals this adaptation occurred in a PGC-1α-
independent manner. This suggests that the absence of Parkin induces alternative signaling 
pathways that govern mitochondrial biogenesis in response to exercise. Indeed, training did not 
improve this mitochondrial dysfunction observed in the absence of Parkin, and this could explain 
why an attenuation in mitophagy by training was not observed, compared to WT animals.     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
114 
 
REFERENCES 
1.  Adhihetty PJ, Uguccioni G, Leick L, Hidalgo J, Pilegaard H, Hood DA. The role of 
PGC-1  on mitochondrial function and apoptotic susceptibility in muscle. AJP Cell Physiol 
297: C217–C225, 2009. 
2.  Bengtsson J, Gustafsson T, Widegren U, Jansson E, Sundberg C. Mitochondrial 
transcription factor A and respiratory complex IV increase in response to exercise training 
in humans. Pflügers Arch 443: 61–66, 2001. 
3.  Bernardini JP, Lazarou M, Dewson G. Parkin and mitophagy in cancer. Oncogene 36: 
1315–1327, 2017. 
4.  Bjørkøy G, Lamark T, Brech A, Outzen H, Perander M, Øvervatn A, Stenmark H, 
Johansen T. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a 
protective effect on huntingtin-induced cell death. J Cell Biol 171: 603–614, 2005. 
5.  Carter HN, Chen CCW, Hood DA. Mitochondria, Muscle Health, and Exercise with 
Advancing Age. Physiology 30: 208–223, 2015. 
6.  Cogswell AM, Stevens RJ, Hood DA. Properties of skeletal muscle mitochondria isolated 
from subsarcolemmal and intermyofibrillar regions. Am J Physiol 264: C383-9, 1993. 
7.  Constable SH, Favier RJ, McLane JA, Fell RD, Chen M, Holloszy JO. Energy 
metabolism in contracting rat skeletal muscle: adaptation to exercise training. Am J Physiol 
253: C316-22, 1987.  
8.  COOPERSTEIN SJ, LAZAROW A. A microspectrophotometric method for the 
determination of cytochrome oxidase. J Biol Chem 189: 665–70, 1951.  
9.  Davies KJA, Packer L, Brooks GA. Biochemical adaptation of mitochondria, muscle, and 
whole-animal respiration to endurance training. Arch Biochem Biophys 209: 539–554, 
115 
 
1981. 
10.  Dudley GA, Tullson PC, Terjung RL. Influence of mitochondrial content on the 
sensitivity of respiratory control. J Biol Chem 262: 9109–14, 1987.  
11.  Egan B, Zierath JR. Exercise Metabolism and the Molecular Regulation of Skeletal 
Muscle Adaptation. Cell Metab 17: 162–184, 2013. 
12.  Fritzen AM, Madsen AB, Kleinert M, Treebak JT, Lundsgaard A-M, Jensen TE, 
Richter EA, Wojtaszewski J, Kiens B, Frøsig C. Regulation of autophagy in human 
skeletal muscle: effects of exercise, exercise training and insulin stimulation. J Physiol 594: 
745–761, 2016. 
13.  Geisler S, Holmström KM, Skujat D, Fiesel FC, Rothfuss OC, Kahle PJ, Springer W. 
PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell 
Biol 12: 119–131, 2010. 
14.  Gleyzer N, Vercauteren K, Scarpulla RC. Control of Mitochondrial Transcription 
Specificity Factors (TFB1M and TFB2M) by Nuclear Respiratory Factors (NRF-1 and 
NRF-2) and PGC-1 Family Coactivators. Mol Cell Biol 25: 1354–1366, 2005. 
15.  Goldberg MS, Fleming SM, Palacino JJ, Cepeda C, Lam HA, Bhatnagar A, Meloni 
EG, Wu N, Ackerson LC, Klapstein GJ, Gajendiran M, Roth BL, Chesselet M-FM-F, 
Maidment NT, Levine MS, Shen J. Parkin-deficient mice exhibit nigrostriatal deficits but 
not loss of dopaminergic neurons. J Biol Chem 278: 43628–35, 2003. 
16.  Gollnick PD, Armstrong RB, Saltin B, Saubert CW, Sembrowich WL, Shepherd RE. 
Effect of training on enzyme activity and fiber composition of human skeletal muscle. J 
Appl Physiol 34: 107–11, 1973.  
17.  Gong G, Song M, Csordas G, Kelly DP, Matkovich SJ, Dorn GW. Parkin-mediated 
116 
 
mitophagy directs perinatal cardiac metabolic maturation in mice. Science (80- ) 350: 
aad2459-aad2459, 2015. 
18.  Gordon JW, Rungi AA, Inagaki H, Hood DA. Effects of contractile activity on 
mitochondrial transcription factor A expression in skeletal muscle. J Appl Physiol 90: 389–
96, 2001.  
19.  Greene JC, Whitworth AJ, Kuo I, Andrews LA, Feany MB, Pallanck LJ. Mitochondrial 
pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc Natl Acad 
Sci U S A 100: 4078–83, 2003. 
20.  Grumati P, Coletto L, Schiavinato A, Castagnaro S, Bertaggia E, Sandri M, Bonaldo 
P. Physical exercise stimulates autophagy in normal skeletal muscles but is detrimental for 
collagen VI-deficient muscles Taylor & Francis.  
21.  He C, Bassik MC, Moresi V, Sun K, Wei Y, Zou Z, An Z, Loh J, Fisher J, Sun Q, 
Korsmeyer S, Packer M, May HI, Hill JA, Virgin HW, Gilpin C, Xiao G, Bassel-Duby 
R, Scherer PE, Levine B. Exercise-induced BCL2-regulated autophagy is required for 
muscle glucose homeostasis. Nature 481: 511–5, 2012. 
22.  Holloszy JO. Biochemical adaptations in muscle. Effects of exercise on mitochondrial 
oxygen uptake and respiratory enzyme activity in skeletal muscle. J Biol Chem 242: 2278–
82, 1967.  
23.  Hood DA. Invited Review: contractile activity-induced mitochondrial biogenesis in skeletal 
muscle. J Appl Physiol 90: 1137–57, 2001.  
24.  Hood DA, Pette D. Chronic long-term electrostimulation creates a unique metabolic 
enzyme profile in rabbit fast-twitch muscle. FEBS Lett 247: 471–4, 1989.  
25.  Hood DA, Zak R, Pette D. Chronic stimulation of rat skeletal muscle induces coordinate 
117 
 
increases in mitochondrial and nuclear mRNAs of cytochrome-c-oxidase subunits. Eur J 
Biochem 179: 275–80, 1989.  
26.  Hoshino A, Ariyoshi M, Okawa Y, Kaimoto S, Uchihashi M, Fukai K, Iwai-Kanai E, 
Ikeda K, Ueyama T, Ogata T, Matoba S. Inhibition of p53 preserves Parkin-mediated 
mitophagy and pancreatic β-cell function in diabetes. Proc Natl Acad Sci U S A 111: 3116–
21, 2014. 
27.  Jin SM, Lazarou M, Wang C, Kane LA, Narendra DP, Youle RJ. Mitochondrial 
membrane potential regulates PINK1 import and proteolytic destabilization by PARL. J 
Cell Biol 191: 933–42, 2010. 
28.  Ju J-S, Varadhachary AS, Miller SE, Weihl CC. Quantitation of &quot;autophagic 
flux&quot; in mature skeletal muscle. Autophagy 6: 929–935, 2010. 
29.  Ju J, Jeon S, Park J, Lee J, Lee S, Cho K, Jeong J. Autophagy plays a role in skeletal 
muscle mitochondrial biogenesis in an endurance exercise-trained condition. J Physiol Sci 
66: 417–430, 2016. 
30.  Kane LA, Lazarou M, Fogel AI, Li Y, Yamano K, Sarraf SA, Banerjee S, Youle RJ. 
PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity. J Cell Biol 
205: 143–53, 2014. 
31.  Kazlauskaite A, Kondapalli C, Gourlay R, Campbell DG, Ritorto MS, Hofmann K, 
Alessi DR, Knebel A, Trost M, Muqit MMK. Parkin is activated by PINK1-dependent 
phosphorylation of ubiquitin at Ser 65. Biochem J 460: 127–139, 2014. 
32.  Kim YA, Kim YS, Oh SL, Kim H-J, Song W. Autophagic response to exercise training 
in skeletal muscle with age. J Physiol Biochem 69: 697–705, 2013. 
33.  Kim Y, Park J, Kim S, Song S, Kwon S-K, Lee S-H, Kitada T, Kim J-M, Chung J. 
118 
 
PINK1 controls mitochondrial localization of Parkin through direct phosphorylation. 
Biochem Biophys Res Commun 377: 975–980, 2008. 
34.  Komatsu M, Waguri S, Koike M, Sou Y, Ueno T, Hara T, Mizushima N, Iwata J, Ezaki 
J, Murata S, Hamazaki J, Nishito Y, Iemura S, Natsume T, Yanagawa T, Uwayama J, 
Warabi E, Yoshida H, Ishii T, Kobayashi A, Yamamoto M, Yue Z, Uchiyama Y, 
Kominami E, Tanaka K. Homeostatic Levels of p62 Control Cytoplasmic Inclusion Body 
Formation in Autophagy-Deficient Mice. Cell 131: 1149–1163, 2007. 
35.  Koyano F, Okatsu K, Kosako H, Tamura Y, Go E, Kimura M, Kimura Y, Tsuchiya 
H, Yoshihara H, Hirokawa T, Endo T, Fon EA, Trempe J-F, Saeki Y, Tanaka K, 
Matsuda N. Ubiquitin is phosphorylated by PINK1 to activate parkin. Nature 510: 162–6, 
2014. 
36.  Kuroda Y, Mitsui T, Kunishige M, Shono M, Akaike M, Azuma H, Matsumoto T. 
Parkin enhances mitochondrial biogenesis in proliferating cells. Hum Mol Genet 15: 883–
895, 2006. 
37.  Larsson NG, Barsh GS, Clayton DA. Structure and chromosomal localization of the 
mouse mitochondrial transcription factor A gene (Tfam). Mamm Genome 8: 139–40, 1997.  
38.  Lee Y, Stevens DA, Kang S-U, Jiang H, Lee Y-I, Ko HS, Scarffe LA, Umanah GE, 
Kang H, Ham S, Kam T-I, Allen K, Brahmachari S, Kim JW, Neifert S, Yun SP, Fiesel 
FC, Springer W, Dawson VL, Shin J-H, Dawson TM. PINK1 Primes Parkin-Mediated 
Ubiquitination of PARIS in Dopaminergic Neuronal Survival. Cell Rep 18: 918–932, 2017. 
39.  Lira VA, Okutsu M, Zhang M, Greene NP, Laker RC, Breen DS, Hoehn KL, Yan Z. 
Autophagy is required for exercise training-induced skeletal muscle adaptation and 
improvement of physical performance. FASEB J 27: 4184–93, 2013. 
119 
 
40.  jAcute endurance exercise increases the nuclear abundance of PGC-1  in trained human 
skeletal muscle. AJP Regul Integr Comp Physiol 298: R912–R917, 2010. 
41.  Little JP, Safdar A, Wilkin GP, Tarnopolsky MA, Gibala MJ. A practical model of low-
volume high-intensity interval training induces mitochondrial biogenesis in human skeletal 
muscle: potential mechanisms. J Physiol 588: 1011–1022, 2010. 
42.  Ljubicic V, Hood DA. Kinase-specific responsiveness to incremental contractile activity 
in skeletal muscle with low and high mitochondrial content. Am J Physiol Endocrinol Metab 
295: E195-204, 2008. 
43.  Ljubicic V, Hood DA. Specific attenuation of protein kinase phosphorylation in muscle 
with a high mitochondrial content. Am J Physiol Endocrinol Metab 297: E749-58, 2009. 
44.  Matsuda N, Sato S, Shiba K, Okatsu K, Saisho K, Gautier CA, Sou Y-S, Saiki S, 
Kawajiri S, Sato F, Kimura M, Komatsu M, Hattori N, Tanaka K. PINK1 stabilized by 
mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent 
Parkin for mitophagy. J Cell Biol 189: 211–21, 2010. 
45.  Menzies KJ, Singh K, Saleem A, Hood DA. Sirtuin 1-mediated effects of exercise and 
resveratrol on mitochondrial biogenesis. J Biol Chem 288: 6968–79, 2013. 
46.  Narendra D, Tanaka A, Suen D-F, Youle RJ. Parkin is recruited selectively to impaired 
mitochondria and promotes their autophagy. J Cell Biol 183: 795–803, 2008. 
47.  Narendra DP, Jin SM, Tanaka A, Suen D-F, Gautier CA, Shen J, Cookson MR, Youle 
RJ. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol 
8: e1000298, 2010. 
48.  Palacino JJ, Sagi D, Goldberg MS, Krauss S, Motz C, Wacker M, Klose J, Shen J. 
Mitochondrial Dysfunction and Oxidative Damage in parkin -deficient Mice. J Biol Chem 
120 
 
279: 18614–18622, 2004. 
49.  Palikaras K, Lionaki E, Tavernarakis N. Coordination of mitophagy and mitochondrial 
biogenesis during ageing in C. elegans. Nature 521: 525–528, 2015. 
50.  Pankiv S, Clausen TH, Lamark T, Brech A, Bruun J-A, Outzen H, Øvervatn A, 
Bjørkøy G, Johansen T. p62/SQSTM1 Binds Directly to Atg8/LC3 to Facilitate 
Degradation of Ubiquitinated Protein Aggregates by Autophagy. J Biol Chem 282: 24131–
24145, 2007. 
51.  Pickrell AM, Youle RJ. The roles of PINK1, parkin, and mitochondrial fidelity in 
Parkinson’s disease. Neuron 85: 257–73, 2015. 
52.  Quinlan CL, Perevoshchikova I V., Hey-Mogensen M, Orr AL, Brand MD. Sites of 
reactive oxygen species generation by mitochondria oxidizing different substrates. Redox 
Biol 1: 304–312, 2013. 
53.  Rothfuss O, Fischer H, Hasegawa T, Maisel M, Leitner P, Miesel F, Sharma M, 
Bornemann A, Berg D, Gasser T, Patenge N. Parkin protects mitochondrial genome 
integrity and supports mitochondrial DNA repair. Hum Mol Genet 18: 3832–3850, 2009. 
54.  Rubinsztein DC, Mariño G, Kroemer G. Autophagy and aging. Cell 146: 682–95, 2011. 
55.  Safdar A, Little JP, Stokl AJ, Hettinga BP, Akhtar M, Tarnopolsky MA. Exercise 
increases mitochondrial PGC-1alpha content and promotes nuclear-mitochondrial cross-
talk to coordinate mitochondrial biogenesis. J Biol Chem 286: 10605–17, 2011. 
56.  Saleem A, Adhihetty PJ, Hood DA. Role of p53 in mitochondrial biogenesis and apoptosis 
in skeletal muscle. Physiol Genomics 37: 58–66, 2009. 
57.  Saleem A, Iqbal S, Zhang Y, Hood DA. Effect of p53 on mitochondrial morphology, 
import, and assembly in skeletal muscle. Am J Physiol - Cell Physiol 308, 2015.  
121 
 
58.  Scherz-Shouval R, Shvets E, Fass E, Shorer H, Gil L, Elazar Z. Reactive oxygen species 
are essential for autophagy and specifically regulate the activity of Atg4. EMBO J 26: 1749–
1760, 2007. 
59.  Shiba-Fukushima K, Imai Y, Yoshida S, Ishihama Y, Kanao T, Sato S, Hattori N. 
PINK1-mediated phosphorylation of the Parkin ubiquitin-like domain primes mitochondrial 
translocation of Parkin and regulates mitophagy. Sci Rep 2: 1002, 2012. 
60.  Shin J-H, Ko HS, Kang H, Lee Y, Lee Y-I, Pletinkova O, Troconso JC, Dawson VL, 
Dawson TM. PARIS (ZNF746) repression of PGC-1α contributes to neurodegeneration in 
Parkinson’s disease. Cell 144: 689–702, 2011. 
61.  Soleimanpour SA, Gupta A, Bakay M, Ferrari AM, Groff DN, Fadista J, Spruce LA, 
Kushner JA, Groop L, Seeholzer SH, Kaufman BA, Hakonarson H, Stoffers DA. The 
diabetes susceptibility gene Clec16a regulates mitophagy. Cell 157: 1577–90, 2014. 
62.  Stevens DA, Lee Y, Kang HC, Lee BD, Lee Y-I, Bower A, Jiang H, Kang S-U, Andrabi 
SA, Dawson VL, Shin J-H, Dawson TM. Parkin loss leads to PARIS-dependent declines 
in mitochondrial mass and respiration. Proc Natl Acad Sci U S A 112: 11696–701, 2015. 
63.  Suen D-F, Narendra DP, Tanaka A, Manfredi G, Youle RJ. Parkin overexpression 
selects against a deleterious mtDNA mutation in heteroplasmic cybrid cells. Proc Natl Acad 
Sci U S A 107: 11835–40, 2010. 
64.  Takahashi M, Hood DA. Chronic stimulation-induced changes in mitochondria and 
performance in rat skeletal muscle. J Appl Physiol 74: 934–41, 1993.  
65.  Uguccioni G, Hood DA. The importance of PGC-1  in contractile activity-induced 
mitochondrial adaptations. AJP Endocrinol Metab 300: E361–E371, 2011. 
66.  Vainshtein A, Tryon LD, Pauly M, Hood DA. Role of PGC-1α during acute exercise-
122 
 
induced autophagy and mitophagy in skeletal muscle. Am J Physiol Cell Physiol 308: C710-
9, 2015. 
67.  Vásquez-Trincado C, García-Carvajal I, Pennanen C, Parra V, Hill JA, Rothermel 
BA, Lavandero S. Mitochondrial dynamics, mitophagy and cardiovascular disease. J 
Physiol 594: 509–525, 2016. 
68.  Lo Verso F, Carnio S, Vainshtein A, Sandri M. Autophagy is not required to sustain 
exercise and PRKAA1/AMPK activity but is important to prevent mitochondrial damage 
during physical activity. Autophagy 10: 1883–94, 2014. 
69.  Villa E, Proïcs E, Rubio-Patiño C, Obba S, Zunino B, Bossowski JP, Rozier RM, 
Chiche J, Mondragón L, Riley JS, Marchetti S, Verhoeyen E, Tait SWG, Ricci J-E. 
Parkin-Independent Mitophagy Controls Chemotherapeutic Response in Cancer Cells. Cell 
Rep 20: 2846–2859, 2017. 
70.  Vives-Bauza C, Zhou C, Huang Y, Cui M, de Vries RLA, Kim J, May J, Tocilescu MA, 
Liu W, Ko HS, Magrané J, Moore DJ, Dawson VL, Grailhe R, Dawson TM, Li C, Tieu 
K, Przedborski S. PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. 
Proc Natl Acad Sci U S A 107: 378–83, 2010. 
71.  Williams RS, Salmons S, Newsholme EA, Kaufman RE, Mellor J. Regulation of nuclear 
and mitochondrial gene expression by contractile activity in skeletal muscle. J Biol Chem 
261: 376–80, 1986. 
72.  Woodson JD, Chory J. Coordination of gene expression between organellar and nuclear 
genomes. Nat Rev Genet 9: 383–95, 2008. 
73.  Yang Y, Gehrke S, Imai Y, Huang Z, Ouyang Y, Wang J-W, Yang L, Beal MF, Vogel 
H, Lu B. Mitochondrial pathology and muscle and dopaminergic neuron degeneration 
123 
 
caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc Natl Acad Sci U S A 
103: 10793–8, 2006. 
74.  Zorov DB, Juhaszova M, Sollott SJ. Mitochondrial reactive oxygen species (ROS) and 
ROS-induced ROS release. Physiol Rev 94: 909–50, 2014. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
124 
 
FIGURE LEGENDS 
Fig. 1. Effect of Parkin deficiency and training on muscle mass. (A): Graphical representation of 
voluntary running distance (kilometers per week) between WT and KO mice (n = 8). Wheels were 
provided in animal cages for a duration of 6 weeks. (B): Total body weight of untrained and trained 
Parkin KO and WT animals (n = 8). (C): Quadriceps muscle mass corrected for total body weight 
(n = 8). (D): Heart mass corrected for total body weight (n = 8). Values are means ± SEM. ¶P < 
0.05, main effect of time. *P < 0.05, main effect of training. WT, wild-type; KO, Parkin knock-
out; UT, untrained; T, trained. 
 
Fig. 2. Effect of training and Parkin on whole muscle protein markers. (A): Representative Western 
blot of Parkin expression in untrained and trained skeletal muscle of control wild-type (WT) mice 
above. A graphical representation is shown below (n = 5, *P < 0.05, vs UT). (B): Representative 
immunoblots of COXI and COXIV expression in untrained and trained skeletal muscle of Parkin 
KO and WT animals. A graphical representation of whole muscle COXI shown below (n = 4, *P 
< 0.05, main effect of training; #P < 0.05, vs trained WT). (C): Representative Western blots of 
PGC-1α and PARIS expression in untrained and trained skeletal muscle of Parkin KO and WT 
animals. (D): A graphical representation of whole muscle PGC-1α (n = 4, *P < 0.05, vs untrained 
WT). (E): Quantification of whole muscle PARIS (n = 6, *P < 0.05, main effect of training; #P < 
0.05, vs untrained WT). Values are means ± SEM. †P < 0.05, interaction effect of training and 
genotype. α-tubulin was used for muscle loading control. WT, wild-type; KO, Parkin knock-out; 
UT, untrained; T, trained; COX1, cytochrome c oxidase subunit 1; COX4, cytochrome c oxidase 
subunit 4; PARIS, Parkin-Interacting Substrate; PGC-1α, peroxisome proliferator gamma 
coactivator-1α; A.U., arbitrary units.   
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Fig. 3. Mitochondrial adaptations following 6 weeks of voluntary wheel running. (A): 
Representative Western blots of COXI, COXIV and TFAM expression on isolated mitochondria 
from untrained and trained skeletal muscle of Parkin KO and WT animals. (B): Graphical 
representation of mitochondrial COXI expression (n = 8). (C): Mitochondrial yield of mixed 
hindlimb muscles of Parkin KO and WT animals (n = 4). (D): Skeletal muscle cytochrome c 
oxidase (COX) activity following training in quadriceps muscle of Parkin KO and WT animals (n 
= 5). (E): Mitochondrial state 4 and state 3 respiration rates in KO compared with WT animals (n 
= 8). (F): Mitochondrial ROS emission expressed per natom of oxygen consumed in Parkin KO 
and WT mice (n = 8; ¶P < 0.05, vs state 4 trained WT). Values are means ± SEM. *P < 0.05, main 
effect of training; #P < 0.05, main effect of genotype; †P < 0.05, interaction effect of genotype and 
training. Voltage-dependent anion channel (VDAC) was used as a mitochondrial loading control. 
WT, wild-type; KO, Parkin knock-out; UT, untrained; T, trained; COX1, cytochrome c oxidase 
subunit 1; COX4, cytochrome c oxidase subunit 4; TFAM, mitochondrial transcription factor A; 
ROS, reactive oxygen species; A.U., arbitrary units. 
 
Fig. 4. Effect of Parkin and training on exercise performance. (A): Representative Western blot of 
Parkin localization on isolated mitochondria from untrained and trained WT muscle, prior to 
exercise (Con) and immediately following exercise (Ex). Quantification of mitochondrial Parkin 
localization is shown below, corrected for loading using mitochondrial voltage-dependent anion 
channel (VDAC) (n = 6, ¶P < 0.05, vs untrained Con). (B): Animal endurance performance (i.e. 
total distance run) of WT and KO animals (n = 8, *P < 0.05, main effect of training). (C): Blood 
lactate levels measured prior to (Con), and immediately following exercise (Ex) (n = 8, #P < 0.05, 
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main effect of exercise). Values are means ± SEM. WT, wild-type; KO, Parkin knock-out; UT, 
untrained; T, trained; A.U., arbitrary units. 
 
Fig. 5. Mitophagic LC3II flux following acute exercise, training, and combined treatments in WT 
and KO animals.  Representative Western blots of mitochondrial LC3II localization of WT (A) and 
Parkin KO (B) mice injected with water (Veh) or 0.4 mg/kg colchicine (Col). Quantification of 
mitochondrial LC3II flux (C) is shown (n = 8). Mitophagic LC3II flux was assessed under basal 
conditions, and immediately following acute exercise, in untrained and trained groups of WT and 
KO animals. The fold change in LC3II flux (D) was calculated with acute exercise-induced values 
over basal values (n = 8). Values are means ± SEM. ¶P < 0.05, vs untrained WT; #P < 0.05, main 
effect of exercise; *P < 0.05, vs all other experimental conditions; †P < 0.05, interaction effect of 
genotype and training. Voltage-dependent anion channel (VDAC) was used as a mitochondrial 
loading control. WT, wild-type; KO, Parkin knock-out; UT, untrained; T, trained; LC3II, lipidated 
microtubule-associated protein 1A/1B-light chain 3; A.U., arbitrary units. 
 
Fig. 6. Mitophagic p62 flux following acute exercise, training, and combined treatments in WT 
and KO animals.  Representative Western blots of mitochondrial p62 localization of WT (A) and 
Parkin KO (B) mice injected with water (Veh) or 0.4 mg/kg colchicine (Col). Quantification of 
mitochondrial p62 flux (C) is shown (n = 5). Mitophagic p62 flux was assessed under basal 
conditions, and immediately following acute exercise, in untrained and trained groups of WT and 
KO animals. The fold change in p62 flux (D) was calculated with acute exercise-induced values 
over basal values (n = 5). Values are means ± SEM. *P < 0.05, a main effect of genotype; #P < 
0.05, main effect of exercise. Voltage-dependent anion channel (VDAC) was used as a 
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mitochondrial loading control. WT, wild-type; KO, Parkin knock-out; UT, untrained; T, trained; 
p62, sequestosome 1; A.U., arbitrary units. 
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CHAPTER 6: 
SUMMARY AND CONCLUSIONS 
 Parkin is a ubiquitin ligase well-known for its ability to selectively target damaged 
mitochondria for degradation (306). Parkin is translocated to mitochondria that can no longer 
generate a membrane potential across the inner mitochondrial membrane (282). It can regulate the 
formation of ubiquitin linkages on target proteins found on the outer surface of the organelle (103, 
305). This process is required for amplifying the signal that is needed to remove a damaged 
mitochondrion by autophagy (200, 206, 228). An impairment of this process in neural tissue is 
thought to contribute to neurodegeneration, a well-studied role for Parkin in Parkinson’s Disease 
(339). As studies emerged on the relationship between mitochondrial perturbations and Parkin, 
research began to expeditiously investigate the mechanisms by which Parkin can regulate 
mitochondrial function in other metabolic tissues. The examination of Parkin function in skeletal 
muscle remains poorly defined, with a handful of studies on lower order organisms (62, 116). 
Muscle is one of the largest organs in the body, and its importance in human health is exemplified 
in several pathological conditions, including type II diabetes (190, 207), obesity (360), heart failure 
(484), as well as in aging (52). Mitochondrial dysfunction is a hallmark feature of many of these 
metabolic conditions, that depend on mitophagy for cell maintenance. My doctoral work has 
focused on investigating the function of Parkin in muscle mitochondrial turnover, and its necessity 
for exercise- and age-induced mitochondrial adaptations.    
 
Objective 1: We first investigated the role of Parkin-mediated mitophagy under basal 
conditions and during acute exercise. We have previously shown that mitophagy flux is enhanced 
following an acute bout of endurance exercise (446). To determine if Parkin is required for 
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exercise-induced mitophagy flux, we utilized a Parkin KO animal model, and pre-treated the 
animals with colchicine (193) via intraperitoneal injection for 2 days prior to endurance exercise 
testing. Isolated mitochondria were obtained from the hindlimb muscles of control and exercised 
animals. We hypothesized that the lack of Parkin would yield an accumulation of dysfunctional 
mitochondria, and reduce the quality of muscle. We did not detect a significant difference in 
mitochondrial content between genotypes when assessed by COX activity. However, KO animals 
displayed a reduction in complex I driven mitochondrial respiration. Furthermore, basal mitophagy 
flux did not differ between genotypes. During acute exercise, Parkin KO mice performed to a 
similar degree to that of WT animals. We also demonstrated that Parkin-mediated mitophagy is 
required during acute exercise, as Parkin KO animals displayed attenuated exercise-induced 
mitophagy flux. Interestingly, mitochondrial ubiquitination increased in KO animals following 
acute exercise. This suggests the existence of alternative ubiquitin ligase(s) (99, 482) that may be 
involved during exercise, but that are unable to compensate for the lack of mitophagic signaling 
that occurs in the absence of Parkin. To specifically examine the role of Parkin in targeting specific 
outer mitochondrial surface proteins, we performed a mitochondrial co-immunoprecipitation of 
mitofusin-2 and its association with ubiquitin. We found that Parkin was required for basal Mfn2 
ubiquitination and that acute exercise enhanced the formation of Mfn2-ubiquitin complexes. To 
elucidate a mechanism for Parkin during exercise-induced mitochondrial biogenesis, we measured 
the expression of transcriptional regulators PGC-1α and PARIS. It was previously shown that 
Parkin can regulate biogenesis by targeting PARIS, a transcriptional repressor of PGC-1α, to the 
proteasome for degradation. Interestingly, the basal expression of PARIS and PGC-1α did not 
differ between WT and Parkin KO animals. However, during acute exercise we detected a 
statistical relevant interaction for each of these regulators that varied according to genotype and 
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exercise. We found that PGC-1α nuclear localization was enhanced immediately following 
exercise in WT animals, but that this effect was abolished in the absence of Parkin. In contrast, 
nuclear PARIS abundance increased in the absence of Parkin during acute exercise. This study 
provided evidence that Parkin is required for maintaining mitochondrial function and exercise-
induced mitophagy flux. We also provided mechanistic insight on how Parkin may regulate 
mitochondrial biogenesis in skeletal muscle.            
 
Objective 2: We next examined the effect of age on Parkin-mediated mitophagy during 
basal and acute exercise conditions. For this study, we compared mitophagy flux between young 
(3 months) and aged (minimum 18 months) animals. We first assessed the expression of Parkin 
with age, and we were surprised to find a robust increase in Parkin expression in aged animals. 
Sarcopenia is characterized by the progressive age-related loss of muscle mass and function (50). 
Thus, we hypothesized that the lack of Parkin with age would evoke additional decrements in 
mitochondrial content and function, as well as reduced muscle mass. We observed significant 
decreases in muscle mass and mitochondrial content of aged animals, but these changes occurred 
independently of Parkin. We did not detect any alterations in mitochondrial respiration with age, 
however, reactive oxygen emission was enhanced in KO animals. In our study, we observed that 
Parkin residence on the mitochondrion was abolished with age and did not increase with acute 
exercise. Aged animals ran significantly less than their young counterparts, and this was reflected 
by their enhanced blood lactate levels. We hypothesized that the lack of Parkin would impair 
mitophagy in aged muscle. To our surprise, basal mitophagy flux was enhanced in aged animals 
compared to young, and did not increase further following acute exercise. A similar trend was 
detected with the association of Mfn2 and ubiquitin with age and exercise. Furthermore, we 
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observed enhanced nuclear PARIS abundance in aged muscle of WT and Parkin KO animals, 
while the levels of nuclear PGC-1α were reduced. This study provides an understanding of the 
molecular underpinnings of age and its influence on exercise-induced mitophagy and organelle 
biogenesis.  
 
Objective 3: Based on our observations that acute exercise can activate mitophagy, we 
subsequently explored the requirement of Parkin for exercise-induced mitochondrial adaptations. 
Specifically, we wanted to determine whether Parkin is involved in mediating the adaptive 
response of muscle to endurance training. We subjected WT and Parkin KO animals to 6 weeks of 
voluntary wheel exercise, and a subset of animals were treated to a similar acute exercise paradigm 
as in objective 1 and 2. We first examined the importance of Parkin on mitochondrial biogenesis 
following exercise training, and noted an increase in COXI protein and COX activity in animals 
deficient in Parkin. However, the expression of the main regulator of mitochondrial biogenesis, 
PGC-1α, in whole muscle was repressed in KO animals following training. Concomitantly, an 
improvement in mitochondrial function commonly associated with mitochondrial biogenesis was 
absent in Parkin null animals. As shown in objective 1, we demonstrated that a bout of acute 
exercise was sufficient to induce mitophagy, and that this activation was dependent on Parkin. 
Moreover, we observed that the expression and localization of Parkin to mitochondria was 
enhanced following training. Despite this, Parkin downstream mitophagic signaling of LC3II and 
p62 flux was not altered with training. This suggested that repeated bouts of exercise can attenuate 
the activation of Parkin-mediated mitophagy to contribute to the attainment of a greater 
mitochondrial content. Indeed, WT trained animals that underwent a subsequent bout of acute 
exercise displayed attenuated mitophagy flux. This adaptive response to training was not observed 
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in the absence of Parkin. These data suggest that the diminishment of Parkin-mediated mitophagy 
is necessary to facilitate endurance exercise-induced mitochondrial biogenesis.   
 Taken together, our data confirm the fundamental role of Parkin as a regulator of 
mitochondrial biogenesis and degradation. In vivo animal studies were mainly used to address this 
topic. Specifically, these manuscripts will 1) further our understanding of Parkin-mediated 
mitophagy during exercise, 2) provide insight into aging-induced regulation of mitochondrial 
turnover in skeletal muscle, and 3) elucidate the regulatory role of Parkin in maintaining 
mitochondrial content and function, ultimately achieving energetic homeostasis.      
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CHAPTER 7: 
EXPERIMENTAL LIMITATIONS 
 Autophagy is a dynamic intracellular mechanism that is involved in the turnover of long-
lived organelles and proteins. In many situations it is necessary to measure if an experimental 
treatment has an inhibitory or stimulatory effect on autophagy. This measurement is termed 
autophagy flux and is poorly understood in vivo. To examine autophagy flux, one must select an 
appropriate inhibitor to “block” or prevent autophagosomal degradation. The role of the 
autophagosome is to transport damaged cellular components to the lysosome for degradation via 
microtubule filaments. Thus, measuring static changes in autophagy protein markers on an 
immunoblot is not adequate to indicate whether autophagy flux is altered. To directly measure 
autophagy flux in vivo, lysosomal degradation must be prevented. Specifically, autophagy flux is 
the difference between a condition treated with an autophagy blocker and the same condition 
treated with a vehicle. The utilization of a lysosomal inhibitor, whether bafilomycin A1, 
chloroquine or microtubule depolarizing agent such as colchicine, must be sufficient to 
significantly increase basal autophagy markers. For example, the use of an autophagy blocking 
agent should always increase basal LC3II levels. A major challenge of measuring autophagy flux 
in vivo is the variability between animals. One should expect that different animals do not always 
activate autophagy at the same time, or to the same degree. Thus, to improve the statistical rigor 
of one’s findings, experiments should be repeated more than once with each experiment involving 
more than a few animals.  
 Another limitation in our studies was the amalgamation of results from both male and 
female mice. It is important that future work on autophagy be completed on both genders, and that 
data on each sex be reported separately. In a recent review by Gottlieb et al., sex differences in 
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autophagy in various tissues have been reported by several laboratories (110). There is little 
controversy on the fact that gender can influence health and disease. However, research limitations 
on animals can exist. For example, female mice are occasionally excluded to prevent hormonal-
related confounding variables. Male mice can also be excluded when they become aggressive and 
must be caged separately, and this can increase the operating costs in low-budget laboratories. To 
combat against gender bias, more research funding agencies are calling on scientists to be mindful 
of considering both genders in research.  
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CHAPTER 8: 
FUTURE DIRECTIONS 
Based on our observations from the three studies summarized in this dissertation, it is 
evident that Parkin is involved in regulating mitophagy and mitochondrial biogenesis during 
endurance exercise. However, several questions arise from our studies on Parkin and its function 
in muscle. These are outlined below: 
 
1. How do exercise and age affect Parkin-mediated mitophagy in the heart? 
In our study, we demonstrate that exercise can induce mitophagy in skeletal muscle. 
However, a role for Parkin in cardiac muscle during exercise remains unknown. Cardiac muscle 
contains a greater mitochondrial density than skeletal muscle, and this likely indicates a greater 
propensity for mitophagy activation. Current data suggest that Parkin is not required for basal 
mitochondrial turnover, but instead functions in a greater capacity during cardiac stress in adult 
murine hearts (230, 249, 342). Recent findings also illustrate the importance of Parkin-mediated 
mitophagy during perinatal cardiomyocyte development in mice (108). Indeed, we have some 
preliminary data to indicate that mitophagy is inducible in the heart during exercise. The role of 
Parkin on cardiac mitophagy flux during exercise and with aging has never been documented. As 
such, the enrichment of Parkin on damaged cardiac mitochondria during exercise may be a viable 
means to treat metabolic defects in heart disease. According to the Government of Canada, heart 
disease is the second leading cause of death in Canada. The results from this future study could 
hold therapeutic potential in reducing the risk of cardiovascular disease. For example, upregulation 
of Parkin following myocardial infarction appears to rescue cardiomyocytes from cell death by 
enhancing mitophagy (230). Thus, Parkin may play a vital role in cardiac adaptation to stress.       
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2. Does Parkin impact the rate of PINK1 protein import into mitochondria?  
The increased localization of Parkin to mitochondria during exercise could be the result of 
increased PINK1 activation. Assessing whether PINK1 is stimulated during mitophagy is a 
challenge. Like mitophagy flux, PINK1 is highly dynamic and can undergo rapid mitochondrial 
protein import (187, 188, 242, 477). Static PINK1 protein measurements are not sufficient to 
conclude an impairment or activation of mitophagy. This can be conducted by mitochondrial 
protein import experiments using a radiolabelled PINK1 precursor protein. The mechanism by 
which PINK1 mitochondrial import operates under exercise and with age remain unclear. We have 
previously shown that the mitochondrial protein import pathway is highly adaptable during chronic 
contractile activity-induced mitochondrial biogenesis. An examination of PINK1 kinetics can 
provide further mechanistic insight on mitochondrial turnover under the influence of different 
stimuli: muscle disuse such as denervation, and increased contractility such as exercise.  
 
3. How does the absence of Parkin impair mitophagic signaling in response to exercise? 
The role of exercise training and the mechanisms controlling the synthesis of new 
mitochondria are well-studied (443). However, our understanding of how exercise can promote 
the removal of damaged and dysfunctional mitochondria remain largely unknown (194, 212, 261). 
A comprehensive examination of downstream exercise-responsive kinases and their activation 
between WT and Parkin KO animals would help. To elucidate this, the measurement of autophagy 
inducers, Ulk1 and TFEB, during acute exercise may provide added evidence of Parkin-mitophagy 
activation on downstream regulators. In vitro studies have revealed that PINK1/Parkin can recruit 
autophagy factor Ulk1 to initiate autophagosomal biogenesis on damaged mitochondria (298). 
Furthermore, it was recently demonstrated that TFEB activation occurs downstream of Parkin 
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(312). Recent evidence indicates that Atg5 activity is required for Parkin-mediated TFEB nuclear 
accumulation (312). Atg5 facilitates the formation of the autophagosomal membrane. The effect 
of Parkin on TFEB subcellular localization could provide evidence of cross-talk between 
mitophagy activation and lysosomal biogenesis. Our study on aging and mitophagy revealed a 
possible dysfunction in lysosomes. Thus, the role of TFEB in regulating lysosomal biogenesis 
during age and exercise remains a potential avenue of future research.  
Furthermore, we examined an overall increase of LC3II localization to the mitochondria in 
KO animals. LC3 is part of the Atg8 family that contains three other mammalian homologues 
including: GABARAP, GATE-16 and Atg8L. There is very little evidence of these proteins 
contributing to autophagosomal biogenesis in mammals. Whether these proteins are regulated in a 
Parkin-dependent manner remains elusive. To further inspect this, we could measure the 
localization of the Atg8 family proteins on mitochondrial fractions in the presence and absence of 
Parkin. Alternatively, we can use CRISPR/Cas9 gene editing technology to generate knockouts of 
each Atg8 subfamily to determine the contribution and necessity for selective mitochondrial 
degradation. In a recent study, it was shown that autophagy adaptor proteins OPTN and NDP52 
are directly recruited to damaged mitochondria (243). To further inspect the process of 
autophagosomal biogenesis, we can subject WT and Parkin KO mice to an acute bout of exercise, 
and immunoprecipitate autophagy adaptor proteins from mitochondrial sub-fractions. The 
precipitates can thereafter be probed for Atg8 family members to directly assess the requirement 
of Parkin on the recruitment of each Atg8 family member to initiate mitophagy.  
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In summary, our research has led to a few research questions and directions which can 
improve our understanding on how mitophagy is regulated in muscle. An impairment in mitophagy 
can contribute to age-associated declines in muscle mass and function. Exercise is a very potent 
stimulus to promote mitochondrial turnover. The answers to these questions can help uncover new 
ways to promote healthy aging.  
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APPENDIX A:  
SUPPLEMENTARY TABLES AND FIGURES 
 
Supplementary Table 1.  
 
            
*Note: Young animals were acclimatized to the treadmill for two days prior to exhaustive 
exercise on Day 3. Aged animals ran a similar protocol but began incremental exercise after 10 
m/min for 10 minutes. 
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Supp. Fig. 1. 
 
Supplementary Figure 1. A graphical representation of animal characteristics of WT and Parkin 
KO mice from Manuscript #1. Values are reported as means ± SEM, n = 6.   * P < 0.05 vs. Young 
counterpart. Wild-type, WT; KO, Parkin KO; TL, tibia length.   
 
 
 
 
 
170 
 
 
Supp. Fig. 2.  
 
   
 
Supplementary Figure 2. A visual representation of voluntary wheel running protocol and 
animal group conditions. Following 6 weeks of endurance training, a subset of animals was 
subjected to acute exercise as illustrated in Supplementary Table 1. Wild-type, WT; Parkin 
knock-out, KO; untrained, UT; trained, T; colchicine, COL.     
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APPENDIX B: 
ADDITIONAL DATA 
 
STUDY 1: The role of Parkin in cardiac autophagy and mitophagy 
Rationale 
In this PhD dissertation, I established a role for Parkin-mediated mitophagy in skeletal 
muscle following acute exercise. However, the functional importance of Parkin in the heart with 
exercise and age remains unknown. Recent evidence suggests that mitochondrial turnover in 
cardiac muscle is mediated by Parkin under stress-induced conditions. A central function of the 
heart during exercise is to provide oxygenated blood to working muscles. Thus, cardiac function 
must increase to match the demands of the muscles and lungs. Because of this energy demand, the 
heart heavily relies on its own abundance of mitochondria for energy. Organelles that are unable 
to meet these demands are targeted for degradation. We sought to investigate whether autophagy 
and mitophagy flux were altered because of age and exercise within whole muscle samples and 
mitochondrial sub-fractions.     
 
Results 
Cardiac autophagy flux is enhanced in aged Parkin KO animals. To investigate the role of 
Parkin on autophagy flux in the heart, we utilized young and old groups of WT and Parkin KO 
animals. Western blot analyses on whole heart samples revealed that basal autophagy flux did not 
differ between young and aged WT animals (Fig. 1A–E). Aged Parkin KO animals displayed 
higher basal LC3II flux in cardiac tissue, compared to young (Fig. 2E, P < 0.05). Surprisingly, we 
detected enhanced p62 flux with age irrespective of genotype (Fig. 3D and 3F, P < 0.05). 
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Endurance training attenuates Parkin-mediated mitophagy flux. To assess the involvement of 
Parkin on mitophagy in cardiac muscle during training, mitochondria were isolated from the heart 
of trained WT and Parkin KO animals following 6 weeks of voluntary wheel running. Endurance 
training resulted in a significant increase in LC3-II localization to the mitochondria (Fig. 4B and 
5B, P < 0.05), and did not increase additionally with a subsequent bout of acute exercise. We found 
that acute exercise significantly attenuated mitophagic LC3II and p62 flux following training in 
WT animals (Fig. 4C and 4E, P < 0.05), and this relationship did not occur in the absence of Parkin.     
 
Conclusions 
There is emerging evidence on mitochondrial dysfunction and its role in heart failure. It is 
relatively unknown if mitochondrial turnover in the heart is influenced by other physiological 
metabolic states, such as exercise and aging. Our results indicate that Parkin may be involved in 
this process. Interestingly, we noted that autophagy LC3-II and p62 flux were enhanced in Parkin 
KO mice with age. The absence of Parkin can impair mitophagy and evoke an accumulation of 
dysfunctional mitochondria in the heart that can execrate with age. The enhancement of autophagy 
flux observed in aged KO animals may function as a compensatory response to the impairment of 
mitophagy. Future work will need to investigate this possibility by directly measuring mitophagy 
flux. Nonetheless, these data indicate that Parkin may play a role in maintaining mitochondrial 
quality in the aging heart.     
Exercise training commonly leads to a physiological, adaptive hypertrophy of the left 
ventricle. This may be accompanied by a proliferation of mitochondria as a response to upregulate 
cardiac energy production and increase cardiac workload. To examine this, we isolated 
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mitochondria from untrained and trained hearts of WT and Parkin KO mice. For WT animals, 6 
weeks of endurance exercise was sufficient to increase the expression and localization of 
autophagosomal marker LC3-II to mitochondria; and with a subsequent bout of acute exercise was 
able to reduce mitophagic flux of LC3-II and p62. These data support our findings from manuscript 
#2 that the occurrence of Parkin-mediated mitophagy is attenuated with successive exercise bouts 
to attain training-induced mitochondrial adaptations.  
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Fig. 1 
A.   
 
 
Figure 1. Expression of autophagosomal protein LC3 in cardiac muscle of young and aged 
WT animals. A) Representative blot of LC3. Quantification of whole heart B) LC3I, C) LC3II, 
D) ratio of LC3II over LC3I, and E) LC3II flux. GAPDH was used as a loading control. Values 
are represented in arbitrary units. (n=6 for all groups).  
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Vehicle         Colchicine         Vehicle         Colchicine
Young                             Aged
20 ⎯
10 ⎯
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Fig. 2 
A.   
 
 
Figure 2. Expression of autophagosomal protein LC3 in cardiac muscle of young and aged 
KO animals. A) Representative blot of LC3. Quantification of whole heart B) LC3I, C) LC3II, 
D) ratio of LC3II over LC3I, and E) LC3II flux. *P<0.05, main effect of age. GAPDH was used 
as a loading control. Values are represented in arbitrary units. (n=6 for all groups).  
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Fig. 3 
       A. WT animals              B. Parkin KO animals 
   
 
Figure 3. Expression of autophagy adaptor p62 in cardiac muscle of WT and Parkin KO 
animals. Representative blots of whole heart p62 in A) WT and B) Parkin KO mice. Quantification 
of p62 content between young and aged C) WT and E) Parkin KO mice. Evaluation of p62 flux in 
the heart between young and aged D) WT and F) Parkin KO mice. *P<0.05, vs young WT. 
*P<0.05, vs young KO control. GAPDH was used as a loading control. Values are represented in 
arbitrary units. (n=6 for all groups).  
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Fig. 4 
          A.               
   
 
Figure 4. Mitochondrial localization of autophagy proteins LC3-II and p62 from WT 
animals. Representative blots of LC3-II and p62 on isolated cardiac mitochondria from WT mice. 
Quantification of B) LC3-II and D) p62 localization on mitochondria between untrained and 
untrained animals. Evaluation of C) LC3-II flux and E) p62 flux on cardiac mitochondria following 
exercise and training. *P<0.05, main effect of training. **P<0.05, main effect of acute exercise. 
VDAC was used as a mitochondrial loading control. Values are represented in arbitrary units. (n=4 
for all groups).  
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Fig. 5 
          A.               
   
 
Figure 5. Mitochondrial localization of autophagy proteins LC3-II and p62 from KO 
animals. Representative blots of LC3-II and p62 on isolated cardiac mitochondria from KO mice. 
Quantification of B) LC3-II and D) p62 localization on mitochondria between untrained and 
untrained animals. Evaluation of C) LC3-II flux and E) p62 flux on cardiac mitochondria following 
exercise and training. *P<0.05, main effect of training. VDAC was used as a mitochondrial loading 
control. Values are represented in arbitrary units. (n=4 for all groups). 
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STUDY 2: Skeletal muscle autophagy proteins in endurance trained, obese and obese 
diabetic individuals (Laval University collaborators: Claire Huth and Dr. Denis Joanisse)  
Rationale 
Emerging evidence points to autophagic dysregulation in obesity and in diabetes. The 
sustained energy surplus of intracellular substrates, such as lipids, can impair autophagy and 
reduce the responsiveness of cells to changes in nutrient status. This close regulation of energetic 
status and metabolism is particularly important in organs like skeletal muscle and liver that are 
insulin-sensitive and responsible for maintaining glucose homeostasis. The energy requirements 
of these organs correspond to the high abundance and turnover of mitochondria. As such, proper 
preservation of mitochondrial function and content in these organs is critical for substrate 
utilization and metabolism.  
 It is now recognized that several metabolic pathologies, including insulin resistance, are 
induced by mitochondrial dysfunction. Physical inactivity and muscle atrophy are also often 
accompanied in individuals with these metabolic pathologies. Furthermore, impairments of 
mitochondrial dynamics and mitophagic clearance are evident. Consequent reductions in muscle 
mass and mitochondrial integrity can, in turn, reduce the aerobic capacity of obese and diabetic 
individuals.  
However, what remains unanswered is whether autophagy contributes to the decline in 
mitochondrial content seen in individuals with obesity and insulin resistance. Furthermore, the 
effect of regular exercise training on autophagy is not fully established. Exercise training is a 
possible non-pharmacological treatment for obesity and diabetes which is known to increase 
mitochondrial content. To assess this, autophagic flux should be measured. However, this is not 
technically feasible in human subjects currently. Thus, we have investigated well established 
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markers of autophagy in human skeletal muscle. We hypothesized that because of autophagy 
upregulation, mitochondrial content and function would be reduced in muscle of obese and insulin 
resistant individuals. This autophagy upregulation would serve to normalize the metabolic “load” 
of having greater dysfunctional mitochondria. In athletic individuals, the preservation of 
autophagy would also assist in the maintenance of healthy mitochondrial turnover in skeletal 
muscle. In this study, we investigated the influence of endurance training, obesity and obesity 
accompanied by Type 2 diabetes on human skeletal muscle autophagy markers and mitochondrial 
dynamic proteins. Muscle biopsies were performed on the Vastus Lateralis muscle from 
individuals that were: sedentary (S), endurance-trained (A), obese (O) or obese with type 2 diabetes 
(I). 
 
Results 
Mitochondrial morphology  
Past research has implicated organelle morphology as an important regulator of skeletal 
muscle metabolism in both rodent and human models. Thus, we sought to examine the expression 
of mitochondrial regulatory fusion (Mfn2 and Opa1) and fission (Drp1 and Fis1) proteins in whole 
muscle. An overall significant 40% decrease in fusion protein Opa1 was present in both obese and 
obese glucose-intolerant subjects, when compared to endurance trained athletes (P < 0.05; Fig. 
1B). However, no group differences were detected in Mfn2, Drp1 or Fis1.  
 
Autophagy protein expression   
Whole muscle autophagy protein expression was examined for ATG7, p62, Parkin and 
PARL. Expression of ATG7 and adaptor protein p62 did not significantly differ between 
conditions. In endurance trained athletes, the mitochondrial protease PARL exhibited a significant 
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2.1-fold increase in expression compared to obese individuals (P < 0.05; Fig. 2B). In contrast, 
athletic participants displayed a ~50% significant decrement in E3 ubiquitin ligase Parkin when 
compared to obese glucose-intolerant subjects (P < 0.05; Fig. 2A). Following the dietary 
intervention, obese glucose-intolerant subjects presented a significant 42% reduction in PARL 
levels (P < 0.05; Table 2B).  
 
Endoplasmic reticulum stress  
To assess a role for endoplasmic reticulum stress in chronic metabolic diseases, whole 
muscle expression of CHOP and BIP, two proteins involved in the unfolded protein response, were 
also examined. Our analyses revealed an overall significant main effect of conditions on CHOP 
expression (P < 0.05; Fig. 3A), but BIP remained unaffected.  
 
Conclusions 
The purpose of our investigation was to examine the influence of endurance training, 
obesity and insulin resistance accompanied by glucose intolerance on human skeletal muscle 
autophagy markers, as well as proteins related to the maintenance of mitochondrial morphology. 
ET athletes displayed 50% higher levels of Opa1 fusion protein. No differences were observed in 
the fission proteins Fis1 and Drp1, suggesting a cellular environment which promotes 
mitochondrial fusion and an expansion of the mitochondrial reticulum with endurance training. 
OBD subjects also exhibited a 50% decrement in PARL and a 100% increase in Parkin levels, 
which are indicators of dysfunctional mitochondria and increased mitophagy. Furthermore, OB 
individuals expressed elevated levels of CHOP, an endoplasmic reticulum (ER) stress-related 
protein, while CHOP levels were significantly lower in ET athletes. Our findings suggest that 
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upregulation of autophagy and the ER-stress response in skeletal muscle appears to be associated 
with impaired insulin sensitivity in obesity. Endurance training may serve to ameliorate the 
relationship between autophagy and insulin resistance and obesity. 
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Fig. 1 
 
                       
Figure 1. Mitochondrial fusion and fission protein expression in sedentary (S), endurance-
trained (A), obese (O) or obese with type 2 diabetes (I) individuals. A to D blots and 
quantification of mitochondrial fusion and fission proteins in Vastus Lateralis muscle. 
Quantification of A) Mfn2, B) Opa1, C) Drp1, and D) Fis1. *P<0.05, main effect of condition. 
Values that share the same asterisk are not statistically different, using the Tukey HSD post-hoc 
test.   (n=8-11 for all groups). 
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Fig. 2 
 
Figure 2. Expression of autophagy and mitophagy markers in sedentary (S), endurance-
trained (A), obese (O) or obese with type 2 diabetes (I) individuals. A to D blots and 
quantification of autophagy and mitophagy proteins in Vastus Lateralis muscle. Quantification of 
A) Parkin, B) PARL, C) p62, and D) Atg7. *P<0.05, main effect of condition. Values that share 
the same asterisk are not statistically different, using the Tukey HSD post-hoc test.   (n=8-11 for 
all groups). 
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Fig. 3 
 
Figure 3. Expression of endoplasmic reticulum (ER) stress in sedentary (S), endurance-
trained (A), obese (O) or obese with type 2 diabetes (I) individuals. A to B blots and 
quantification of ER stress proteins in Vastus Lateralis muscle. Quantification of A) CHOP and, 
B) BIP. #P<0.05, main effect of condition.   (n=8-11 for all groups). 
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STUDY 3: PINK1 import in skeletal muscle mitochondria 
Rationale 
The selective degradation of dysfunctional mitochondria is termed mitophagy. Recently, 
key proteins such as PINK1 and Parkin have been implicated in regulating this process. Mutations 
arising from these genes are thought to contribute to the development and pathogenesis of human 
neurological disorders such as Parkinson’s Disease. While an extensive amount of research has 
focused on the function of PINK1 and Parkin function in the brain, very little research has 
examined these proteins in muscle – an organ that relies heavily on mitochondria to meet its high 
energy requirements. 
Under normal conditions, functional respiring mitochondria rapidly degrade PINK1 
through the assistance of PARL. PARL is an enzyme found within the inner mitochondrial 
membrane that proteolytically cleaves PINK1. The half-life of PINK1 has been estimated to be 
less than 30 minutes. When a mitochondrion become dysfunctional, the loss of membrane prevents 
PINK1 from being subjected to PARL degradation, resulting in its accumulation on the outer 
membrane. Immediately after, PINK1 recruits and activates Parkin from the cytosol to the 
dysfunctional mitochondrion. Parkin then mobilizes a suite of mitophagy proteins that surround 
the mitochondrion, sequestering it for lysosomal degradation in the cell. Amino acid remnants are 
reused for the synthesis of new organelles and proteins in the cell. Currently, it is not known how 
PINK1 import is regulated in skeletal muscle. Static protein measurements of PINK1 import are 
not wholly accurate, and only provide a snapshot of the process like that of mitophagy flux.    
The purpose of this study was to examine how PINK1 mitochondrial protein import is 
regulated in skeletal muscle and investigate how mitochondrial dysfunction affects PINK1 import.  
 
187 
 
Results 
PINK1 is a protein kinase implicated in mitophagy as a sensor of mitochondrial 
dysfunction. Under healthy conditions, PINK1 is translocated into mitochondria by the protein 
import machinery (PIM) and proteolytically processed by the protease PARL. When mitochondria 
become dysfunctional, the dissipation of the membrane potential prevents the import and 
processing of PINK1 resulting in its accumulation on the outer membrane. Once on the outer 
membrane, PINK1 activates Parkin-mediated ubiquitination leading to the degradation of 
damaged mitochondria. However, the mechanisms of PINK1 import and its role in muscle remain 
unclear. In this study we examined PINK1 import into mitochondria isolated from mouse muscles 
(Fig. 1). A rapid increase in PINK1 insertion into the outer membrane (59 ± 6.9%) and processing 
(56 ± 7.3%) was observed by 15 minutes of incubation with mitochondria (Fig. 2B). When an 
uncoupler (CCCP) was supplemented, PINK1 import was reduced by 50%, confirming that 
complete PINK1 import is membrane potential-dependent (Fig. 2B).  
Skeletal muscle contains two distinct mitochondrial populations that differ biochemically. 
To investigate this comparison, we examined PINK1 protein import into SS and IMF 
mitochondria. Surprisingly, our preliminary data indicated that SS mitochondria exhibited greater 
PINK1 import (Fig. 3). SS mitochondria are considered more labile than IMF mitochondria, and 
may indicate that SS mitochondria are more susceptible to mitophagy.  
This work presents the PINK1 protein import assay as a viable method to study 
mitochondrial function and mitophagy activation in skeletal muscle.  
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Fig. 1 
 
 
  
Figure 1. Schematic outline of PINK1 import into isolated mitochondria. Full length cDNA 
encoding PTEN-induced putative kinase 1 (PINK1, from Dr. Richard J. Youle, National Institutes 
of Health, Maryland, USA) was linearized and transcribed. In vitro translation was performed 
using cell free rabbit reticulocyte lysate (Promega, Fisher Canada) in the presence of [35S]-
methionine (Perkin Elmer, Canada). Afterwards, isolated mitochondria and reticulocyte lysate 
containing the translated radiolabeled precursor PINK1 were initially allowed to equilibrate 
separately at 30 °C for 25 minutes. To examine the dissipation of membrane potential, isolated 
mitochondria were pre-treated with carbonyl cyanide m-chlorophenyl hydrazone (CCCP). The two 
samples were combined and further incubated at 30 °C for 25 minutes. To standardize import 
reactions using SDS-PAGE, 75 μg of mitochondria and 18 μl of reticulocyte lysate were used. 
Mitochondria were recovered by centrifugation (16,000 x g) through 600 μl of 20% sucrose in 0.1 
M potassium chloride, 2 mM magnesium chloride, and 20 mM HEPES (pH 7.4) at 4 °C for 15 
minutes. For outer membrane proteins, such as PINK1, the mitochondrial pellet after the sucrose 
gradient spin was re-suspended in freshly prepared 0.1 M sodium carbonate (Na2CO3). The 
samples were left on ice for 30 minutes to eliminate any bound, peripheral PINK1 to the outer 
mitochondrial membrane that was not imported. Mitochondria were recovered after centrifugation 
(16,000 x g) at 4 °C for 15 minutes. Samples were denatured at 95 °C for 5 minutes and 
electrophoresed through a 12% SDS-polyacrylamide gel. Following electrophoresis, gels were 
treated for 5 minutes in boiling 5% trichloroacetic acid, followed by a 1-minute wash in distilled 
water, 5 minutes in 10 mM Tris base (pH 9.0), and 30 minutes in 1 M sodium salicylate. Gels were 
subsequently dried with a vacuum gel dryer (Model 583; Bio-Rad). Radiolabeled precursor 
proteins were detected using storage phosphor imaging (Typhoon Trio; GE Healthcare Life 
Sciences) and quantified using ImageJ software. 
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Fig. 2 
                    A. 
 
                        B. 
 
Figure 2. PINK1 protein import and processing in IMF mitochondria. A) Import blot of 
translated radiolabeled PINK1 protein into IMF mitochondria over 15 minutes. For time “zero”, 
CCCP was added to isolated mitochondria to dissipate the membrane potential. B) Graphical 
representation of PINK1 protein import and processing over 15 minutes represented as percentage 
of total available protein (N = 7). For each 5-minute period, the quantification of all bands was 
represented as “% Import”. The quantification of all bands except the full length PINK1 band was 
calculated as “% Processed”. 
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Fig. 3 
 
Figure 3. PINK1 protein import and processing in IMF and SS mitochondria. Import blot of 
translated radiolabeled PINK1 protein into IMF and SS mitochondria over 20 minutes. Following 
20 minutes, CCCP was added to isolated mitochondria to dissipate the membrane potential. Full 
length, FL; MTS, mitochondrial targeting sequence.  
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APPENDIX C:  
LABORATORY METHODS 
 
MITOCHONDRIAL ISOLATIONS FROM MUSCLE 
References: Cogswell et al. Am J Physiol, 1993, 264: C388-C389 
Krieger et al. J Appl Physiol, 1980, 48: 23-28 
Reagents:  
All buffers are set to pH 7.4 and stored at 4 °C  
- Buffer 1       - Buffer 1 + ATP  
100 mM KCl       Add 1 mM ATP to Buffer 1  
5 mM MgSO4  
5 mM EDTA  
50 mM Tris base  
- Buffer 2      - Resuspension medium  
100 mM KCl       100 mM KCl  
5 mM MgSO4      10 mM MOPS  
5 mM EGTA       0.2% BSA  
50 mM Tris base  
1 mM ATP  
- Nagarse protease (Sigma, P-4789) 
10 mg/ml in Buffer 2  
Make fresh for each isolation, keep on ice  
 
Procedure:  
1. Remove various muscles from mouse and place in a scintillation vial containing ice cold buffer 1.  
2. Place muscles on a watch glass that is also on ice and trim away fat and connective tissue. Proceed 
to thoroughly mince the muscle sample with forceps and scissors, until no large pieces are 
remaining.  
3. Place the minced tissue in a plastic centrifuge tube and record the exact weight of tissue.  
4. Add a 10-fold dilution of Buffer 1 + ATP to the tube.  
5. Homogenize the samples using the Ultra-Turrax polytron with 40% power output (9.8 Hz) and 10 
sec exposure time.  
6. Using a Beckman JA 25.50 rotor, centrifuge the homogenate at a setting of 800 g for 10 min. This 
step divides the IMF and SS mitochondrial subfractions. The supernate will contain the SS 
mitochondria and the pellet will contain the IMF mitochondria. 
SS mitochondrial isolation:  
7. Filter the supernate through a single layer of cheesecloth into a second set of 50 ml plastic 
centrifuge tubes.  
8. Centrifuge tubes at 9000 g for 10 min. Upon completion of the spin discard the supernate and gently 
resuspend the pellet in 3.5 ml of Buffer 1 + ATP. Since the mitochondria are easily damaged, it is 
important that the resuspension of the pellet is done carefully.  
9. Repeat the centifugation of the previous step (9000 g for 10 min) and discard the supernate.  
10. Resuspend the pellet in 100 μl of Resuspension medium, being gentle so as to prevent damage to 
the SS mitochondria. Some extra time is needed during this final resuspension to ensure the SS 
pellet is completely resuspended.  
11. Keep the SS samples on ice while proceeding to islolate the IMF subfraction.  
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IMF mitochondrial isolation: 
7. Gently resuspend the pellet (from step 6) in a 10-fold dilution of Buffer 1 + ATP using a teflon 
pestle.  
8. Using the Ultra-Turrax polytron set at 40% power output, polytron the resuspended pellet for 10 s. 
Rinse the shaft with 0.5 ml of Buffer 1 + ATP.  
9. Centrifuge at 800 g for 10 min and discard the resulting supernate.  
10. Resuspend the pellet in a 10-fold dilution of Buffer 2 using a teflon pestle.  
11. Add the appropriate amount of nagarse. The calculation for the appropriate volume is 0.025 ml/g 
of tissue. Mix gently and let stand exactly 5 min.  
12. Dilute the nagarse by adding 20 ml of Buffer 2.  
13. Centrifuge the diluted samples at 5000 g for 5 min and discard the resulting supernate.  
14. Resuspend the pellet in a 10-fold dilution of Buffer 2. Gentle resuspension is with a teflon pestle.  
15. Centrifuge the samples at 800 g for 10 min. Upon the completion of the spin, the supernate is 
poured into another set of 50 ml plastic tubes (on ice), and the pellet is discarded.  
16. Centrifuge the supernate at 9000 g for 10 min. The supernate is discarded and the pellet is 
resuspended in 3.5 ml of Buffer 2.  
17. Centrifuge samples at 9000 g for 10 min and discard the supernate.  
18. Gently resuspend the pellet in 200 μl of Resuspension medium.  
 
 
MITOCHONDRIAL RESPIRATION 
Reference: Estabrook, R.W., Meth. Enzymol., 10: 41-47 (1967) 
 
The rate of mitochondrial respiration is an important consideration in the biochemical analysis of 
mitochondria.  There are three phases of interest in analyzing the respiratory ability of mitochondria.  
Mitochondria produce ATP in the presence of oxygen.  The respiratory ability of the freshly isolated IMF 
and SS mitochondrial fractions and the homogenates can be illustrated by measuring the rate of oxygen 
consumption using a Clark oxygen electrode in the presence of a) the substrate alone (e.g. glutamate for 
state 4 or resting respiration); b) ADP, (state 3 or active respiration); and c) NADH+, which is used to 
measure the amount of damage that has occurred to the mitochondria, since the inner membrane is 
impermeable to NADH+. 
 
Reagents: 
1.    VO2 Buffer for muscle mitochondria: 
 
250 mM Sucrose  42.8 g/500 ml 
     50 mM KCl 1.86 g/500ml 
     25 mM Tris-HCl * 1.97 g/500ml             
     10 mM K2HPO4  0.871 g/500ml 
  pH to 7.4 
 * In place of 25mM Tris-HCl you can use 25 mM Tris (aka Tris (hydroxymethyl) methylamine).  
This works out  to 1.5125 g/500ml (FW=121.4).  Using Tris in place of Tris-HCl means 
that you will have to add more HCl to get the pH down to 7.4 
2.  Glutamate - final conc. of 11.1 mM.............................2.0 M initial conc. (406.4 mg/ml) 
3. ADP - Final conc of 0.44 mM ..................................... 20 mM initial conc.  (8.54 mg/ml)  
4.  NADH - Final conc.: 2.8 mM........................................0.5 M initial conc. (354.7 mg/ml) 
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Procedure: 
 1.  Set water bath at 30oC -- clean out chambers (Clark oxygen electrode; Yellow Springs Inst. Co., Yellow 
Springs, OH) and stir bars. 
 2.  Add 250uL of VO2 Buffer to each chamber. 
 3.  Insert electrode # 2 into the chamber. 
 4.  Remove all bubbles in the chamber and allow it to reach equilibrium temperature (30oC) while spinning. 
 5.  Set recorder for chamber # 2 and paper speed for 3 cm/min.  
 6.  Set monitor and recorder to 100 %. 
 7.  Remove electrode.  Add 50 µl of mitochondria into the chamber. 
8.  Allow a steady state to be reached. 
 9.  Add 12.5 µl of pyruvate and 12.5 µl of malate (heart) or 12.5 µl glutamate (muscle).  
10.  Wait approximately 3 minutes then add ADP: 50 µl for muscle, 100 µl for heart. 
11.  Wait (about 2-3 minutes) for a steady rate of state 3 respiration before adding 12.5 µl of NADH.  
Prepare the next chamber while the respiration recordings are being made. 
12.  Clean out the chamber in the following manner: Remove the electrode and aspirate, remove the 
magnetic stir bar and aspirate, and finally, clean the electrode by rinsing with distilled water and 
pat dry. 
13.  Put electrode in the next chamber (which should already have the buffer and sample in it).  
14.  Prepare the next chamber while measuring the respiration of the current chamber (ie. add 2 ml of VO2 
Buffer and allow to equilibrate). 
15.  Calculate the state 4, state 3 and NADH+ rates for each sample. Remember that the chart speed is 3 
cm/sec and full scale is 100 %. (slope=rate=blocks/min) 
16. Calculate the rates of state 3 and state 4 respiration per mg of mitochondrial protein by dividing the 
state 3 and 4 rates by the amount of protein (mg) added to the VO2 Buffer.  
 
 
 
ROS EMISSION 
Background: Mitochondria are the primary source of reactive oxygen species (ROS) to the cell.  It is 
estimated that about 2% of total cellular oxygen is converted to ROS by the inappropriate reduction of 
molecular oxygen by intermediate members of the electron transport chain (ETC).  ROS are damaging 
molecules that can compromise the integrity of macromolecules within the mitochondria and may lead to 
overall organelle dysfunction.  MtDNA may be prone to attack by ROS because 1) mtDNA is near the ETC, 
2) mtDNA lacks the protective sheath of histones compared to nuclear DNA and, 3) mitochondria have an 
insufficient repair system for mtDNA mutations.   ROS can exist in a variety of molecular permutations 
such as superoxide (O2-), hydroxyl radical (OH-) and hydrogen peroxide (H2O2).    
DCF (2,7, -dichloro-fluorescein; Fig.1) is a reagent that is non-fluorescent until the acetate groups 
are removed by intracellular esterases and oxidation occurs within the mitochondria (Figure 1).  DCF is 
oxidized by all the different forms of ROS and this can be detected by monitoring the increase in 
fluorescence with a fluorometric plate reader.  The appropriate plate reader filter settings for fluorescein 
are the following: Excitation 485/20 and Emission 528/20 (Figure 2).  
194 
 
   
 
  Figure 1. DCF molecule and oxidation of DCF resulting in fluorescence 
 
    
Figure 2. Absorption and Emission Spectra of oxidized dye               
KC4 Software Settings: The Settings icon in the upper left corner allows the alteration of various 
parameters.  Once clicked, another window appears, click on the Wizard Icon.  In this window there will 
be a variety of components that can be altered.  The following are the parameters that need to be changed 
to utilize the DCF and measure time-dependent ROS production from isolated mitochondria: 
1) Top Middle Panel- Absorbance, Fluorescence, Luminescence- choose Fluorescence 
2) Top Left Panel- End Point, Kinetic, Spectrum- choose Kinetic 
3) Top Middle Panel- Click on larger box labeled Kinetic to set parameters- Run Time 1:20:00, Interval 
5:00 (takes a measure every 5 minutes), click on box labeled Allow Well Zoom during Read, and click 
on box labeled Individual Well Auto Scaling- The Well Zoom and Auto scaling allows for monitoring 
each individual well during the experiment and scales it appropriately. 
195 
 
4) Middle Panel-Filter Set- Choose #1, then set the excitation to 485/20, and emission to 528/20 as 
described above.  The optics position should be set to the TOP (i.e. readings are taken from the top of the 
well) and the sensitivity is set at 50 (depending upon the amount and/or nature of the sample).  
5) Plate-Type-choose 96-well plate, choose which wells are to be read i.e. A1-C12. 
6) Shaking-Intensity set at 1, Duration set at 15s and then click the box that is labeled before every 
reading (it shakes the samples for 15 s before every reading). 
7) Temperature Control- Click on the box indicating YES, also click on box labeled pre-heating, and put 
37°C into the temperature box. 
Reagents: 
DCF (2,7,-dichlorodihydrofluorescein diacetate) reagent MW=487.29 (Molecular Probes D-399/ 100mg) 
1° STOCK- Make up 50mM Stock Solution in EtOH- 24 mg/ml- only make about 500ul i.e. 12 mg per 
500ul EtOH. Wrap stock solution in aluminum foil and limit exposure to light since DCF is light-sensitive. 
Working Stock Solution-2° STOCK- Dilute 50mM by 100-fold by taking 10ul and adding 990 ul of EtOH 
to attain a 500uM DCF Stock Solution.  This will be the DCF concentration used to add to the reaction 
mixture. 
VO2 Buffer- refer to mitochondrial respiration protocol 
Procedure: 
1. SS and IMF mitochondria are isolated as described in the mitochondrial isolation protocol.  Alternatively, 
frozen mitochondrial extracts can also be used.  
2. Determine the volume necessary for 50ug of mitochondria.  Typical volumes should range between 5-
40ul depending upon concentration of mitochondrial extracts. 
3. Final concentration of DCF is 50uM.  The total volume of the reaction mixture is 250ul.  Thus, 25ul of 
DCF is used in the reaction mixture since this represents a 10-fold dilution. Set up table and determine 
the amount of VO2 buffer necessary to make each of the reaction mixtures equal to 250 ul.  (Remember 
to include a control with only VO2 buffer and DCF reagent)           
4. Once table is complete and volumes for all samples have been determined, place the frozen (already 
thawed) or fresh mitochondria, VO2 buffer and DCF (500uM) into a 37°C circulating water bath for 5-
10 min. 
5. Pipette the volume of VO2 buffer required for each of the samples followed by the mitochondrial samples 
into the appropriate wells of a 96-well plate.  In addition, include a well (usually in the corner well) with 
only 250 ul of VO2 buffer to monitor temperature (see below). Place the 96-well plate with the VO2 
buffer and mitochondria into a 37°C incubator.  Using the YSI temperature probe, place the recording 
electrode into the well with buffer only and monitor the temperature until 37°C is reached.  During this 
time, be sure that the KC4 software is set up and that the Biotek plate reader is pre-heating to 37°C. 
6. Once mitochondria and buffer have reached temperature (37°C), take the DCF out of the circulating          
water bath (37°C) and quickly add the DCF to each of the reaction mixtures.   Following addition of DCF, 
promptly place the plate into the Biotek plate reader for fluorescence measurement and start the KC4 
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program by pressing READ plate on the upper left portion of the computer screen.  Kinetic program will 
operate for 1 h and 20 min. 
 
 
WESTERN BLOTTING 
Reagents: 
1. Acrylamide/Bis-Acrylamide, 30% Solution 37.5:1 (BioShop 10.502) 
a. Store at 4°C 
2. Under Tris Buffer 
a. 1M Tris-HCl, pH 8.8 (60.5g/500ml) 
b. Store at 4°C 
3. Over Tris Buffer 
a. 1M Tris-HCl, pH 6.8 (12.1g/100ml) 
b. Bromophenol Blue (for colour) 
c. Store at 4°C 
4. Ammonium Persulfate (APS) 
a. 10% (w/v) APS in ddH20 (1g/10ml) 
b. Stored at 4°C 
5. Sodium Dodecyl Sulfate (SDS) 
a. 10% (w/v) in ddH20 (1g/10ml) 
b. Store at room temperature 
6. TEMED (Sigma T-9281) 
7. Electrophoresis Buffer, pH 8.3 (10L) 
a. 25mM Tris 30.34g, 192mM Glycine 144g, 0.1% SDS 10g 
b. Volume to 10L with ddH20 
c. Store at room temperature 
8. 6X SDS 
a. Warm 100% glycerol in water bath at 65°C for 30 minutes 
b. Combine 1.2g SDS, 0.06g Bromophenol Blue, 3mL of 1M Tris, pH 6.8 and 1ml of ddH2O 
and stir at 4°C for 5 minutes 
c. Add 3mL of 100% glycerol, stir and aliquot mixture. 
d. Store at -20°C 
e. Add 5% (v/v) ß-mercaptoethanol (Sigma M6250) to 6X SDS just prior to use 
9. tetra-Amyl alcohol ReagentPlus, 99% (Sigma 152463) 
 
Procedure: 
1. Prepare electrophoresis rack: 
a. Clean glass plates thoroughly with soap followed by 95% ethanol then ddH2O.  
b. Dry carefully with a kimwipe.  
c. Assemble glass plates as shown below: 
d. Check the seal by adding a small volume of ddH2O then pour off and let dry.  
2. Prepare separating gels: 
a. Mini Protean 3 Bio-Rad System volumes: 
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 8% 10% 12% 15% 18% 
Acrylamide 2.7 ml 3.3 ml 4.0 ml 5.0 ml 6.0 ml 
ddH20 4.1 ml 3.5 ml 2.8 ml 1.8 ml 0.8 ml 
Under Tris 3.0 ml 3.0 ml 3.0 ml 3.0 ml 3.0 ml 
SDS 100µl 100µl 100µl 100µl 100µl 
APS 100µl 100µl 100µl 100µl 100µl 
TEMED 10µl 10µl 10µl 10µl 10µl 
 
b. Mix the contents of the separating gel without adding APS or TEMED. Stir.  
c. Add APS and TEMED. Stir.  
d. Slowly pour the entire volume of the solution into the space between the two plates while 
keeping plates tilted to prevent bubble formation. 
e.  Add tert-Amyl alcohol to coat top surface of gel solution. 
f. Allow 30 minutes for gel polymerization.  
g. Remove tert-Amyl alcohol by pouring it off and remove any remainder with a kimwipe. 
Rinse with ddH20. 
 
3. Prepare stacking gel: 
a. For a single mini gel use the following volumes: 
 
Acrylamide 500 µl 
Over Tris 625 µl 
ddH20 3.75 ml 
SDS 50 µl 
APS 50 µl 
TEMED 7.5 µl 
 
b. Mix the contents of the stacking gel without adding APS or TEMED. Stir.  
c. Add APS and TEMED. Stir.  
d. Using a Pasteur pipette slowly add the entire volume from the beaker in between the plates.  
e. Add comb for desired number of wells. 
f. Allow 30 minutes for gel polymerization. 
 
4. Prepare samples: 
a. Turn on the block heater to 95ºC.  
b. Pipette required volume of sample into new Eppendorf tube with same amount of lysis 
buffer and 5 µl of sample dye. Keep samples on ice until all samples are prepared (use 
pipette plan). 
c. Briefly centrifuge each sample to bring volume to the bottom of the Eppendorf tube. 
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d. Incubate each sample at 95 ºC for 5 minutes in the heating block to denature the proteins.  
e. Briefly centrifuge again to return volume to the bottom of the Eppendorf tube. 
 
5. Assemble Mini-PROTEAN gel caster system: 
a. See images below 
b. If you are only running one gel a plastic rectangular pseudo plate must be clamped on the 
other side of the caster.  
c. Fill with electrophoresis buffer between the plates and outside of the plates in the chamber.  
d. Slowly remove the comb using both hands (one on each side) by pulling the comb straight 
upwards.  
e. Fix any wells that are deformed using a small spatula.  
f. Clean out the wells using a syringe filled with electrophoresis buffer.  
g. Withdraw the entire volume of the sample using a Hamilton syringe. Inject volume slowly 
into the bottom of the well.  
 
6. Gel electrophoresis  
a. Immediately after all samples are loaded place the lid on the gel chamber. 
b. Place positive and negative plugs into the power supply and turn on power supply.  
c. Set power supply to 120V. Gel will run for ~2 hours depending on percent gel made. 
d. When the bromophenol blue has run off the bottom of the gel (or when gel has separated 
the desire amount) turn off the power supply. Remove plugs from power supply and 
remove lid. 
e. Prepare for electrotransfer of proteins from the gel to nitrocellulose membrane.  
 
Western Blotting-Transfer and Immunodetection: 
Reagents: 
1. Transfer Buffer 
a. 0.025M Tris-HCl pH 8.3  12.14g 
b. 0.15M Glycine    45.05g 
c. 20% Methanol   800ml 
d. make up to 4L with ddH20 
e. store at 4°C 
2. Ponceau S stain 
a. 0.1% (w/v) Ponceau S  
b. 0.5% (v/v) Acetic Acid 
c. Store at room temperature 
3. Wash Buffer 
a. Tris-HCl pH 7.5  12g 
b. NaCl   58.5g 
c. 0.1% Tween  10ml 
d. Store at room temperature 
4. Blocking Solution 
a. 5% (w/v) skim milk power in wash buffer OR 
b. 5% (w/v) BSA in wash buffer 
5. Enhanced Chemiluminescence Fluid (ECL; Santa Cruz sc-2048) 
6. Film/Developer/Fixer 
 
Procedure: 
1. Transfer Procedure 
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a. Remove electrophoresis plates from chamber and separate the plates. 
b. Cut away unnecessary parts of the gel using a spatula and measure remaining gel size. 
c. Using a paper cutter cut 6 pieces of Whatman paper per gel to the same size as the gel. 
Wearing gloves cut nitrocellulose membrane (GE Healthcare RPN303D) to the dimensions 
of the gel.  
d. Assemble Whatman paper, nitrocellulose memebrane and gel as shown above: 
e. Close the cassette and place in the transfer chamber with the black side of the cassette 
facing the back side of the chamber.  
f. Place ice pack in the chamber. 
g. Place lid on the chamber and connect the leads to the power supply.  
h. Turn on the power supply and run at 120V for 2 hours. This can vary depending on the size 
of the protein of interest. 
 
2. Removal of transfer membrane: 
a. Turn off the power supply and disconnect leads from the power supply then remove the lid 
from the chamber. 
b. Remove the cassette from the chamber.  
c. With gloves on, remove the Whatman paper and gel and place the nitrocellulose membrane 
in a plastic dish.  
d. Add Ponceau S stain on the membrane and gently swirl.  
e. Drain off the remaining Ponceau S and save for reuse. 
f. Rinse the membrane with ddH2O to reduce the red background. Wrap membrane in saran 
wrap and scan image. 
g. Cut the membrane while protein bands are still visible at the desired molecular weight. 
h. Rotate membrane at room temperature in wash buffer until remaining Ponceau S has been 
removed. 
i. Incubate membrane for 1 hour with rotation in blocking solution.  
j. Incubate membrane with desired antibody diluted in blocking solution overnight at 4ºC. 
Membrane is placed face up into the solution on a glass plate covered in parafilm. To 
maintain a moist environment overnight, wet a small kimwipe and form it into a ball and 
place in each corner of the dish. Cover the dish with saran wrap. 
 
3. Immunodetection 
a. Wash the blots in wash buffer with gentle rotation for 5 minutes 3X. 
b. Incubate the blots for 1 hour in room temperature with the appropriate secondary antibody 
diluted in blocking solution. 
c. Membrane is placed face up in solution on a glass plate covered with parafilm. Place moist 
kimwipes in each corner of the dish and cover the dish with saran wrap. 
d. Following the incubation, wash the membrane 3X for 5 minutes with wash buffer. 
 
4. Enhanced Chemiluminescence Detection 
a. Mix ECL fluids “A” and “B” in a 1:1 ratio in a disposable Rohr tube. 
b. Place blots on saran wrap face up and apply ECL solution for 2 minutes.  
c. Dab off excess ECL on a kimwipe and place blots face down on a fresh piece of saran wrap 
and wrap tightly. 
d. Expose blot to film (time will vary depending on protein and antibody).  
e. Place film into developer (time will vary). 
f. Once image appears place film into fixer for 2 minutes. Wash with fresh water when 
complete. 
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CYTOCHROME C OXIDASE ASSAY FOR MICROPLATE READER 
References: J. Biol. Chem. 189:665, 1951, 
Meth. Biochem. Anal. 2:427, 1955, 
Meth. Enzymol. 10:245, 1967. 
 
THEORY: 
Tissue extract containing cytochrome c oxidase is added to the test solution containing fully 
reduced cytochrome c. The rate of cytochrome c oxidation is measured over time as a reduction in 
absorbance at 550 nm. The reaction is carried out at 30o C.  
 
REAGENTS: 
1. 20 mM KCN;  MW= 65.12, 13.02 mg/10 ml dH2O 
2. 100 mM K-Phosphate Buffer 
 
- make up 0.1 M KH2PO4;     MW= 136.09  
= 13.6 g/1000 ml 
 (pH approx. 5) 
 (rm. temp) 
- make up 0.1 M K2HPO4.3H2O;   MW= 174.18 
= 17.4 g/1000 ml 
 (pH approx. 8) 
 (rm. temp) 
- mix in equal proportions, pH to 7.0 
 
3. 10 mM K-Phosphate Buffer 
- dilute 0.1 M KPO4 Buffer prepared above 1:10 with ddH2O (eg. 10 ml buffer + 90 ml ddH2O) 
4.  Extraction Buffer (100 mM Na-K-Phosphate, 2 mM EDTA; pH 7.2) 
- 500 ml 0.1 M Na2HPO4. 2H2O;  
   Combine 8.9 g sodium phosphate with 0.372 g EDTA up to 
500 ml. 
- 200 ml 0.1 M KH2PO4;                               
Combine 2.7 g potassium phosphate with 0.149 g EDTA up 
to 200 ml. 
- combine both solutions and pH to 7.2                           
5. Test Solution (reduced cytochrome c, 2 mg/ml), for 10 ml (enough for 36 microplate wells); 
- weigh out 20 mg of horse heart cytochrome c (Sigma, C-2506) in a scintillation vial 
- add 1 ml of 10 mM KPO4 buffer and dissolve cytochrome c 
- make up a small volume of 10 mg/ml sodium dithionite-10 mM KPO4 stock solution (make fresh 
each experiment and use within twenty minutes) 
- add 40 μl of the dithionite stock solution to the test solution and observe red-orange colour change 
- add 8 ml of ddH2O 
- add 1 ml of 100 mM KPO4 buffer. 
 
PROCEDURE: 
1. Place powdered muscle samples in liquid N2. 
2. Add 50 μl of extraction Buffer to 1.5 ml Eppendorf tubes in the aluminum block on ice.  (One 
Eppendorf per sample).  
3.  Add 5-7.5 mg tissue to each tube, recording exact tissue mass.  Mix by tapping.  
4.  Add the volume of Extraction Buffer required to obtain a 20-fold dilution.   
5. Add a stir bar and mix for 15 min. Make up Test Solution during this time and wrap in foil.  
6.  Sonicate each tube 3 x 3 seconds, cleaning the probe between samples. 
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7. Pipette some of 20-fold sample extract into new Eppendorf tube and add volume of Extraction 
Buffer required to obtain an 80-fold dilution.  (eg. 50 μl of 20-fold extract + 150 μl Ext. Buffer = 
200 μl of 80-fold sample extract).  Keep 80-fold sample extract tube on ice for duration of 
experiment  
8.  Add 270 μl of Test Solution into 4-8 wells of 96-well microplate and incubate at 30°C for 10 
minutes to stabilize the temperature and absorbance. 
9. Open KC4 plate reader program (on Triton).  Select CONTROL icon, then PRE-HEATING tab, 
enter 30°C and select ON.  (Do not run assay until KC4 temperature has reached 30°C.) 
10. Select WIZARD icon, then READING PARAMETERS icon. 
 Select Kinetic for Reading Type. 
 Select Absorbance for Reader and 550 nm for wavelength (drop-down menu). 
 Select Sweep for Read Mode. 
 Select 96 Well Plate (default) for Plate Type. 
 Enter first and last well to be read (eg. A1 and A4 if reading 4 samples simultaneously). 
 Select Yes and Pre-heating and enter 30 for Temperature Control. 
 For Shaking enter 0 for both intensity and duration (shaking is not necessary and it will 
delay the first reading).  
 Do not select either of the two options for Pre-reading. 
 Click on the KINETIC… rectangular tile to open the Kinetic window. 
 Enter run time (1 minute is recommended) and select MINIMUM for Interval time (under 
these conditions the minimum Interval time should be 3 seconds). 
 Select Allow Well Zoom During Read to see data in real time (optional). 
 Under Scales, checkmarks should appear for both Auto check boxes.  Do not select 
Individual Well Auto Scaling. 
 Press OK to return to Reading Parameters window.  Press OK to return to Wizard 
window.  Press OK.  Do not save the protocol. 
 
11. Set the multipipette to 250 μl and secure 4-8 yellow tips on the white projections (make sure they 
are on tight and all at the same height). 
12. In a second, clean 96 well plate, pipette samples into 4-8 empty wells (start with A1).  
Recommended volumes: 30 μl of 80-fold extract for Mixed Gastroc, 10 μl for Heart.  Adjust 
volumes according to oxidative capacity of the tissue.  (eg.  25 μl for Red Gastrocnemius and 35 μl 
for White Gastrocnemius).  
13. Remove microplate with Test Solution in 4-8 wells from the incubator (if it has been incubating 
for 10 minutes).  Place this plate beside the plate with the sample extracts in it. 
14. On KC4 program, select the READ icon and press the START READING icon, then press the 
READ PLATE button.  A box will appear that says, “Insert plate and start reading”.  Do not press 
OK yet, but move the mouse so that the cursor hovers over the OK button. 
15. Using the multipipette (set to 250 μl) carefully draw up the Test Solution.  Make sure the volume 
is equal in all the pipette tips, and that no significant air bubbles have entered any of the tips. 
16. Pipette the Test Solution into the wells with the sample extracts (the second plate).  As soon as all 
the Test Solution has been expelled from the tips (do not wait for the second push from the 
multipipette), place the plate onto the tray of the plate reader and with the other hand on the mouse, 
press the OK button.  (Speed at this point is paramount, as there is an unavoidable latency period 
between the time of pressing the OK button and the time of the first reading.)  
17. If desired, add 5 μl KCN to one of the wells to measure any absorbance changes in the presence of 
the CYTOX inhibitor. 
18. Once reading is complete, hold the CTRL key on the keyboard, and use the mouse to click once on 
each of the squares corresponding to a well that had sample in it.  Once all the desired wells have 
been highlighted by a black square (up to a maximum of 8 wells), let go of the CTRL key and a 
large graph will appear with lines on it representing each sample.   
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19. To obtain the rate of change of absorbance over different time periods, select Options and enter the 
amount of time for which you would like a rate of change of absorbance to be calculated.  The 
graph, along with one rate (at whichever time interval is selected) for each sample can be printed 
on a single sheet of paper, and the results can be saved. 
20. The delta absorbance will appear in units of mOD/min and the number given will be negative.  
Convert this to OD/min by dividing by 1000 and omit the negative sign in the calculation.  (eg. if 
Mean V: -394.8 mOD/mn, then use 0.395 OD/min) 
 
CALCULATION: CYTOX activity (μmole/min/g tissue) 
=  delta absorbance/min x total volume (ml) x 80 (dilution) 
18.5 (μmol/ml extinction coeff.) x sample vol (ml) 
 
 
MITOCHONDRIAL PROTEIN IMMUNOPRECIPITATION 
 
Mitochondrial Sample Solubilization 
1. Take isolated mitochondria (Whole tissue 200–300 mg) and dilute with mitochondrial isolation buffer to 
give a final protein concentration of 1 mg/ml. 
2. Add 1/10 volume of 10% Triton X-100 detergent (final detergent concentration 1%) and mix well with 
isolated mitochondria fraction.  
3. Add protease inhibitor cocktail and incubate on ice for 30 minutes. 
4. Centrifuge at 12,000g for 10 minutes at 4°C in ultracentrifuge and collect the supernatant. Keep the 
sample on ice until immunoprecipitation is performed. 
 
Immunoprecipitation 
1. Add desired amount of polyclonal or monoclonal antibody of interest to the solubilized mitochondrial 
supernatant. A pilot experiment should be completed beforehand with a fixed amount of protein and 
precipitated by an increasing amount of antibody. Alternatively, one can check the antibody datasheet for 
recommended antibody concentration. Allow this mixture to mix overnight at 4°C on a nutator mixer. 
2. Add Protein A/G-coupled agarose beads (~100 mg, prewashed with PBS) to the mixture and incubate 
for 1 hour at 4°C on a nutator mixer. Collect the beads by centrifuging for 1 minute at 3,000g on a bench 
top microfuge. Remove the supernatant from the beads. This represents unbound proteins. 
3. Carefully wash the beads to remove any non-specific bound proteins by adding 2 volumes of PBS 
containing detergent to the beads. Gently mix for 5 minutes by inverting, and collect the beads by 
centrifugation as performed in step 2. 
4. Remove the PBS from the beads and discard. Wash the beads with PBS two additional times to remove 
non-specific binding. Repeat depending on the stringency. 
5. Elute the complex by adding 50 ul of SDS-PAGE gel loading buffer. The purified complexes have 
now been released into the supernatant, which should be collected from above the beads. Repeat 
the elution twice to ensure that the entire captured complex has been released from the beads.  
6. Run the samples on a Western blot to check the precipitation of proteins. 
 
Table 1. Pipette plan for mitochondrial Mfn2 immunoprecipitation  
 
Sample Condition
Mito 
Concentration 
(ug/uL)
Amount for 
IP (ug)
Vol of Mito 
Lysate (uL)
Vol of isolation 
buffer to dilute 
to 1 ug/uL
Vol required from 
10% Triton X-100 
stock to 1% (ul)
Vol of Mfn2 
Ab added 
(uL)
WT CON 7.1122 200 28.12 171.88 22 10
WT EX 8.0305 200 24.91 175.09 22 10
KO CON 6.6709 200 29.98 170.02 22 10
KO EX 5.9911 200 33.38 166.62 22 10
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BREEDING AND PCR GENOTYPING OF WT and PARKIN KO MICE 
 
Breeding: Homozygous mice (~2 months of age) may be bred. A female KO mouse can breed with a male 
KO mouse, and generate viable homozygote KO offspring. There is no need to generate heterozygotes for 
this strain of animal.  
 
WT:   Stock No. 000664 (C57BL/6J, The Jackson Laboratory) 
Parkin KO:  Stock No. 006582 (B6.129S4-Park2tm1Shn/J, The Jackson Laboratory)   
 
Background:  This protocol is designed to detect sequences in the murine genome that differ between wild-
type and null animals using polymerase chain reaction amplification.  PCR is a rapid, inexpensive and 
straightforward way of copying specific DNA fragments from minute quantities of source DNA material.  
There are basically 3 procedural steps involved in PCR: 
 
1) Denaturation:  DNA is heated to hot temperature to separate the DNA double helix to single strands 
making them accessible to primers.  During denaturation, the DNA strands separate to form single strands.   
2) Annealing: The reaction mixture is cooled down.  Primers anneal to the complementary regions in the 
DNA template strands, and double strands are formed again between primers and complementary 
sequences.  During annealing one primer binds to one DNA strand and another bind to the complementary 
strand.  The annealing sites of the primers are chosen so that they will prime DNA synthesis in the region 
of interest during extension.  
3) Extension: The DNA polymerase synthesizes a complementary strand.  The enzyme reads the opposing 
strand sequence and extends the primers by adding nucleotides in the order in which they can pair.  During 
extension, DNA synthesis proceeds through the target region and for variable distances into the flanking 
region, giving rise to long fragments of variable lengths.  The entire process is repeated over and over. 
 
 
  
Figure 3. Schematic of basic PCR procedures. 
 
The DNA polymerase, known as Taq polymerase, is named after the hot-spring bacterium Thermus 
aquaticus from which it was originally isolated.  The enzyme can withstand the elevated temperature 
needed for DNA-strand separation.  The cycle of heating and cooling is repeated over and over, stimulating 
the primers to bind to the original sequences and to newly synthesized sequences.  The enzyme will continue 
to extend primer sequences.  This cycling of temperatures results in copying and then copying of copies, 
leading to an exponential increase in the number of copies of specific sequences.  Because the amount of 
DNA placed in the tube at the beginning is very small, almost all the DNA at the end of the reaction cycles 
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are copied sequences. The reaction products are then separated by gel electrophoresis and visualized with 
the use of ethidium bromide. 
 
Reagents 
Lysis Buffer (pH=8.0) 
10 mM Tris HCl (0.121g/100ml) 
150 mM NaCl  (0.8766g/100ml) 
20 mM EDTA  (0.744g/100ml) 
Autoclave for 30min and store at room temperature. 
 
Supermix 
Sigma Jumpstart REDtaq Ready Mix PCR Reaction Mix (P0982) 
Product contains 20 mM Tris-HCl, pH 8.3, 100mM KCl, 4 mM MgCl2, 0.002% gelatin, 0.4 mM each 
dNTP (dATP, dCTP, dGTP, TTP), inert dye, stabilizers, 0.06 unit/μl Taq DNA polymerase, JumpStart Taq 
antibody. 
 
Primers 
Common and Reverse for WT and KO Stock Concentration 500 pmol/μl 
Working Concentration of Primers (10X dilution): 50 pmol/ul 
To make up 50 pmol/μl: use 5 μl of 500 pmol/μl stock and add 45μl of sterile water 
 
Table 2. Protocol Primers  
Primer 5' Label Sequence 5' --> 3' 3' Label Primer Type 
oIMR7026   CCT ACA CAG AAC TGT GAC CTG G   Wild-type Reverse 
oIMR7027   GCA GAA TTA CAG CAG TTA CCT GG   Wild-type Forward 
oIMR7028   ATG TTG CCG TCC TCC TTG AAG TCG   KO Reverse 
 
Proteinase K 
ProK- concentration of 1mg/ml 
 
Reagents for Agarose Gel Electrophoresis of PCR product 
Agarose     50XTAE 
50 X TAE     242 g TRIS 
1X TAE (dilute 50X TAE with stH2O)  500ml dH2O 
10mg/ml EtBr     100ml 0.5M EDTA (pH 8.0) 
Sterile water     57.1ml Glacial Acetic Acid 
      Make up to 1L and autoclave  
 
DNA Extraction from ear clippings 
1. Make (fresh) 10:1 mixture of lysis buffer to ProK (@concentration of 1mg/ml-fresh) 
2. Add 20 μl of this mixture to a 1.5 ml sterile eppendorf tube. 
3. Obtain ear clipping from animal, add to tube and vortex (ensure ear clipping is immersed in solution). 
4. Incubate in a 55 °C water bath (no higher than 60 °C) for 30min, vortexing every 15 minutes. 
5. Add 180 μl sterile distilled water. 
6. Place in boiling water for 5 minutes (use hot plate) and then vortex. 
7. Store at -20°C, or use immediately for PCR 
 
PCR method 
1. Make mastermix for each of the primers you will be using.   
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Mastermix contains:  25 μl of Supermix sample per sample 
1 μl of WT Reverse Primer per sample 
2 μl of WT Forward per sample 
2 μl of KO Reverse per sample 
Enough sterile distilled water for a volume per sample of 48 μl. 
 
2. For each sample use 48 μl of mastermix and 2 μl of template DNA extracted from procedure described 
above.  Add 1 drop of mineral oil to each PCR tube to prevent evaporation of sample during cycling. 
 
3. Cycling times: Initial Denaturation  94°C  3min 
    
35 cycles:  Denaturation 94°C  30sec 
Annealing 60°C  1min 
Extension 72°C  1min     
    
Final Extension   72°C  2min 
   Hold    10°C     
 
Electrophoresis of PCR products 
 
1. Loading buffer is already included in Supermix. 
2. Preparation of a 1.2% agarose gel.  For large gel system: 3.6g Agarose, 6 ml 50X TAE and volume up 
to 300 ml with sterile H2O.  Mix solution and note weight followed by boiling in microwave.  Remove 
periodically to mix during boiling procedure in microwave.  Upon complete dissolving of agarose and a 
homogenous and relatively clear agarose solution, weigh solution and replace lost amount of evaporated 
H2O. Add 25μl of EtBr (10mg/ml), slightly cool solution at room temperature (5-10min), then pour into 
caster. For small gel system: 1.92g Agarose, 3.2 ml 50X TAE, and 156.8ml st H2O; follow same procedure 
as noted above.  Only add 8 μl of EtBr (10mg/ml). 
Electrophoresis Running Buffer: 1X TAE: 40 ml of 50X TAE made up to 2L with H2O.    
3. Electrophorese 40 μl of PCR product reaction on either a small or large 1.2% agarose gel for 1hr @ 
approximately 120V. 
4. Visualize PCR products using UV lightbox. Parkin KO PCR product should be about 500bp whereas 
WT PCR product will be about 250bp. 
 
 
Figure 4. Typical agarose gel displaying PCR products and animal genotypes. 
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APPENDIX D: 
OTHER CONTRIBUTIONS 
During my doctoral studies, I made the following contributions to literature that are not included 
in my dissertation: 
 
Refereed Publications 
 
3. Hood, D.A., Tryon, L., Carter, H.N., Yuho, K., Chen, C.CW. Unraveling the mechanisms 
regulating muscle mitochondrial biogenesis. Biochemical Journal, 473(15): 2295 – 2314, 2016. 
 
2. Carter, H.N., Chen, C.C.W. & Hood, D.A. Mitochondria, muscle health, and exercise with 
advancing age. Physiology, 30(3): 208 – 223, 2015. 
 
1. Hood, D.A., Tryon, L., Vainshtein, A., Memme, J., Chen, C., Pauly, M., Crilly, M., Carter, H. 
Exercise and the Regulation of Mitochondrial Turnover. Progress in Molecular Biology and 
Translational Science, 135: 99 – 127, 2015. 
 
 
Published Abstracts 
 
5. Chen, C.C.W. & Hood, D.A. Parkin-Mediated Mitophagy in Skeletal Muscle with Endurance 
Training. Experimental Biology (EB) 2017 Meeting, Chicago, Illinois. The FASEB Journal. 31 
(Suppl 1): 839.18, 2017.     (poster)    
 
4. Chen, C.C.W. & Hood, D.A. Parkin-Mediated Mitophagy in Skeletal Muscle with Aging and 
Exercise. Experimental Biology (EB) 2016 Meeting, San Diego, California. The FASEB Journal. 
30 (Suppl 1): 764.3, 2016.     (oral and poster)    
 
3. Chen, C.C.W. & Hood, D.A. The role of Parkin during acute exercise-induced mitophagy. 
Proceedings of the Canadian Society for Exercise Physiology (CSEP) Annual General Meeting − 
Where Science is the New Steel, Hamilton, Ontario. Appl. Physiol. Nutr. Metab. 40 (Suppl 1): 
S11-S12, 2015.     (oral)   
 
2. Chen, C.C.W. & Hood, D.A. Parkin and its Role in Skeletal Muscle Function. Experimental 
Biology (EB) 2015 Meeting, Boston, Massachusetts. The FASEB Journal. 29 (Suppl 1): 821.3, 
2015.     (poster) 
 
1. Chen, C.C.W. & Hood, D.A. PINK1 import in skeletal muscle mitochondria. Proceedings of 
the Canadian Society for Exercise Physiology (CSEP) Annual General Meeting − Science on the 
Edge of the Continent, St. John's, Newfoundland. Appl. Physiol. Nutr. Metab. 39 (Suppl 1): S9, 
2014.     (poster finalist) 
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Conference Proceedings 
 
6. Chen, C.C.W. & Hood, D.A. Mitochondrial degradation in skeletal muscle with aging and 
exercise. Multi-disciplinary Perspectives in Aging Research Symposium, York University, 
Ontario, 2016.     (oral) 
 
5. Joanisse, D.R., Huth, C., Chen, C.C.W., Hood, D.A. Skeletal muscle mitochondrial quality 
control and mitophagy in obese and endurance trained men. 21st Annual Congress of the European 
College of Sport Science, Vienna, Austria, 2016. 
 
4. Samoilov, L., Chen, C.C.W. and Hood, D.A. The effects of Parkin on mitophagy flux. NSERC 
Undergraduate Student Research Award Day, York University, Ontario, 2015.  
 
3. Huth, C., Chen, C.C.W., Hood, D.A. & Joanisse, D.R. La mitophagie est suractivée dans le 
muscle squelettique d’hommes obèses (mitophagy is hyperactive in skeletal muscle of obese 
individuals). The Quebec Association of Physical Activity Sciences Symposium, Laval 
University, Quebec, 2015. 
 
2. Chen, C.C.W., Huth, C., Joanisse, D.R. & Hood, D.A. Skeletal muscle autophagy proteins in 
endurance trained, obese and obese diabetic individuals. Obesity Symposium, York University, 
Ontario, 2014.     (poster) 
 
1. Hood, D.A., Vainshtein, A., Carter, H.N., Chen, C.C.W. & Tryon, L. Molecular mechanisms 
of mitochondrial biogenesis during chronic muscle use and disuse. Proceedings of the Symposium 
on Integrative Physiology, Busan, South Korea, 2014.      
